On Public Health Insurance

Original Language Title: o veřejném zdravotním pojištění

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now

Read the untranslated law here: https://portal.gov.cz/app/zakony/download?idBiblio=45178&nr=48~2F1997~20Sb.&ft=txt

48/1997 Coll.



LAW



of 7 November. March 1997



on public health insurance and amending and supplementing certain

related laws



Change: 242/1997.



Modified: 2/1998 Coll.



Change: 127/1998 Coll.



Change: 225/1999 Coll.



Change: 363/1999 Coll.



Modified: 18/2000 Sb.



Change: 459/2000 Sb.



Change: 132/2000 Coll., 155/2000 Coll., 220/2000 Coll. 258/2000 Coll.



Change: 176/2002 Coll. (part)



Change: 176/2002 Sb.



Change: 285/2002 Sb.



Change: 198/2002 Coll., 320/2002 Coll.



Change: 274/2003 Coll.



Change: 424/2003 Coll. (part)



Change: 222/2003 Coll., 424/2003 Coll., 425/2003 Coll., 455/2003 Coll.



Change: 176/2002 Coll. (part), 85/2004 Sb.



Change: 359/2004 Sb.



Change: 438/2004 Sb.



Change: 422/2004 Sb.



Change: 436/2004 Sb.



Change: 123/2005 Sb.



Change: 168/2005 Sb.



Change: 253/2005 Sb.



Change: 361/2005 Coll.



Change: 350/2005 Sb.



Change: 47/2006 Sb.



Change: 117/2006 Sb.



Change: 245/2006 Sb.



Change: 340/2006 Sb.



Change: 214/2006 Sb.



Change: 165/2006 Sb.



Change: 362/2003 Coll., 109/2006 Coll., 112/2006 Coll. 264/2006 Sb.



Change: 181/2007 Sb.



Change: 57/2007 Coll. 261/2007 Coll. 296/2007 Sb.



Change: 137/2008 Sb.



Change: 270/2008 Sb.



Change: 189/2006 Coll., 129/2008 Coll., 274/2008 Sb.



Change: 59/2009 Sb.



Change: 306/2008 Coll., 362/2009 Sb.



Change: 227/2009 Sb.



Change: 281/2009 Sb.



Change: 298/2007 Sb.



Change: 298/2007 Coll. (part), 365/2011 Sb.



Change: 1/2012 Sb.



Change: 369/2011 Coll., 458/2011 Sb.



Change: 275/2009 Sb.



Change: 401/2012 Coll. 401/Sb.



Change: 44/Sb.



Change: 238/Sb.



Change: 238/2013 Coll. (part)



Change: 60/2014 Sb.



Change: 109/2014 Sb.



Change: 458/2007 Coll., 60/2014 Coll. (part), 250/2014 Coll. 256/2014 Sb.

267/2014 Sb.



Change: 1/2015 Sb.



Change: 200/2015 Sb.



Parliament has passed the following Act of the United States:



PART THE FIRST



BASIC PROVISIONS



§ 1



(1) this Act incorporates the relevant provisions of the European Union ^ 1b),

at the same time follows the directly applicable European Union regulations ^ 51) and

modifies the



and) public health insurance (hereinafter referred to as "medical insurance"),



(b)) the extent and conditions under which are based on this Act of

health insurance covered medical services (the "paid for by

services "),



(c)) the way pricing and reimbursement of medicinal products and food for

Special medical purposes covered by health insurance.



(2) this law shall apply, unless otherwise provided in the applicable rules directly

The European Union governing the coordination of social security systems

(hereinafter referred to as "coordination regulation") otherwise ^ 49).



Participation in the health insurance



§ 2



Personal health insurance range



(1) pursuant to this Act are insured:



and) persons having permanent residence in the territory of the Czech Republic,



(b)) persons on the territory of the Czech Republic do not have permanent residence, if the

they are employees of an employer, having its registered office in the territory of the United

Republic,



(b)) persons on the territory of the Czech Republic do not have permanent residence, if the

are employees of the employer, which has its registered office or permanent residence on the

the territory of the Czech Republic,



(hereinafter referred to as the "insured persons").



(2) for the purposes of the employer health insurance means a legal

or a natural person who is the payer of income from employment and

emoluments under special legislation ^ 1a), employs

employees and has its registered office or permanent residence on the territory of the Czech Republic,

as well as the organisational unit of the State. ^ 1 c)



(3) for the purposes of employment, health insurance means the activity

employees [section 5 (a))], from which it flows from the employer income

from employment and functional benefits taxed under a special

^ law 1a).



(4) for the purposes of employer Based health insurance means for

the seat of the legal person, as well as the seat of its organisational units,

which is registered in the commercial register or in another law

the specified index or is conducted within the established registration with the competent

authority in the Czech Republic, and in the case of a natural person instead of a permanent

of stay, where appropriate, in the case of a foreign physical person, the place of

business.



(5) the health insurance Of persons who are excluded in the Czech

States carry out illegal work under section 5 (b). e) point 3 of the law on

employment, and persons who do not reside in the territory of the United

States and actions are in the Czech Republic for employers who

enjoy diplomatic advantages and immunities, or for employers who

do not have a registered office in the territory of the United Kingdom, and people over the long term

staying in a foreign country and do not pay the premiums (section 8, paragraph 4).



§ 3



Commencement and termination of health insurance



(1) the health insurance begins on the day:



and) of birth, if it is a person with permanent residence in the territory of the Czech Republic,



b) where the person without permanent residence in the territory of the Czech Republic has become a

an employee of the [section 5 (a))],



(c)) to obtain permanent residence in the territory of the Czech Republic.



(2) health insurance expires on the date:



the death of the insured person) or his declaration of death,



(b)) when the person without permanent residence in the territory of the United States has ceased to be

an employee of the [section 5 (a))],



(c)) their permanent residence in the territory of the Czech Republic.



PART TWO



INSURANCE



Premiums health insurance payers



§ 4



the title of the paid



Payers of health insurance premiums (hereinafter referred to as the "payer insurance")

they are:



and insured persons referred to in §) 5,



(b)), employers,



c) State.



Categories of insured persons



§ 5



The insured person pays insurance premiums where the



and is an employee); an employee for the purposes of health insurance

a natural person shall be considered, that arise or should flow income from

employment under special legislation ^ 1a), with the exception of



1. a person who only has income from dependent activities which are not

subject to tax or exempt,



2. the pupil or student who only has income from employment for

the work of practical training,



3. persons employed on the basis of the agreement on the implementation of work, or more

agreements for work for one employer, if the sum of income from

such agreements in a calendar month fell short of the amount of the income, which

It is a condition for the participation of such a person to sickness insurance according to the

the law governing sickness insurance (hereinafter referred to as "creditable

income "); per zúčtovaný income by the employer until the end of

the agreement on the implementation of the work shall be considered as income to zúčtovaný

the calendar month in which this agreement has ended,



4. a member of a cooperative that is not in the employment relationship to the cooperative, but

exercises for team work, for which he is rewarded, and that in the

calendar month has not reached the prescribed reckonable income



5. persons employed on the basis of contracts for work, or more

agreements for work for one employer, if the sum of income from

such agreements in a calendar month has not reached the prescribed reckonable income;

per zúčtovaný income by the employer until the end of the agreement on the

working activities shall be considered as income zúčtovaný to the calendar

the month in which the agreement has ended,



6. voluntary worker nursing services, in a calendar

the month has not reached the prescribed reckonable income



7. a member of the District Election Commission at the elections to the European Parliament, the

The Senate and the Councils of territorial self-governing units and a member of the Anne Arundel

the Electoral Commission and special district election Commission at the elections to the

The Chamber of Deputies and in the choice of the President,



(b)) is a self-employed person. For self-employed persons

persons shall be deemed, for the purposes of health insurance:



1. the persons doing business in agriculture; ^ 1 d)



2. persons engaged in Business; ^ 2)



3. the persons carrying on business in accordance with special legislation; ^ 3)



4. persons engaged in artistic or other creative activities based on

Copyright relations, ^ 4) with the exception of the activity from which the revenues are

under special legislation with a separate basis for income tax

natural persons for the taxation of the special tax rate ^ 4a);



5. shareholders public companies and partners

limited liability partnerships; ^ 5)



6. persons performing an independent profession, that is not a trade or

business under the specific legislation. ^ 6)



7. persons performing activities on the basis of a mandate agreement by the agent

concluded under the commercial code, ^ 6a) If this activity is not

considered the employment referred to in subparagraph (a)), and the contract has not been

concluded in the framework of other self-employment,



8. cooperating persons self-employed persons, pursuant to the

the law on income tax, you can distribute the income accruing to them performance

cooperation and the expenditure incurred in their reach, ensuring and maintaining,



(c)) has a permanent residence in the Czech Republic, but is not listed under the

previous letters and not the premium payer State for him, if

above still occur throughout the calendar month.



§ 6



The employer pays part of the premiums for their employees, with the exception

employees who are advancing according to § 8 para. 4. the employer is

the payer of the income portion of premiums from employment and functional


benefits under special legislation cleared former ^ 3)

employees after the end of employment.



§ 7



(1) the State is liable for insurance through the State budget, in

the insured person:



and dependent children); nezaopatřenost of a child are to be judged according to the law on

State social support; ^ 7)



(b)) of those receiving pensions pension insurance has been granted

pension before 1. before 1 January 1993 in accordance with the laws of the Czech and Slovak Federal

Republic and after 31 December 2006. December 1992 in accordance with the laws of the United States. For

a pensioner for the purposes of this Act, the person shall be deemed to

the previous sentence even in months when it according to the regulations on pension

insurance payout annuity does not belong;



(c) the recipient parent's allowance;) ^ 7)



d) women on maternity and parental leave and persons receiving

maternity benefit according to the regulations on sickness insurance ^ 8);



(e)) job seekers, including job seekers, who have accepted the

short-term employment; ^ 9)



f) persons receiving benefit assistance in material need and those with them together

^ 10) under consideration, provided that they are not based on the Bill-confirmation

assistance in material need benefits on work or similar relationship or

do not exercise a self-employed person are not in registration

and it's not about those receiving old-age pensions, invalidity

pension for disability of the third degree, the widow's or widower's

retirement, or those receiving parental allowance or dependent

the child,



g) persons that are dependent on the care of another person in stage II (medium

heavy dependency) or level III (severe dependence) or stage IV

(total dependence) ^ 11), and persons taking care of these people, and those working

persons under the age of 10 years, which are dependent on the care of another person in the degree of

I (light addiction)



h) occupants of service in the armed forces, with the exception of

occupations, and persons called to military exercises,



(I) persons in the performance of security) detention or custody or the person in

imprisonment;



(j)) a person referred to in section 5 (b). (c)), that are beneficiaries of sickness

insurance; ^ 14)



k) persons who are disabled in the third degree, or who have reached the age of

required for entitlement to a retirement pension, but do not comply with other conditions

for the award of disability pension for disability of the third degree, or

old-age pension and have income from employment, from a separate

gainful employment and who do not enjoy no pension from abroad, or this

the pension does not exceed the amount equal to the monthly minimum wage; ^ 15)



l) people all day personally and properly looking after at least one child to

seven years of age, or at least two children under 15 years of age, unless the person

referred to in point (c)), or (d)). The condition is considered to be full-day care

to be fulfilled, even if it is a child of preschool age placed in the Manger

(nursery school), or a similar device at the time that

does not exceed four hours per day, and in the case of a child performing compulsory school

attendance, for visits to schools, with the exception of the location on the device with the

weekly or year-round residents. For such a person is considered to be only

one person, either the father or mother of the child, or the person who

took over the child to the permanent care replacing parental care, ^ 16) if they do not have

income from employment or from self-employment,



m) juvenile placed in school facilities for institutional upbringing

and protective care,



n) persons carrying out a long-term volunteer service on the basis of

the contract with the broadcasting organization which has been granted accreditation

The Ministry of the Interior, which go beyond the average of at least 20

hours per calendar week, if there is a volunteer insurance payer

under section 5, or it is not the premium payer State under the previous

letters and) to m)



o) spouses or registered partners of State employees under the Act

the civil service or other employees in the organizational components of the State,

If you follow to their place of posting to work abroad

or for the performance of foreign service with the consent of the organizational folder

State, and are not employees or self-employed persons

According to § 5 or are persons carrying out similar activities under

the law of the foreign State to which their spouses or registered

partners sent to work abroad or to the performance of foreign

services,



p) foreigners who have been granted permission to stay in the territory of the United

States to provide temporary protection by a special

^ law 16a) if they do not have income from employment or from

self-employment,



q) applicants for international protection and the child born on

the territory of the alien who has been granted a visa to stay over 90 days for the purpose of

leave to stay, and the child born on the territory of ^ 16b), if they don't have receipts

from the employment or from self-employment,



r) recipients of old-age pension for specified period of time, a lifetime pension or pensions

the specific time period with a fixed amount of income exactly according to the law

governing supplementary pension savings to reach the age required for

entitlement to old-age pension pursuant to section 32 of the Act on pension

insurance, provided that the conditions laid down in § 22 para. 4 or §

23 para. 6 Act No 427/2007 Coll. on supplementary pension savings; When

the determination of this age for women shall be treated as men of the same

the date of birth.



(2) the Government insured are persons referred to in paragraph 1 (b). a) to i)

and r) even if they have income from employment or from a separate

gainful employment.



§ 8



The obligation to pay the insurance



(1) the health insurance premium shall be paid, for which the insured person is

insured, (hereinafter referred to as "the relevant health insurance"). The obligation to pay

insurance the insured person arises on the day:



and employee to employment) (§ 2 (3));



b) self-employment [section 5 (b))];



(c)) when he became insured under section 5 (b). (c));



(d)) to which it will return to the United States after the insured person has logged in

in accordance with paragraph 4 for the health insurance companies;



(e)) return to the United States after continuous residence in a foreign country, that

started before 1. in January 1993, if the day falls on a return period

After 30. April 1995; above, the insured person is obliged to the competent

health insurance company to prove;



(f)) return to the United States after continuous residence in a foreign country, that

commenced between the 1. before 1 January 1993 and 1. July 1993, if the day of return

falls on the period after 30 June. April 1995, if the insured person



1. overseas of affiliation,



2. during this period paid for by the service has been provided to him,



3. has applied retroactively relevant health insurer about the procedure under

of paragraph 4.



This does not affect the obligation to pay the premiums for the period preceding stay

in a foreign country.



(2) the obligation of the employer to pay part of the premiums for their employees

created the day of onset of an employee to a job (§ 2 (3)) and

the date of employment, with the exceptions set out in section 6. Per day boarding

employee to employment is considered to be



a) for employment including employment contracted by foreign

the legislation of the day on which the employee joined the work, and

the day of termination of employment shall be the date of termination of employment,



(b)) in the service of the day on which the employee joined the performance

the service, if it is a State employee, and the date of commencement of the service per day

termination of employment shall be the date of termination of service,



(c)) for team members in cooperatives, where the condition of membership is their

the working relationship with the team, if outside the employment relationship

exercising for team work, for which they are rewarded by day

the start of work for the team, and their employment is considered to be

the day of the termination of membership in the cooperative,



d) for employees working on the basis of contracts for work day

which for the first time after the conclusion of the work the employee started

to carry out the agreed work and termination of employment shall be deemed to

day, by which time has elapsed, at which the agreement was negotiated, in

employees operating on the basis of the agreement on the implementation of the work is progressing

Similarly,



(e)) at the date of commencement of the judge judges into the function, and the date of the end of employment

shall be the date the end of the performance of the duties of a judge,



(f)) for members of the Councils of territorial self-governing units and councils

boroughs or municipalities disaggregated territorial statutory

the towns and the city of Prague, who are for the long term

released or who before electing a member of the Municipal Council were not

in employment, but acting in the same range as

the long-term release of members of the Municipal Council of the date from which member belongs to

the reward for the performance of the paid members of the Councils of local

local authorities and councils of districts or city

circuit broken down territorial statutory towns and the city of Prague, who

are for the long term performance of relaxation or who before election to the

Member of the Municipal Council were in employment, but they perform


function in the same range as the long-term release of members

the Municipal Council, and in the day of termination of employment shall be the date on which the

This reward does not belong. Where the former mayor or mayor of tasks after

the expiry of the term until the date of the constituent meeting of the newly

the elected Municipal Council and he receives remuneration referred to in the sentence

First, it is considered an employee for a period of time that it

This remuneration; This applies to the County Governor and the Mayor of the

the city of Prague,



g) for members of the Chamber of Deputies and Senators of the Senate of the Czech

the Republic and the members of the European Parliament elected in the territory of the United

the Republic day of the election, and for the day of termination of employment shall be the date

the expiry of the term, where applicable, date of termination of the mandate,



h) for members of the Government, the President, Vice-President and members of the Supreme

Audit Office, members of the Council for radio and television broadcasting,

the members of the Council of the Czech Telecommunications Office, the financial arbiter,

the representative of the financial arbiter, Ombudsman and a representative of the

The Ombudsman function, the date of commencement and the date of the end

employment is considered to be the day of the end of the performance,



I) for individuals not referred to in points (e) to (h)))

were appointed or elected to functions and their appointment did not arise

work or service, the date of taking up their duties, and the date of the end

employment is considered to be the day of the end of the performance,



j) for voluntary workers day care service, in which he began to

voluntary worker to provide care, and the date of the end

employment is considered to be the day ceased to be a willing worker

care services,



to a person) takes care of the child and the person who is registered in the register of persons

that can perform foster care on a temporary basis, if these

persons paid the foster parent allowance under the Act on social and legal protection

children ^ 16 c), the date from which this reward belongs to, and the date of the end

employment shall be the date from which that remuneration is not part of the other

than temporary incapacity,



l) for inmates in the performance of the protective measures and security detention

a sentence included in the classification of the work day to work, and for

the day of termination of employment shall be the date of the appeal of the work,



m) for persons in employment, the employment relationship that has the content, but

the employment relationship did not arise, since the conditions laid down have not been met

labour law for its origin, for starting the work, and

for the day of termination of employment shall be the date of termination of the work,



n) for employees other than those listed in subparagraphs) to n) day, when he began

the employee to perform the work, on the basis of the revenue shall come from him

dependent work and emoluments, and the date of the end of employment

shall be the date of termination of the work.



(3) the obligation of the State pay a premium for insured person begins on the day when the

State pursuant to § 7 becomes liable for insurance premiums. This obligation shall cease on the date on

which the State ceased to be under section 7 of the premium payer.



(4) an insured person is not required to pay a premium for, which is a long-

in a foreign country, if it is in a foreign country of affiliation and made about this

the fact of the appropriate health insurance a written declaration.

The obligation to pay the premiums, however, shall cease on the date on which an insured person in

the statement said, according to the first sentence, but not earlier than on the day following

the date on which this statement was delivered to the respective health

the insurance company. From the same date to the date when the insured person for the

health insurance companies once again signed up, does not have an insured person entitled to

the provision of paid services. At the same time with then logging back on for

the health insurance policy holder is obliged to this insurance company

Additionally to provide proof of health insurance abroad, closed and

its length. If the insured person does not submit the relevant health insurance company

proof of health insurance abroad, closed, and its length is

required to retroactively premiums as if to avoid;

the penalty payment, in this case to enforce. If the insured person shall submit to the

proof of the closed health insurance abroad, which does not cover the entire

the time when he was not required to pay in the Czech Republic by the phrase

First, it is required to retroactively premiums for each calendar month,

in which health insurance abroad did not take all such

calendar month; the penalty payment, in this case to enforce. For more

the statement in the first sentence can be lodged after the first health insurance company

2 full calendar months following the date of re-

login. For a long-term stay abroad is considered to be a continuous stay

longer period of six months.



(5) if the payer to pay the insurance premiums in the specified amount and on time

It is competent health insurance company required to enforce on the debtor's

payment including penalties.



(6) the periodic penalty payment to enforce during the long stay of the insured person in a foreign country, before the

which has not made a written declaration in accordance with paragraph 4, paying insurance premiums

and for the entire stay abroad paid for by the nečerpal service. In such a

If the policy holder is obliged to submit proof of the closed medical

insurance in foreign countries and its length, which covers all the time fixed

the stay in a foreign country. Time for a long-term stay abroad, in this case

starting on the date referred to as insurance in the proof of origin

the closure of health insurance abroad.



§ 9



The amount and method of payment of premiums and penalties



(1) the amount of the premiums, penalties and the method of payment provides for specific

^ 17) Act.



(2) insurance premiums paid by the employees of one third of the staff of the two

thirds of the employer.



PART THREE



THE RIGHTS AND OBLIGATIONS OF INSURANCE PAYERS



§ 10



Notification obligation of insurance payers



(1) the employer shall, not later than eight days from the occurrence

the fact that announces the health to do so for

insurance companies notice of:



and employee to employment) (§ 2 (3)) and its termination;

in the case of insured persons according to § 2 (2). 1 (b). (b)), to announce whether or not this

the fact



(b)) change in employee health insurance, if this fact

said; notification shall be made from the payment of premiums by opting out at the original

health insurance companies and logging on to the premium payments for health

insurance companies, which the employee has chosen,



(c) the facts decisive for the obligation) of the State to pay for employee

insurance, even in those cases where the obligation of the State was at the time,

When an employee has provided the time off work without compensation income, if

These facts are known.



About the reported facts, the employer is obliged to keep a register and

the documentation. In the performance of the notification obligation mijnbouwregeling employer

name, surname, residence and social security number of the employee or other

the number of the insured person.



(2) the employee is required to notify the competent health insurance company

the fact under the preceding paragraph shall, without delay, if it finds that its

the employer has not complied with this obligation, or if the information referred to under

(b)), and (c)) your employer has not communicated.



(3) an insured person who is self-employed, is obliged to

notify the competent health insurance company separate start and end

employment no later than eight days from the date of this activity

began or ended. The insured person, doing business on the basis of the trade

permissions, fulfills this obligation even if the make a notification to the competent

the Trade Office ^ 17b).



(4) the insured shall, within eight days from the date when the insured person became

pursuant to section 5 (b). (c)), notify the competent sickness

the insurance company.



(5) the insured person is obliged to notify the competent health insurance company

at the latest within eight days, the operative events for the creation or termination of

the obligations of the State to pay the premium for it under section 7. For persons employed

they have this obligation to the employer, if he is the fact

known. For a person with limited legal capacity shall fulfil this obligation the

guardian, custodian or guardian.



(6) the Birth of the insured person is his legal guardian, legal guardian or

the trustee shall be obliged to report within eight days from the date of birth health

the insurance company, which is insured by the child's mother on the day of his birth;

If it is not the child's mother are medically insured under this Act, it shall notify

guardian, guardian or guardian of the child's birth

health insurance, for which the insured is the child's father on the day of its

the birth of. The competent municipal authority entrusted with the direction of the Registrar shall notify the

the birth of the insured person to a central register of insured persons ^ 18) immediately

After the social security number allocations.



(7) the Death of the insured person or his or her declaration of death is required to notify

A central register of insured persons ^ 18) within eight days of the entry into the register

the competent municipal authority entrusted with the direction of the Registrar.



section 10a



Business offices



(1) the trade authorities that have adopted a notice under section 10, paragraph 1. 3 sentences

Second, shall transmit this information in due time ^ 18a) health insurance,

which the insured person has stated in its notification (hereinafter "the appropriate

insurance company ").




(2) Business offices shall be communicated not later than 5 working days, the competent

the insurance company first, or the demise of the last permission to operate

and suspension of trades, with an indication of the date on which

These facts have occurred.



(3) the authorities shall, at the request of business health insurance company a copy of the

the documents, which the insured person is joined to its notification referred to in paragraph 1.



(4) the business offices and health insurance companies in the limits of their

the scope of each other shall transmit the data required for the implementation of the public

health insurance of self-employed persons, which

operating on the basis of trade licence.



PART FOUR



THE RIGHTS AND OBLIGATIONS OF THE INSURED



§ 11



(1) an insured person has the right to



and) the selection of health insurance company, unless otherwise provided by this Act,



(b)) on the selection of providers of health services in the territory of the Czech Republic

(hereinafter referred to as "provider"), which is under contract to the competent

health insurance company, and in the selection of medical equipment of this

the provider; in the case of a registered provider can this right

apply once per 3 months,



(c)) on time, and the local availability of paid services provided

by the appropriate health insurance providers,



(d)) to provide covered services to the extent and under the conditions laid down

This Act, while the provider shall not for such paid services

accept no remuneration from the insured person,



e) on medicines and foods for special medical purposes without

direct remuneration, in the case of medicines and foods for special

medical purposes paid from health insurance and prescribed in accordance

with this Act; This is true even in cases where the provider of Pharmacy

care insurance of the insured person does not yet have a contract,



(f)) to provide health care paid to the extent and under the conditions

laid down in this Act related with diseases with very low

incidence in the population in the sense of directly applicable legislation

The European Union ^ 19a) (hereinafter referred to as "orphan"), including

orphan medicinal products covered under this Act,



(g) to obtain information from) health insurance companies about him provided by the

paid services



h) contribute to the scrutiny provided by the health care paid for by the health

insurance,



I) on the issue of the payment of the regulatory charge under section 16a,



(j)) on the issue of the payment of the balance due for release in part

paid by the medicinal product or foods for special medical purposes

Pharmacy,



to the payment of amounts exceeding) the limit for payments for prescribed

partly paid for by medicines or foods for special medical

purposes under section 16b health insurance within the time limit under section 16b, para. 2,



l) the costs, incurred to emergency care

pumped abroad, and only up to the amount provided for the reimbursement of such care,

If it has been granted on the territory of the Czech Republic,



m) the costs, incurred to the health services, pumped in

another Member State of the European Union, with regard to health services, which

It would have been when the provision on the territory of the Czech Republic covered by health

insurance (hereinafter referred to as "paid for by cross-border services"), and only in the amount of

laid down for the payment of such services should have been provided in the territory of

The United States,



n) to information about options to draw health services in other

the Member States of the European Union.



(2) If an insured person for that, he paid for the services are not provided in the

accordance with this Act, may file a complaint under the Act on health

services.



(3) Soldiers in active service with the exception of soldiers, reservists called up to

military exercises and military schools, students who are preparing to

the service of a soldier by profession and there are soldiers in active service, they are insured

for Military health insurance. The soldiers and the students of military schools are

Military health insurance policyholders to the last day of the calendar

the month in which a study on the military school. From the first day

the next calendar month are insured with health

insurance companies, which were insured prior to going into the military

health insurance companies. For this purpose, is a military health insurance

required to communicate once a month the central insurance company General

health insurance company ^ 18) name, surname, permanent residence and social security numbers

insured persons who have started or completed studies at the military school. For

change of health insurance by the insured person under the preceding paragraph to the

the time limit of 12 months shall not be counted in the Military health insurance

the insurance company. For soldiers in active service, ^ 22a) with the exception of soldiers in ambush

called up for military exercises, and for students of military schools, ^ 22b) who

preparing for the service of a soldier by profession and there are soldiers in Active

the service will pay the Ministry of defence through military health

insurance companies



and the difference between the amount of the remuneration) covered services provided by your

laid down by special legislation governing the service of the

troops from the occupation, which are partly covered by public health

insurance pursuant to this Act, and the amount of remuneration provided by the Military

health insurance company; This does not apply for reimbursement of dental products



b) preventive care provided beyond the covered services according to § 29 in

the scope of the Decree of the Ministry of Defense.



(4) in the case of a merger by acquisition, the military health insurance with another

health insurance company under special legislation ^ 28) at which

Military health insurance expires, rights and obligations

established by this Act of military health insurance company, as well as

obligations laid down in the Ministry of defence and others to the military

health insurance company, to the acquiring health insurance. The information about the

the merger of merger of Military health insurance with another health

the insurance company, in which the Military health insurance lapse, publish

The Ministry of health in a way allowing remote access.



(5) in the case of persons to whom services are provided in the area of employment ^ 22 c)

and for the people, which is to be carried out to determine the examination by a doctor,

whether it can be placed in a police cell or should be released from it, and

people in the performance of the security of the detention or custody or imprisonment

imprisonment is the selection of the provider of medical equipment and

medical transport services limited under the specific legislation.



§ 11a



(1) a health insurance company can be changed once every 12 months, and it always just

to 1. day of the calendar half-year. An application form bearing the signature of the

the insured person, his legal representative, a guardian or trustee shall be obliged to

submit the selected health insurance company in the course of the calendar half-year

immediately preceding that in which the change of health

insurance company occur not later than 3 months before the requested date changes.

Application to change the health insurance companies can submit only one in

calendar year; any other applications will no longer be disregarded,

even then, if they are submitted within the prescribed time limit.



(2) an insured person is entitled to change the health insurance company i within the time limit

shorter than that referred to in paragraph 1, if the



and health insurance), for which it is insured, gone into liquidation



(b)) was over health insurance that is insured, introduced compulsory

Administration, or



(c)) saw the merging of health insurance companies, which also applies to health

insurance company that is insured, always on the first day 3 calendar

months following the month in which occurred the events listed

in points (a) to (c)).)



(3) the health insurance fund carried out a person with limited legal capacity

their legal guardian, custodian or guardian.



(4) when the child is born with the right to choose health insurance

does not apply. The date of birth of the child is insured health

insurance company that is insured by the child's mother on the day of his birth.

If the mother of the child who was born disabled insured under this

the law, the date of birth of the child becomes the insured person's health insurance company

that affiliation is the child's father on the day of his birth.



(5) the health insurance of the child may Change its legal representative,

guardian or trustee may be made only after the allocation of the child, the social security number

and that, on the date laid down in paragraph 1 or 2.



§ 12



The insured person is obliged to:



and) perform the notification obligation under section 10,



(b)) at date of commencement of employment for which the employer

health insurance is insured. The same obligation even if the

If the insured person other health insurance companies at the time duration

employment; This obligation will meet within eight days from the date of the changes to the health

the insurance company. Receipt of the communication referred to in the previous sentences, the employer is

the insured person must confirm in writing. The employer has the right to request

to employees or former employees of the payment of the penalty paid by the

connection with any health changes or late notification

insurance by the insured person,




(c) pay the relevant health insurance) premiums, if this law

provides otherwise, the



(d)) to assist in the provision of health services and control of

the course of individual treatment and to comply with provider

medical regime,



e) undergo preventive examinations on request, if so determined by the

This Act or generally binding legal regulations,



(f)) to comply with measures to prevent diseases



g) avoid negotiations whose objective is the conscious damage to your

health,



h) demonstrate the provision of health services, with the exception of

the provision of medicinal products, foods for special medical purposes and

medical devices, a valid proof of the policy holder or replacement

a document issued by the relevant health insurance,



I) report within eight days of the loss or the competent health insurance company

damage to the insured person's card,



(j)) return within eight days of the relevant health insurance company insurance card

When



1. the demise of health insurance pursuant to § 3 (2). 2 (a). (b)), and (c));



2. change the health insurance companies;



3. a long-term stay abroad according to § 8 para. 4,



to the competent health insurance company) to notify changes of name, surname,

permanent residence, or social security number, and within 30 days of the date when the

change occurred; If the insured person in the place of permanent residence, it is

obliged to notify the competent health insurance company also the address of the place of stay

on the territory of the Czech Republic, where it mostly resides (hereinafter referred to as

"residence"),



l) when you change health insurance companies to submit the newly selected health

insurance proof of the amount of the advances on the premiums calculated based

the base, in the case of a self-employed person,



m) pay regulatory fees to the provider pursuant to section 16a.



PART FIVE



CONDITIONS FOR THE PROVISION OF PAID SERVICES



Health care currently paid from health insurance



section 13 of the



Paid services



(1) the health insurance covers medical services provided

insured persons in order to improve or maintain his health or

to relieve his suffering, if



and the insured's State of health) and the purpose of which is to be their

the provision has been reached, and for insured persons are reasonably safe,



(b)) are in accordance with the current available knowledge of medical science,



(c)) there is evidence of their effectiveness in view of the purpose of their

the provision.



(2) the Paid services are within the scope and under the conditions laid down in this

by law



and preventive health care,), dispensary, diagnostic, therapeutic,

the pharmacy, klinickofarmaceutická, sanatorium rehabilitation, Spa

hospital rehabilitation, assessment, nursing, palliative and

the health care of donor blood, tissues and cells, or organs related to the

their collection, and in all forms of the provision under the law on

health services,



(b)) the provision of medicinal products, foods for special medical

purposes, medical devices and dental products



(c) the transport of the insured and refund) travel costs



(d)) and the collection of blood samples of tissues, cells and organs intended for transplantation and

the necessary handling (storage, storage, processing and

examination),



(e) the transport of living donor to) place of collection and from this place to the place of

the provision of health care associated with the collection and from this place and

reimbursement of travel costs,



f) transport a deceased donor to the sampling point and from this place,



g) carriage of removed tissues, cells and organs,



(h) the deceased insured person and tour) autopsy, including transport,



and the insured's Wizard) in the clinic bed care,



j) health care related to pregnancy and childbirth child whose

the mother asked for confidentiality in connection with childbirth; This care

are paid by the health insurance company, which is based on the identification of the data

the insured person shall ask the appropriate provider for reimbursement.



§ 14



(1) the health insurance covers medical services provided on

the territory of the Czech Republic.



(2) from health insurance to insured persons on the basis of its application

will provide a reimbursement of costs incurred for emergency care,

the need arose during his stay abroad, and only up to the amount

laid down for the payment of such services should have been provided in the territory of

Of the Czech Republic.



(3) the health insurance Of the insured person on the basis of its application

will provide a refund of the cost of cross-border services, and paid for by

It's only up to the limits laid down for the payment of such paid services, if

would have been granted on the territory of the Czech Republic. If the refund is

the cost of cross-border services subject to the granting of paid by the previous

consent under section 14b, to pay costs only if the

If prior consent has been granted.



(4) in the case when the provision covered by the cross-border services a necessary

care paid for by the coordination regulation and the costs associated with its

drawing on the coordination regulation are covered only partly,

It shall apply to compensation for the costs incurred by the insured person and company

According to the coordination regulation, the first sentence of paragraph 3. In this case,

the insured shall provide the refund of the costs incurred by it in the amount of

calculated as the difference between the total amount of the remuneration of such health

the service, which would provide in the territory of the Czech Republic was covered

from health insurance, and the total amount of the amount for such

health service paid for by the coordinating regulation. If the calculated

amount is greater than the amount which the insured person has made, he shall provide the

refund only the amount spent.



(5) If this Act or decision of the State Institute for the control of

of medicinal products (hereinafter referred to as "the Institute") issued pursuant to the conditions

for payment of covered services, the following conditions must be met for

compensation paid to cross-border services; for such a condition is

does not consider the conclusion of a contract for the provision and payment of covered services.



§ 14a



The amount of reimbursement of costs pursuant to § 14 para. 2 to 4 shall be determined on the basis of the

This law, Decree issued pursuant to § 17 para. 4, price regulation,

measures of a general nature referred to in article 15, paragraph 2. 5 and the decision of the Institute according to

effective on the date of the copy of the accounting document on which

the basis of the refund is carried out; This applies mutatis mutandis to the reimbursement of costs,

that the insured person has incurred in connection with drawing on health services in the

another Member State of the European Union, European economic area

or the Swiss Confederation, which has been allocated an authorisation under

coordination of regulation to ensure the payment of health services

(hereinafter referred to as "the authorisation according to the coordination regulation").



section 14b



Prior consent of the



(1) the Government may by regulation define paid for by cross-border services for which

is to provide reimbursement of costs pursuant to § 14 para. 3 subject to the granting of an

prior consent. As paid for by cross-border services, which is

refund of costs subject to prior approval, may be defined

only



and the planned paid services), for which the regulation of the local government and

availability of health services stated time

availability and which at the same time require hospitalization or highly

specialized instrumentation or medical equipment, or



(b)) paid services, which include a treatment that constitutes a specific

the risk for the patient or the population.



(2) the Ministry of health shall notify the European Commission, which

covered services is subject to prior approval of the reimbursement of costs.



(3) on the granting of prior consent shall be decided by the appropriate health

the insurance company, at the request of the insured person. The request must be submitted before the

the start of pumping paid cross-border services.



(4) the health insurance fund may refuse to grant prior approval only,

If



and the insured person) would be due to their health condition during pumping

financed by the cross-border service is exposed to the risk that cannot be attributed

to be acceptable, taking into account the potential contribution of drawing these paid

cross-border services,



(b)) is a reasonable concern that the drawdown would be covered by the cross-border services

could result in substantial danger to public health,



(c)) about who is paid to provide cross-border services,

There is justified concern regarding compliance with the standards and guidelines

regarding the quality of health services provided and on the safe

the insured person, or



(d)) can be required to provide medical services to the insured person on the territory of the United

Republic within the period of time laid down by regulation of the Government of the availability

local and temporal availability of health services.



(5) the health insurance of the insured person when examining an application for the grant of

prior consent must also consider whether in the present case are not

the conditions for the issue of permits under the coordination regulation.

If these conditions are met, the health insurance fund shall issue to the insured

authorisation in accordance with the coordination regulation; This does not apply if the insured person in

the request stated that asks only about the granting of prior informed consent and its


grant requests, even after he was informed of the health insurance company

the advantages of that bringing the issue of permits under the coordination of regulation

as opposed to the granting of prior consent.



§ 14 c



(1) information concerning the drawing of health services in the Member

States of the European Union provides a national contact point, which is

the body, which was intended for a range of health insurance as a liaison

in accordance with the coordination regulation (hereinafter referred to as the "focal point").

The Department of health says the name and contact details of the contact

the place of the European Commission and published on the official Board and is in the

The Ministry of health. The name and contact information of the focal point

published on their website and the health insurance companies.



(2) point of contact provides, in particular, information about



and drawing options) of health services in the Member States of the European

of the Union,



(b)), providers



(c)) the contact details of national focal points in other

the Member States of the European Union,



(d)), the United Kingdom legislation governing standards and guidelines

on the quality and safety of delivery of health services, including

provisions on the supervision and evaluation of providers, and providers, the

that these standards and guidelines apply,



e) patients ' rights, procedures for the submission of complaints and mechanics

to rectify the situation and how to resolve disputes in the Czech Republic,



f) terms, to be under the laws of the United

States listed on the prescriptions that are displayed on the

the request of the patient who is going to use in another Member State of the European

Union.



(3) at the request of contact point provides information about



and provide a specific provider) health care services or

about any limitations of its permissions,



(b) the accessibility of specific medical devices) in the Czech Republic

for persons with disabilities,



(c) draw health services) options under the coordination of regulation,



(d) the insured person's rights) in connection with the drawing of health services in the

other Member States of the European Union, and in particular on the rules and

conditions of reimbursement of costs and procedures for their application,



(e)) the rights of the patient from another European Union Member State on the territory of the

The United States in connection with the drawing of health services, in particular on

How to appeal and the remedy, if the patient has considered that was damaged on

their rights, including in cases where the injury occurs as a result of the pumping

health services.



(4) to provide information relating to the disbursement of health services

in another Member State of the European Union contact point shall communicate which rights

result of the coordination regulation and resulting from this Act.

The information referred to in paragraph 2 of point of contact exposes on their

website. The information referred to in paragraphs 2 and 3 shall, at the request

shall provide, in a form which allows them to be with the following information in

extent necessary to ascertain and persons with disabilities.



(5) the contact point works in order to exchange the necessary information

and examples of good practice with the national contact points of the other

Member States of the European Union, European Commission, health

insurance companies and associations operating in the field of protection of patients rights

These people.



(6) providers, the authorities competent to issue permissions to provide

health services and health insurance companies are obliged to call

a place to provide information on his application, in accordance with paragraphs 2 and 3

without delay and free of charge, if you have this information available.



§ 15



(1) health insurance is, or is to be paid only in certain

conditions, medical procedures referred to in Appendix No. 1 to this Act.



(2) health insurance won't cover a further performances of acupuncture.



(3) the health insurance Of health services provided on the basis of

recommendation of a registered provider in the field of obstetrics and

obstetrics in connection with artificial insemination, if it is a form of

discontinued and fertilisation (in vitro fertilization) shall be borne by



and women with a double-sided obstruction) of the fallopian tubes in the age from 18 years to

delivery reaching thirty-ninth year of age,



(b)) other women aged between 22 years to the day of the thirty-ninth achievement

year of age,



most three times in your life, or if it was in the first two cases

transferred to the genitals of a woman no more than 1 human embryo resulting from

fertilization of the eggs of sperm outside the body of a woman four times in a lifetime.



(4) health insurance fully paid in at least

economically challenging medicinal products containing these active substances:



and serum stafylokokovým infections),



b) serum against diphtheria,



c) serum snake venom



d) serum botulism,



e) gas gangrene, serum



f) rabies serum



g) immunoglobulin against tetanus,



h) immunoglobulin hepatitis B,



I) tetanus toxoid,



j) stafylokokovým infections, vaccine



the vaccine against rabies),



l) antidotes (used in the treatment of poisoning organophosphates, heavy metals and

hydrogen cyanide).



(5) health insurance is to be covered in the provision of out-patient

health care medicines and foods for special medical

purposes, unless the Department decided on the amount to be paid (section 39 h). In each

a group of active substances referred to in annex No. 2 of the health

insurance always fully paid at least one medicinal product or foodstuff

for special medical purposes. Additionally, from health insurance shall be borne by

individually prepared medicinal products, radiopharmaceuticals, blood transfusion

preparations for advanced therapy medicinal products, and tissue and cells of

fixed the Institute measures of a general nature. From health insurance to

in the provision of fully paid bed care medicines and foods

for special medical purposes, individually prepared medicines

medicinal products, radiopharmaceuticals, blood products, medical devices,

advanced therapy medicinal products, and tissue and cells, in the implementation of

at least economically challenging, depending on the extent and severity of the

disease of the insured person and their remuneration is not taking part.



(6) health insurance is not reimbursable medicinal products and food

for special medical purposes referred to in the first sentence of paragraph 5, if the

The Institute admitted by a decision of the reimbursement. The Institute will not admit to a remuneration, in the case of

medicines and foods for special medical purposes



and supporting and complementary)



(b)) the use of inappropriate is from the professional point of view,



(c)) do not have sufficient evidence of the therapeutic efficacy,



d) fulfil the conditions effective therapeutic intervention, or



(e)) which are the similar treatment under section 39b of paragraph 1. 4 in the

the reference group, which was according to the law on medicinal products registered as

biological medicinal product or a generic medicine, and the marketing authorisation holder shall

in writing, together with the application for determination of the amount and terms of payment of the committed

deliver medicine or food for special medical purposes

the Czech market for a period of 12 months from the effective date set forth above and the terms and conditions

the remuneration,



(f)) which can be issued without a prescription with the exception of

foods for special medical purposes and such medicinal products, the

where in the course of proceedings for the determination of the amount and conditions of payment with a confession

the remuneration shall be expressed on the basis of public interest under § 17 para. 2 the consent

all health insurance companies.



(7) the Therapeutic effect is the ability to induce desirable

the effect of using the medicinal product or foods for special

medical purposes in normal clinical practice. Efficient

therapeutic intervention means the medical services provided to the

prevention or treatment of diseases in order to achieve the most effective and

the safest treatment while maintaining cost effectiveness.



(8) Cost effectiveness means the determination of the ratio between the cost and the

the benefits associated with the use of the medicinal product or food for

Special medical purposes, compared with the use of another of the medicinal

medicine, foods for special medical purposes or treatment

the procedure; cost effectiveness is evaluated in comparison with such

therapeutic procedure borne out of the health insurance funds,

that is generally accepted as usual. Cost effective are such

medical treatment at comparable costs bring the same

or a higher therapeutic effect of life extension,

improve the quality of life or to improve a substantial and measurable

the criteria of the relevant diseases, or at least comparable

therapeutic effect of mean lower total cost for the system

health insurance, or at higher costs and higher

therapeutic effect of this ratio is comparable with other therapeutic

the procedures covered by the health insurance funds. Reviews

cost effectiveness is required for medicinal products or food for

Special medical purposes that are not included in the reference group


pursuant to section 39 c of paragraph 1. 1, or for which it is proposed for prescription or

indicator limit in principle contrary to therapeutically interchangeable

medicinal products or foods for special medical purposes, or

required the determination of the next higher remuneration under section 39b of paragraph 1.

11, or for which it is required an increase in the remuneration of the medicinal product

or food for special medical purposes, as opposed to basic pay.



(9) the Institute shall decide on the



and determination, alteration and) cancellation of the level of remuneration of medicinal products and food

for special medical purposes,



(b) the making of payments) of medicines and foods for special medical

purposes referred to in subparagraph (a)) in a way, Bill preskripčními and

indicating constraints or use in providing health care to the

specialised workplaces (hereinafter referred to as the "terms of payment"),



(c) the refusal of payment) medicines and foods for special

medical purposes,



(d)), and the cancellation of the determination of the change in the maximum price under the legislation on

regulate prices announced in the journal of the Department of health (hereinafter referred to

"price regulation") ^ 23 c),



(e)) on the classification of the medicinal product, the reference group.



(f) basic pay) reference group.



(10) the medicinal product whose remuneration from health insurance is

by decision of the Constitution subject to the use of a specialized workplace,

health insurance company pays only providers with which to

the efficient use of such medicinal products has entered into a special

the contract. Part of such a contract must be a medicinal product and

workplace medical equipment provider.



(11) the medical devices referred to in section B of annex 3 of this

the law of health insurance. Medical devices

listed in section C of annex 3 of this Act from the health

insurance paid in the amount and under the conditions laid down in this annex.



(12) medical devices not listed in paragraph 11, the health

insurance pays 75% of the cost of the medical device design

at least economically challenging, depending on the extent and severity of the

disability; the price of the least economically demanding the implementation of

medical device detects the health insurance market.

From health insurance under this paragraph shall be borne by the medical

the funds prescribed for the purpose of



and) continue in the treatment process,



(b) to support the stabilisation of health) of the insured person or the significantly

improve or eliminate its deterioration, or



(c)) to compensate or mitigate the consequences of health defects including compensation or

modification of the Anatomy or of a physiological process.



(13) from the health insurance covers dental products in the range

and under the conditions specified in annex 4 of this Act.



(14) health insurance is no cost examination, inspection, medicinal

products, foods for special medical purposes and medical

resources and other performances made in the personal interest of and at the request of

natural persons, or in the interest of and at the request of legal persons, with the aim of

It is not to maintain or improve the State of health of the insured person. Paid services

also do not include examinations, examinations, medicines, food for

Special medical purposes and medical devices and other health

performances carried out at the request of the Court, the public prosecutor's Office, the institutions

the State administration and the authorities of the police of the Czech Republic. The reimbursement of medical

services under the preceding sentence shall provide the authority for the medical facility

that health services are carried out, in the amount set by the list

medical procedures with spot values ^ 25) in accordance with decision

The Ministry of health; in the case of remuneration at the request of the police authorities

The United States, the provider will send an expense report to the Interior Ministry, and

within 15. day of the calendar month following the

the calendar month in which the medical services provided.



(15) a health service provided in children's homes for children up to 3 years

the age of health care professionals who are employees of the provider

health services in this facility, shall be paid from the budget of the

of the founder. From the budget of the founder to be paid whether or not medical rescue

the service, with the exception of medical procedures in accordance with section 28.



section 16 of the



(1) the health insurance fund pays in exceptional cases

health care services health insurance otherwise unpaid, if the

provision of such health services is the only option in terms of

the State of health of the insured person.



(2) except in cases where there is a risk of late payment, the provision of

health services under the preceding paragraph shall be bound to the previous

medical consent.



section 16a



Regulatory fees



(1) the insured person or his legal representative for him, is obliged to pay the

provider of regulatory fee of 90 € for the use of medical

emergency services or emergency services in the branch of dental medicine

(hereinafter referred to as "the emergency").



(2) the regulatory fee referred to in paragraph 1 shall not apply,



a) in the case of an insured person placed in children's homes for children up to 3 years

^ age 53), in school facilities for institutional upbringing or

protective care ^ 54) or for the performance of institutional care in nursing homes

for persons with disabilities ^ 55) or in the case of the insured person

located on the basis of the decision of the Court in facilities for children in need

immediate help ^ 56) or the insured person assigned by the Court to the

foster care, guardian care or custody under other

^ Law 57),



(b)) in the case of insured persons, which is shown by the decision, notification or

certificate issued by the authority on assistance in material need a dose that is him

provided by other legislation ^ 10), not the older 30 days,



c) in the case of insured persons who are under another law ^ 58)

provided social services in the residential homes for persons with

disabilities, homes for the elderly, nursing homes with special regime or in the

bed care establishments, if this insured person after

remuneration for Board and lodging shall be determined by the balance of at least 15

% of his income ^ 59) less than $ 800, or if he has no income; This

the fact proves the insured person confirms no earlier than 30 days, which

at his request, is obliged to issue a social service provider, or



d) if within the emergency services attending physician found that the status of the

the insured person requires hospitalization.



(3) the regulatory fee is the income provider that regulatory

fee. The provider is obliged to apply the selected regulatory

fees to cover the costs associated with the operation and modernization

the health care facility in which the contingency service

paragraph 1 is granted.



(4) the provider is obliged to expose the insured person or his legal

representatives at his request, proof of payment of the regulatory charge, with

the number of insured persons, the stamp and the signature of provider

a person who has adopted a regulatory fee. The provider is obliged to

communicating to health insurance in the Bill provided by the

covered services for the applicable calendar month, or for the

calendar quarter, information about regulatory fees selected

referred to in paragraph 1, indicating the number of the insured person, to which the regulatory

fee binds, and the date on which the regulatory fee.



(5) the provider is obliged to control the charge referred to in paragraph 1 from

the insured person or his legal representative to choose, unless it is an exception from the

payment of regulatory charge referred to in paragraph 2.



section 16b



Limits of arrears on medicines or foods for special medical purposes



(1) if the total amount paid by the insured person or his legal

Representative for additional payment for prescribed health insurance partially

paid for medicines and foods for special medical purposes,

issued on the territory of the Czech Republic, in a calendar year exceeds the limit

the amount of 5 000 CZK, children under the age of 18 years, including the calendar year in

which have reached 18. year of age, and for insured persons older 65 years, including

the calendar year in which the aged 65. year of age, in the amount of 2 500 CZK

is the health insurance company have to pay to the insured person or his legal

representatives of the amount by which this limit is exceeded. To the limit by

the first sentence shall be included in part paid for by the medicinal supplements on

products or foods for special medical purposes, containing the same

the active substances and the same route of administration only in the amount calculated in accordance with

the balance of a medicinal product or a foodstuff for special medical

the purposes for which a supplement to the volume of this active substance is

the lowest and which has not been found to interrupt or discontinue the delivery.

This does not apply, if the prescriber on the recipe marked that

prescribed medicinal product cannot be replaced (§ 32 para. 2); in such a

the case is within the limit of the balance to be counted in full. To the limit

do not count towards partially paid supplements on medicinal products or


foods for special medical purposes containing active substances intended for

additional support or treatment; This does not apply in the case of medicinal products and

foods for special medical purposes prescribed on a prescription insurance policy holders

the older 65 years, including delivery, which reached 65. a year age. For a list of

active substances intended for supporting or complementary treatment lays down

The Ministry of Health decree.



(2) the health insurance fund is required to pay to the insured person or his or her

legal representative the amount by which it exceeds the sum of arrears

pensionable service to the limit, notified the providers of care

health insurance company referred to in paragraph 4, the limit referred to in paragraph 1, the

60 calendar days after the end of the calendar quarter in which the

limit exceeded. In calendar quarters following the

calendar quarter in which the limit referred to in paragraph 1 no longer

exceeded, the health insurance fund is required to pay to the insured person or his or her

legal representative a sum equal to the sum of the fees eligible for the

the limit for the relevant calendar quarter, notified to the provider

care health insurance company pursuant to section 16a para. 6 and 7, to the

60 calendar days after the expiry of each such calendar

quarter. The amount referred to in the first or second sentence that in a calendar

quarter does not exceed $ 50, will pay the health insurance company within 60

calendar days after the expiry of the last calendar quarter in

calendar year.



(3) when changing the health insurance fund during the calendar year is

health insurance, for which the insured person insured required to notify

new health insurance company insured the grounds for calculating

the amounts referred to in paragraph 2. The amount pursuant to paragraph 2 shall be reimbursed by the insured person or

the legal representatives of the health insurance fund, for which the insured person is

insured up to the last day of the calendar year in which the limit was

has been exceeded. Health insurance company referred to in the second sentence shall notify the health

insurance companies, for which the insured person is insured in the calendar year,

the total amount by which the limit was exceeded, and the insured person

a proportional amount, calculated in accordance with the periods of insurance attributable to the

the insurance company, which is the amount announced. Health insurance companies are

the amount attributable to them are required to pay a health insurance company listed

in the sentence the second within 30 days from the date of receipt of notice of the amount.



(4) the pharmacy shall be obliged to communicate to the health

at the same time with billing insurance companies for the period information about

drug benefits, which will be included in the limit referred to in paragraph 1, with the

the number of the insured person, to which it attaches, the amount of the surcharge

paid the balance due and the date of issue partially borne by the medicinal product

or foods for special medical purposes.



(5) the pharmacy shall be obliged to issue to the insured person or

his legal representative at his request, proof of payment of the balance due for the

partially paid medicine or food for special medical

purposes, which will count towards the limit referred to in paragraph 1. In the document

Pharmacy shall indicate the name of the part paid by the pharmaceutical

medicine or food for special medical purposes, to which the

the balance of the balance, attaches, social security number and proof of imprint

his stamp and signature of the person that the supplement has adopted.



§ 17



(1) for the purpose of providing benefits in kind in the provision of paid services

the insured shall conclude in general health insurance company of the United States and

other health insurance companies, established pursuant to other legal

prescription ^ 28), contracts with providers about provision and reimbursement for covered

services. Contract for the provision and payment of covered services can be closed

only for health services that the service provider is authorised to provide.

Part of the contract for the provision and payment of covered services by the phrase

the first, including its amendments and additions relating to the scope covered by the

services covered by the contract is concluded, it is always an enumeration of health

list of medical procedures by a decree issued pursuant to paragraph 4, which

This contract includes. The contract is not required in the provision of



and emergency care to the insured person),



(b)) to the insured health services in custody or serving a sentence

deprivation of liberty or security of the detention designated provider performance

The prison service



(c) health services to insured persons), which is in the performance of the protective treatment

ordered by the Court, in the case of health services provided in the context of the

with a disease for which the insured person is obliged to submit to treatment.



(2) the contract referred to in paragraph 1 concluded between the health insurance company and

the provider shall be governed by the framework agreement, which is the result of

the conciliation procedure between the representatives of associations of health insurance companies and

representatives of the Group of the represented providers

their interest associations. Conciliation may invoke any of the

his party or the Ministry of health. Each of the framework contract

are submitted to the Ministry of health, which shall examine them from the

for compliance with the law and the public interest in ensuring

quality and availability of paid services, the functioning of the health system

and its stability within the financial possibilities of the system of public

health insurance (hereinafter referred to as "public interest"), and then issues as

a decree. If conciliation does not occur between the parties to the agreement on

content of the framework agreement within six months, or if the presented framework

the contract is contrary to the legislation or to the public interest, is entitled to

make the decision to the Ministry of health. The framework agreement contains

always the provision, which refers to the efficacy, methods and time because of the

termination of the contract pursuant to paragraph 1, that it is possible to terminate the contract

always to 1. January of the following year, with the period of notice must be

at least six months. This notice does not apply in cases where, in

as a result of serious circumstances cannot reasonably be expected for more performance

of the Treaty. Furthermore, the framework agreement shall include arrangements for the implementation of the remuneration

provided covered services, the rights and obligations of the parties to the Treaty

referred to in paragraph 1, if they are not determined by law, the General conditions

the quality and effectiveness of the provision of paid services, the conditions necessary for

performance of the contract referred to in paragraph 1, the control mechanism of quality

paid services provided and the accuracy of the posted amounts, as well as

the obligation of mutual communication of the information necessary to check the performance of the contract

on the granting and reimbursement for covered services, the way and the reasons for their

the contract referred to in paragraph 1, the provisions on arbitration.



(3) providers, and other entities providing paid services are

the Bills health insurers are required to indicate the number of insured persons,

who paid for the services provided.



(4) providers, and other entities providing paid services when

reporting of medical procedures use a list of medical procedures with

point values and with the rules for their reporting and health

the insurance company accepts this method of reporting, unless you

health insurance company a different way of reporting. The Ministry of

Health shall decree a list of medical procedures with spot

values and with the rules for their reporting.



(5) unless otherwise provided by this Act, the point values, the amount of the reimbursement paid by the

services and regulatory restrictions in respect of the following calendar year

in conciliation the parties agree that the representatives of the general health insurance company

The United States and other health insurance companies, and the respective

professional associations as representatives of the providers

providers. Svolavatelem of conciliation is the Ministry of

the health sector. If there is agreement, the Ministry will assess its contents

health care in terms of compliance with the law and the public interest.

If the agreement is in accordance with the law and the public interest, it shall issue

The Ministry of health as a decree. In the absence of the conciliation

management of the agreement until 30 June. 6. the calendar year or, if the Court finds

The Ministry of health that this agreement is not in conformity with the laws and

legislation or public interest, determines the value of a point, the amount of remittances

covered services, the amount of the advances to the payment of covered services and regulatory

restrictions for the following calendar year of the Ministry of health

the decree by the deadline of 31 December 2006. October of the calendar year. The decree by the phrase

the fourth and fifth shall apply, if the provider and health insurance company

in compliance with the health insurance plan health insurance

agree on the method of payment, amount of payment and regulatory limitations otherwise.



(6) the health insurance fund shall be borne by the providers, with the exception of

providers of pharmaceutical care, medicines in a lump sum, the

above shall negotiate in the Treaty under paragraph 1. Beyond the agreed lump-sum

the amount of the relevant health insurance company will pay, in the amount set by the

The Institute, providing outpatient health care providers, medical

preparations which decides to Institute such a method of payment. In the contract


can health insurance company to arrange another method of reimbursement of medicinal products

in the provision of institutional care, which has negotiated amount and conditions for reimbursement

with the holder of the registration or with the manufacturer.



(7) the health insurance fund shall pay always on the basis of:



and) a prescription issued by a contractual provider, physician

providing emergency care to the insured person, the doctor providing the

paid services in the social welfare facilities and contract physician providing

paid services together, my husband, my parents, grandparents, children, grandchildren

and siblings, if his expertise guarantees the Czech Medical Chamber

or the Czech dental Chamber and if a doctor concludes

a special contract with a health insurance company



1. providers of pharmaceutical care medicines and health

resources, and even if it does not have a pharmacy

Yet an agreement referred to in paragraph 1,



2. providers of pharmaceutical care and other Contracting bodies the glasses and

AIDS eye optics, hair replacements, orthopaedic prosthetic devices

standard and individually manufactured, AIDS for the disabled, including the

trucks and jacks for immobile people and AIDS for the hearing impaired

disabled, blind and partially sighted,



3. patient care providers and other bodies of the instruments used

to therapy



(b)) submitted by the contractors account



1. dental prosthetic replacements and therapeutic rehabilitation AIDS



2. orthodontic devices,



c) submitted by the contractors account or other contractual

operators of the service provided by medical interventions,



(d)) of the Treaty to persons that have permission to distribute medicinal products

According to the law on pharmaceuticals, medicinal products containing vaccines for

regular vaccination according to the composition of vaccines antigenního

established by the Ministry of health according to the law on the protection of

public health,



e) submitted by the account in accordance with the implementing regulation and price

Regulation of persons authorized to transport human remains under the law

about the funeral industry, the transport of the deceased insured person to autopsy the body and from the autopsy.



(8) if the transfer of all property rights relating to the

provision of health services from the provider, who asked for the withdrawal of

permissions to the delivery of health services under the health

^ 60), services to another person that was granted in response to

permissions to the provision of health services, or provides other

a person medical services on the basis of a certificate of compliance with the conditions for

the continuation of the provision of health services after the death of the provider

According to the law on health services ^ 61) or subsequently granted her

permissions to the provision of health services, the health insurance fund shall conclude a

with that person, on request and payment of the contract paid by the

services to the same extent as the original provider, within 180

days from the date of receipt of the request, your health insurance company; the contract is not

obliged to take out health insurance in the event that the original

provider contract. The request of the person referred to in the sentence

the first to submit no later than 30 days from the date of granting permission to

provision of health services, in the case of a person, which has been converted

property rights relating to the provision of health services, or to

30 days from the date of the grant of the certificate of compliance with the conditions for the continuation of the

provision of health services, in the case of a person who continues

provision of health services after the death of the provider. By the time of

the conclusion of the contract and payment of covered services to the person

referred to in the first sentence the right to reimbursement of the paid services provided in

the range represented by the contract for the provision and payment of covered services

concluded between the provider and the health insurance company, for a maximum

However, after a period of 210 days from the date of transfer of the economic rights relating to the

provision of health services, or from the date from which continues

provision of health services based on the permissions of the deceased

of the provider.



(9) the health insurance fund shall publish the contract referred to in paragraph 1 and paragraph 7

(a). (d)) in a way allowing remote access no later than 60 days from the

the date of conclusion of such an agreement. In the same way and at the same time

health insurance company shall publish each supplement or amendment to the contract under

paragraph 1 and paragraph 7 (b). (d)), which shows the amount of the reimbursement of medical

the insurance company paid for the provided service providers or range

provided covered services (the "amendment"). The Treaty according to the

paragraph 1 and paragraph 7 (b). (d)) or Appendix shall become effective on the date

publication referred to in the first sentence. If the health insurance company and

the parties agree to another method of the provider or the amount of payment, than it is for

the calendar year specified in a decree in accordance with paragraph 5, it shall publish this

the fact of the contract pursuant to the first sentence. Health

the insurance company shall not disclose information and data which are the subject of protection

under other legislation. Health insurance company also will not disclose

the contract, information and data relating to the provider that is

at the Intelligence Agency.



§ 17a



To ensure that contributions in kind in the provision of nursing care

insurance policy holders located in the facilities of the social services providing

residential social services concluded in general health insurance company of the United

States and other health insurance companies set up under the Special

the law ^ 28) specific contracts with providers of social services.

Appropriate health insurance special contract, if

social service provider so requests and at the same time proves that the

nursing care will be provided by healthcare professionals

provider of social services, who are eligible for the performance

the medical profession under special legislation ^ 28a).



section 17b



paid



section 18



Conditions for the provision of paid services



(1) unless otherwise provided by this Act, provide paid services, others

healthcare professionals than doctors, with the exception of clinical psychologists and

pharmacists, only on the basis of the indications of the treating physician of the insured person

(hereinafter referred to as "doctor").



(2) the treating physician for the purposes of health insurance means



and a registered provider, physician)



(b) specialized providers) the doctor out-patient care,



(c) the day care provider) the doctor, or



(d) the doctor with specialised competences) provider of inpatient care.



§ 19



cancelled



section 20



cancelled



section 21



cancelled



section 22



Special outpatient care



Paid services is also the special outpatient care provided

insurance policy holders with acute or chronic disease, the insured people,

sensory or mentally disabled and dependent on foreign aid and

palliative care, provided to the insureds in the Terminal State in their

their own social environment; This care is provided as



and home health care), if it is provided on the basis of the recommendation of the

a registered provider of outpatient care in General

practical medicine or in the field of practical medicine for children and adolescents

or the treating physician during hospitalization or on the basis of a recommendation

the attending physician, if it is a palliative care client in

end-stage condition,



(b)) health care in social welfare institutions, if it is provided on the basis of

the recommendation of the attending physician,



c) healthcare provided by inpatient care in medical facilities

persons who are placed in them for other than medical reasons, ^ 30)



d) health care in social service facilities,



e) nursing care provided on the basis of practice prescribing

a physician to the insured that are located in residential social services establishments

the competent employees of these facilities, unless

providers of residential social services have concluded a specific agreement with the

appropriate health insurance under section 17a.



§ 22a



Special inpatient care



Paid for services is the treatment palliative and symptomatic persons in

end-stage condition provided in special inpatient facilities

the hospice type.



the title launched



Article 23 of the



cancelled



section 24



cancelled



§ 25



Stay guide client in inpatient care



(1) If during hospitalization of the insured person in the clinic

bed care needed all day because of the presence of the wizard



and the insured's medical condition), or



(b)) to the insured person's guide training in the care and treatment

rehabilitation of the insured person, accompanied by an

is the insured person's Guide to the age of the stay of the sixth year of age

accompanied by the insured, including the contribution to be paid by the service; stay Guide

the insured person of an older 6 years it is paid by the service only with the consent

the review of the doctor.



(2) a guide shall be borne by health insurance company, for which it is insured

accompanied by the insured person.



section 26



Equipment of the insured person after their hospitalization



(1) paid for services is insured and medicinal products,


foods for special medical purposes and medical devices after

their hospitalization for 3 days or in duly substantiated cases, on the

Next, absolutely necessary.



(2) if the insured person is discharged to home on a pass,

the provider is not for the duration of the passes are entitled to charge the health

the insurance company charges for in-patient care, with the exception of medicinal products and

medical devices, which the insured person for the duration of the passes

equip.



section 27 of the



cancelled



section 28



Medical rescue service and emergency services



(1) Paid services include medical procedures carried out in the framework of the

emergency medical services.



(2) Paid services include medical procedures carried out in the framework of the

the emergency services, and even if it were urgent medical

performances carried out by a doctor outside his expertise.



Preventive care



section 29



(1) Paid services are also preventive examinations, which are

be carried out



and in the first year of life) nine times a year, of which at least six times in the

the first half year of life and of which at least three times in the first three

months of life if they are not provided dispensary care,



(b)) at 18 months of age,



(c)) in three years and then every two years, however, the first 18

months after making the last preventive examinations.



(2) in the field of dental medicine preventive inspection:



a) for children and adolescents under the age of 18 years, twice a year



(b)) twice in pregnant women during pregnancy,



(c)) in adults once a year.



(3) in the field of gynaecology and obstetrics, preventive inspection of the

at the completion of compulsory schooling and, starting with the 15th year

age once a year.



section 30



(1) the services are paid for by the tests and examinations carried out in the framework of the

measures against infectious diseases. ^ 34) tours of the insured

carrying out activities carried out in the context of severe epidemiological

with the issuance of a medical certificate to the covered services not included.



(2) the following are services paid for by the



vaccination and payment) of medicinal products containing vaccines for

regular vaccination according to the composition of vaccines antigenního

established by the Ministry of health according to the law on the protection of

public health,



b) vaccination and reimbursement of medicinal products containing vaccine in the

at least economically challenging



1. rabies



2. tetanus when injuries and healing wounds,



3. against tuberculosis for insured persons who meet indications for vaccination

provided for by the law governing the vaccination against infectious

diseases, including tuberkulinového of the test carried out in cases where it is

need to vaccinate a child older than 6 weeks; vaccination is in this case

be carried out only if the tuberculin test is negative,



4. the insured persons against influenza over the age of 65, the insured after

Splenectomy or stem cell transplant, for insured persons,

suffering from serious chronic heart disease, and to resist the pharmacologically

and blood vessels, or respiratory tract, or kidney, or diabetes, and for insured persons

located in health-care facilities long-term provider

inpatient care or homes for the elderly, or in homes for persons with

a disabled person or in homes with special regime; paid for by the

following is the service for insured persons over 65 years of age vaccinated against

pneumococcal infections according to the approved schedule,



5. against pneumococcal infections, if 3 doses of the vaccine have been

applied to the seventh month of age of the insured person; paid service is also

a booster made to the 15th month of age of the insured person; paid for by the

the service is further vaccination made after expiry of the time limits laid down in

This provision, if there is a postponement of the application of one or more benefits

vaccines because of the State of health of the insured person,



6. against the human papilloma virus, and that for girls, where vaccinations started

from the completion of the 13th year of age up to the age of the fourteenth.



(c) carried out in materials) of medical devices

health care provider on the microbiological, immunological and

parasite examination for clinical purposes and in connection with the occurrence of

diseases,



d) examination of the materials referred to in (c)) laboratories of the

providers,



(e) HIV diagnostics, anti), HCV and HBsAG in donors of blood, tissues, organs, and

the gametes and the HIV diagnosis carried out in health facilities

providers, preventive care in cases of preventative

procedures and in cases where it's suspected the insured person has requested it, with

the exception:



1. anonymous examination,



2. examination of private and business trips abroad.



(3) the services are not paid for by the



and) the provision of vaccines with the exception referred to in paragraph 2 (a).

(b)),



b) subscriptions of materials and their examination carried out for the purposes of the State

health surveillance National Health Institute and the health institutes,



(c) HIV diagnostics including investigations) carried out in the national health

the Institute and the health institutions at the request of the insured person including anonymous

examination.



section 31



Dispensary care



(1) in the framework of the covered services, dispensary care provides to the insured

healthy and the sick, endangered in these groups:



and children up to one year),



(b)) to children from selected one year of age, the chronically ill and vulnerable

health disorders, and as a result of the unfavourable family

or another social environment,



c) selected to minors,



d) pregnant women from the date of detection of pregnancy,



e) women who used hormonal and intrauterine contraception



(f)) affiliated persons at risk or suffering from serious diseases.



(2) an insured person to a dispensary care classified according to technical criteria

the doctor of the registering a provider that is responsible for the effectiveness and

coordination of dispensary care. The insured person can be dispenzarizován for

one diagnosis with only one doctor.



§ 32



Provision of medicinal products and medical devices



(1) the dispensing of medicinal products and medical devices by governing

special legislation. ^ 36)



(2) if so requested by the insured person for the issue of another medicinal product with the same

the active ingredient, the same route of administration and the same pharmaceutical form,

replaces it with the pharmacy in accordance with a special law ^ 37) other

medicinal product with a lower payment, if the prescriber to

the recipe has not indicated that the prescribed medicinal product cannot be replaced.



(3) the health insurance fund may lend some medical

resources; lease medical devices keeps records. Release

medical devices or their lease will record the prescribing

the doctor in the medical records.



(4) the provider of a legitimate supply medicinal products shall not in respect of

dispensing of the medicinal product bound to prescription, person

public health insurance, provide, offer or promise

monetary or non-monetary transactions, benefits or gifts of property or non-material

nature, even through third parties; This does not affect the possibility

discount or reduction of the final price not the maximum

margin at the time of such medicinal product.



(5) the provider authorized to supply medicinal products is committed

the administrative offense, if you commit a breach of the prohibition referred to in paragraph 4. For administrative

the offence is a fine of up to Czk 1 0000 0000 stores. Administrative offence dealt with and

a fine Department stores. The fine enforced by the Customs Office. Income from fines is

State budget revenue. A fine may be imposed within 1 year from the date on which

The Institute has detected a violation of the prohibition, but within 3 years from the date on which the

There has been a violation of the prohibition.



§ 33



Hospital rehabilitation care



(1) Paid by them on hospital rehabilitation care, provided by the

as a necessary part of the process, the provision of recommended

the attending physician and confirmed by the auditing physician. A proposal on hospital

rehabilitation care serves on the health insurance company doctor

the registering of the provider or the treating physician during hospitalization;

in the case of the provision of a spa hospital rehabilitation care, the proposal contains

also specify the degree of urgency.



(2) the Spa sanatorium rehabilitation care is provided solely as a

subsequent inpatient care in health facilities, which are located

at the site of the occurrence of the natural medicinal resources or territory with the climate

conditions favourable for healing, and in the provision of care are the following

of natural medicinal resources or climatic conditions favourable for healing

used.



(3) the Spa sanatorium rehabilitation care is provided and paid for by as

comprehensive Spa sanatorium rehabilitation care or Government-funded Spa

hospital rehabilitation care.



(4) comprehensive Spa sanatorium rehabilitation care builds on the bed

care or specialized out-patient health care and is focused on

rehabilitation, prevention of disability and the lack or


minimize the extent of the disability. For participants in the sickness insurance scheme is

provides at the time of their temporary inability to work. Of the insured person

summons to a spa hospital rehabilitation care facilities of Spa care.

The insured person in the first order of urgency is to get the Spa hospital

rehabilitation care summoned not later than one month from the date of

exposure draft, or with the agreement of the attending, the review and

Spa doctor is translated into medical equipment provider

Spa sanatorium rehabilitation care directly from the health care facility

provider of inpatient care. In the second order of the urgency of the patient's

summoned not later than within three months, children and adolescents within six months from the

the date of the proposal. Comprehensive Spa sanatorium rehabilitation care is

fully covered by health insurance.



(5) the Contribution of the Spa sanatorium rehabilitation care is provided

insurance policy holders with chronic diseases especially in cases when they are not

compliance with the conditions referred to in paragraph 4. Paid services are only

examination and treatment of the insured person. This care may be given once in a

for two years, unless otherwise decided by the auditing physician otherwise.



(6) Children and adolescents under 18 years of age, the Spa sanatorium rehabilitation care

provides pursuant to paragraph 4, if not at the request of the parents is provided

in accordance with paragraph 5. Transfer of an insured person under 18 years of

medical equipment providers in the medical bed care

the device provider Spa sanatorium rehabilitation care review

the doctor does not qualify.



(7) in the case of occupational disease and other damage to health from work

the Spa hospital provides rehabilitation care referred to in paragraph 4,

If it is recommended or endorsed the expert for indication

occupational disease.



(8) the Spa sanatorium rehabilitation care in accordance with paragraphs 4 and 5, granted to the

the insured person for the first time indication is referred to as the basic treatment

the stay. For more curative stay corresponding indication, based on which it was

made a basic therapeutic stay, is referred to as a recurring therapeutic

stay, if not in annex 5 to this Act provides otherwise.



(9) of the disease, which can be a spa hospital rehabilitation care

provide ways of providing the Spa sanatorium rehabilitation care for

indications, the length of the basic treatment and repeated

treatment for each indication, the frequency of the recurring therapeutic

stay, the time limit for the stay at the onset of treatment indications, where is this period

reasonably provide in terms of therapeutic effect, the possibility of extending

treatment by individual indications and ways of providing

Spa sanatorium rehabilitation care and other professional criteria related

to each of the indications set out in annex 5 to this

law (indication list of Spa care for hospital rehabilitation).



(10) the extension of the length of the basic treatment or

repeated treatment provided as a comprehensive Spa

hospital rehabilitation care, may propose to the competent doctor

medical equipment provider of the Spa rehabilitation clinic

care, if this option is in the appropriate indications indicated in annex No. 5

to this Act. The proposal to extend the treatment is administered

review the health insurance companies, the doctors that the extension and

its length.



(11) the extension of repeated treatment provided as

contributory Spa sanatorium rehabilitation care to 21 days in cases

When was such a stay on the basis of the indications of the resolution proposing the doctor approved

the review by a doctor the competent health insurance company only 14 days in length

(hereinafter referred to as "indicated the case"), your doctor may suggest a competent

medical equipment provider of the Spa rehabilitation clinic

care. The proposal to extend the treatment is administered review doctors

competent health insurance company that the extension and the length of the

hereby approved.



(12) the Ministry of health shall for each indication

display the elements of the draft decree on the Spa hospital

rehabilitation care for adults, children and adolescents, indicating the assumptions

contra-indications, the technical criteria for the granting of Spa Clinic

rehabilitation care including necessary examination, field of specialization

a doctor who recommends such care, requirements on availability

health workers in the clinic provider

Spa sanatorium rehabilitation care and Spa focus indicator

places in which is a natural source or climate

conditions suitable for the treatment of diseases.



§ 34



Care in professional children's hospitals and Sanatorium schools



(1) health care as an essential part of the treatment

process, on the recommendation of the attending physician in children and adolescents under 18 years of age

in the children's specialized hospital and Sanatorium schools shall be borne by the health

the insurance company. Proposal on health care of children's hospitals and in specialized

Sanatorium schools served on the health insurance companies registering

general practitioner, general practitioner for children and adolescents, or attending

physician during hospitalization. Proposal for revision of the relevant doctor confirms

health insurance companies; the review does not consider the transfer of the insured's physician

hospitalization to specialist children's Hospital.



(2) Disease in which children and adolescents under 18 years of age provides health

care in specialist children's hospitals, and the focus of these indicator

hospitals (indication list for health care in specialist children's

hospitals) the Ministry of health shall lay down by Decree. In cases

When the indication to treat in children's specialist hospitals overlap with

indications for the treatment of Spa provider in healthcare facilities

hospital rehabilitation care, decides on the suitability of treatment in

the medical equipment of the provider of the Spa rehabilitation clinic

care or children's specialized hospital care, physician recommended.

The length of treatment in specialist children's hospitals are governed by the

health of the sick, and decides on her head doctor institutes.



(3) for children from three to 15 years due to adverse health weakened

environment, children with health problems associated with

improper lifestyle and children in recovery, whose health

the State does not require specialist treatment in a medical facility

Spa sanatorium rehabilitation care or in a children's specialized hospital,

provides the committed revision draft of the attending doctor doctor

health insurance care in ozdravovně. Length of stay in ozdravovně

does not normally exceed 21 days; extended stay is only possible with the consent of

the review of the doctor.



§ 35



cancelled



section 35a



The transplantation of tissues and organs



Collection of tissues, cells and organs from living or deceased donors, testing

potential donors necessary to assess the fitness for a particular

the recipient, the necessary waste taken from tissues, cells and organs, and

transport of a living donor or to pay his travel expenses and transportation

deceased donor shall be borne by the recipient's health insurance company.



Transport and reimbursement of the travel costs



section 36



(1) the service is paid for by the insured person's transport to the territory of the Czech Republic to the

contract providers, from contract to permanent provider

or to the place of residence or residential social

services between the provider and the provider, as part of the contractual

in the event that the insured person's State of health does not permit the carriage of ordinary

way without the use of medical transport services. If the disease

of the insured occurred in the place of residence, to the place of permanent

the stay, which is more than the place of residence, covered only

If it's according to the attending physician necessitates

the State of health of the insured person. Carriage is performed, the contracting vehicles

medical transport services. If the attending physician indicated

the escort shall be borne by the insured person's sickness insurance fund, which shall be borne by the transport

the insured person, as well as the transport of accompanying persons, and to the same extent

as the transport of the insured person.



(2) the carriage referred to in paragraph 1 shall be borne by health insurance company in the amount of

corresponding to the distance of the nearest provider of contract which is

able to provide the required by the service.



(3) in exceptional cases, or in cases where the



and it's more economical), are paid by the health insurance fund on the basis of

indication of the treating physician and the medical approval and the necessary

air transport,



(b) there is a risk of default), are paid by the health insurance costs and

another provider of health services; for such carriage shall be decided by

the attending physician,



(c)), the person moving mostly in a wheelchair for the disabled and

is indicated by the transport of medical transport for medical reasons

the service is paid by the health insurance company and other carriers, transport if

This transport is provided by means of specially adapted for


transporting people in a wheelchair for the disabled; for such carriage

shall be decided by the attending physician.



(4) if required by the State of health of the insured person absolutely and, if

immediately threatened his life, paid by the health insurance fund in the territory

The United States transport blood products, special healing

products, tissues, cells and organs for transplantation, as well as the transport of

a doctor or other healthcare professional to specialised and

the necessary performance.



§ 37



(1) the health insurance shall be paid to transport doctors and indicated

other health care workers for the insured person.



(2) if the insured person, who is entitled to carriage under section 36,

decides on transport by private car controlled by another person and if the

the attending physician approves such a transport, an insured person has the right to

reimbursement of travel expenses in the amount corresponding to the distance of the nearest

contract provider that is capable of the required health services

provide.



§ 38



Advisory work



The service is paid for and the assessment of temporary incapacity and

temporary inability to study the treating physician and the assessment of

the fact that, pursuant to section 191 of the labour code important personal

obstacles at work, and similar feats for pupils and students.



§ 39



Tour of the deceased insured person and autopsy



The service is paid for by the tour of the deceased insured person, autopsy, transport to

the autopsy to the nearest contract providers, able to specified

type of inspection according to the autopsy of the deceased, and the transport of

the autopsy into the place where the death occurred, or to the place of burial, if

This space the same distance or closer than the place where the person died.

The service is not paid for by the dissections and judicial autopsy and transport to

such execution and from them.



PART SIX



PRICE CONTROLS AND REIMBURSEMENT OF MEDICINAL PRODUCTS AND FOODS FOR PARTICULAR

MEDICAL PURPOSES



§ 39a



The fixing of maximum prices for medicines and foods for special

medical purposes



(1) the maximum prices of proprietary medicinal products and the

foods for special medical purposes, which is based on the price

prescription ^ 23 c) determined by this method of price control, decisions of the Institute.



(2) the Institute shall determine the maximum price of the manufacturer, with the exception of the procedures referred to in

paragraphs 4 to 6, at the rate of



and the average of the prices of the manufacturer) of the medicinal product under consideration, or food

for special medical purposes of the 3 Member States of the European Union, with the

the exception of Bulgaria, the Czech Republic, Estonia, Germany, Luxembourg,

Austria, Romania, Cyprus and Malta (hereinafter referred to as "the land of the reference basket"),

that have the lowest price of the medicinal product under consideration, or food

for special medical purposes, when the medicinal product under consideration, or

food for special medical purposes on the market in at least 3 countries

the reference basket,



(b) the manufacturer of a medicinal product prices), or foods for special medical

the purposes contained in the written agreement closed in the public interest pursuant to section

Article 17(1). 2 health insurance with the holder of the marketing authorisation

of the medicinal product, the importer or domestic manufacturer of food for

Special medical purposes, by the importer or by the promoter of the specific

the treatment program, if the arrangement is concluded for a period of at least 1 year with

at least 3 months ' notice for all supplies of medicinal

medicine or food for special medical purposes on the Czech market

Republic, and if you cannot do this under (a)),



(c)) the producer price of the nearest therapeutically correspond to those of the medicinal

medicine or food for special medical purposes identified in countries

the reference basket or in the Czech Republic, if you can not follow the

letters and) and (b)). If the nearest therapeutically comparable pharmaceutical

product or foodstuff for special medical purposes available in Czech

Republic, then applies its lowest cost manufacturer established in the United

Republic; If in such therapeutically correspond to those of the medicinal

medicine or food for special medical purposes, the holder of the

the decision on the registration of identical to that of the medicinal product under consideration

or foods for special medical purposes, this price shall apply,

If it was established pursuant to subparagraph (a)). If you cannot do this

in a way, it is the lowest price the manufacturer identified in countries

the reference basket. When selecting the nearest therapeutically correspond

medicinal product or foods for special medical purposes

the criteria taken into account in the following order: the active substance,

pharmaceutical form, strength of the medicinal product, the size of the package.



(3) the Ministry of health shall lay down the implementing regulation



and rules for the selection) the vesting period for the conversion of foreign prices from

foreign currency,



(b)) the vesting period and the rules for price and manufacturer for

the assessment of the availability of the medicinal product or foods for special

medical purposes,



(c) maximum above) how the price of a similar product by

paragraphs 4 to 6,



d) rules to exclude foreign producer price levels identified pursuant to

paragraph 2 of the application for the fixing of maximum prices



e) tolerance in the size of the Pack in search of foreign prices

the manufacturer referred to in paragraph 2,



(f) increase the maximum) the prices in the public interest pursuant to section 17

paragraph. 2,



(g) the method of determining the maximum prices) for highly innovative medicinal

products for which the application is made on the fixing of maximum prices in the

the same amount for all strengths of the medicinal product, regardless of the content of the

the active substances,



h) rules relating to notification of the highest price at which the holder intends to

the marketing authorisation for the medicinal product, the importer or the domestic

manufacturer of foods for special medical purposes or an unauthorised

the medicinal product is used in the context of a specific treatment program

indicate a medicine or food for special medical purposes

the market for medicinal products or foods for special medical purposes,

not subject to the control of the producer price fixing maximum prices.



(4) the Institute shall determine the maximum price of a similar product as the maximum

the price of the medicinal product, which is the medicinal product under consideration

similar to, in the case that



and the determination is not required) maximum price in excess of the maximum prices

a medicinal product which is similar to that of the medicinal product under consideration

accordance with the application under section 39f of paragraph 1. 8,



(b) the applicant in the request for) the fixing of maximum prices for similar product

ask for the maximum price in the proceedings under section 39 g of paragraph 1. 9, and



(c) the remuneration does not prevent conditions) pursuant to § 15 para. 6 (a). e) or section

39 g of paragraph 1. 10.



(5) the Institute shall calculate the maximum price of a similar product in the first

the reference group referred to in paragraph 4 and that price will be reduced by



and) 15% in the case that it is a product that was under the law on

Pharmaceuticals registered as a biological medicinal product, in a situation where

the system of payments from health insurance (hereinafter referred to as "the system of payments")

only one similar to a product which has been registered as a biological medicinal product

medicine,



(b) in the case of 32%), that it is a product that was under the law on

Pharmaceuticals registered as a generic medicine in a situation where the system of payments

only one similar to a product which has not been registered as a generic medicine,



c) 15% in the case that it is a product that was not in accordance with the law on

Pharmaceuticals registered as a generic medicine, in a situation where the system of payments

only one similar to a product which has not been registered as a generic medicine.



(6) the Institute shall calculate the maximum price of a similar product in the first

the reference group, for which the conditions are not fulfilled in accordance with paragraph 4,

procedure laid down in paragraphs 2 and 5 and the maximum price shall be fixed at a level which

According to this calculation, the lowest.



(7) the maximum price of the medicinal product as provided for in accordance with paragraphs 5 and 6

You cannot increase the execution of the first following an in-depth revision pursuant to §

39 l.



(8) the maximum price of the medicinal product or foods for special

medical purposes, containing the active substance, which can be used to treat

the disease, which has not yet been influenced by another medicinal product

or food for special medical purposes or represents a major

improvement of the treatment (hereinafter referred to as "highly innovative product"), that is

I know plenty of data on the cost effectiveness or results of your treatment

use in clinical practice, and which is subject to a maximum price regulation

price according to price prescription ^ 23 c), shall be determined in accordance with paragraph 2 (a).

and cannot be determined). If the maximum price referred to in paragraph 2 (a). and)

the maximum price shall be fixed at the average manufacturer prices found in the 2

countries of the reference basket; in cases where you cannot use this procedure,

proceed as indicated in paragraph 2 (a). (b)), or (c)).



The determination of the policy, or changes in the amount and conditions of payment of medicinal products and

foods for special medical purposes



section 39b



(1) the amount and conditions for reimbursement of medicinal products and food for

Special medical purposes shall be decided by the Department. Such a decision may Institute

issue in the case, that the medicinal product has been authorised, or was


approved the use of an unauthorised medicinal product in the context of the

a specific treatment program under a special legal

^ Regulation 42b). In the case of a medicinal product or a foodstuff for special

medical purposes subject to price regulation the maximum price ^ 23 c), Institute of

issues a decision, if this price was fixed or

determination of the maximum price is at the same time with the management about the determination of the amount and

the terms of payment.



(2) in determining the amount and terms of payment in the medicinal product, or

foods for special medical purposes shall be considered



and) its therapeutic efficacy and safety,



(b) the severity of the disease) to which the treatment is intended,



c) submitted by the party to evaluate the cost-effectiveness of and impact of

on the financial resources of health insurance caused by use of

medicinal product or foods for special medical purposes,

by expressing the cost of 1 and the estimated number of patients treated with

for the year, and that in those cases the setting or change of the terms and conditions of payment

or deep or shortened revision for medicinal products or food

for special medical purposes, for which the extension is requested, the conditions

payments to increase the number of patients treated, the increase of the remuneration

compared to the basic payment or other remuneration 1 increased compared to the current

State or over other medicines or food for

Special medical purposes in the reference group,



(d)) in the public interest (section 17 (2)),



e) appropriateness of the route of administration, dosage form, strength and package size,



(f)) to the normal dosage,



(g) the necessary duration of treatment),



h) the level of synergies between the person to whom it is given,



I) its substitutability another medicine or food for

Special medical purposes, paid from health insurance and compare

their prices and remittance with the price set by the medicinal product under consideration

or foods for special medical purposes,



(j) the estimated impact of the remuneration) the financial resources of the health

insurance,



k) best practices professional institutions and experts, and it's always from the

the perspective of cost effectiveness and taking into account the impact on the financial

health insurance resources.



(3) the Institute may provide remuneration for an unauthorised medicinal product,

If its use is sufficiently justified by current scientific

knowledge and treatment is the only option, or if its use of cost

efficient compared to available therapy, and for the period of the approved

a specific treatment program ^ 42b). The Department may provide for the payment by the

authorised medicinal product for the indication in the summary of

product not listed, if the use of the medicinal product is sufficiently

justified by current scientific knowledge and if the use of the

of the only treatment options, or if it is cost effective in

comparison with existing treatment.



(4) a similar product for the purposes of this Act, a medicinal

a product that has the same active substance or active substances and the same

or similar pharmaceutical form of the medicinal product with borne, which is

in principle, therapeutically interchangeable. Additionally, similar with means

a biological medicinal product which is similar to a biological substance or

biological substances and the same pharmaceutical form or similar with borne

medicinal product, which is in principle, therapeutically interchangeable.

The first similar product means a similar product for

that is the request for the fixing of the maximum price or amount and conditions

payment of the first in the sequence.



(5) the Institute shall determine the amount of payment under consideration of a similar product by

the amount and conditions of payment of the medicinal product, which is a medicinal product under consideration

the preparation is similar to, in the case that



and is not required to determine the amount) and the conditions of payment beyond the amount and

the terms of payment of the medicinal product, which is a medicinal product under consideration

the preparation is similar to that in accordance with section 39f of paragraph 1. 8,



(b) the applicant in the request for) fixing the amount and conditions of payment of a similar

the product requests a determination of the amount and terms of payment in the proceedings under section

39 g of paragraph 1. 9,



(c) the remuneration does not prevent conditions) pursuant to § 15 para. 6 (a). e) or section

39 g of paragraph 1. 10 and



(d) whether or not the request is made) on the fixing of maximum prices pursuant to § 39a para. 4

or 5, if the medicinal product or foodstuff for special medical

purposes shall be subject to price regulation.



(6) the Institute calculates the amount to be paid for a similar product in the first reference

the group referred to in paragraph 5 and this payment will decrease in the manner prescribed in

§ 39a para. 5.



(7) in the event that the first similar product in the reference group

does not meet the conditions referred to in paragraph 5, the Institute calculates the amount of payment

pursuant to section 39 c of paragraph 1. 8 and this further reduces the remuneration referred to in paragraph 6.



(8) the Department with legal force of the decision determining the amount and terms and conditions

the remuneration referred to in paragraph 6 or 7 shall forthwith initiate the procedure pursuant to § 39 c

paragraph. 9.



(9) to change the decision on the registration or transfer of registration of medicinal product

the medicine has no effect on a fixed maximum price or amount and conditions

payment of an authorised medicinal product if the change registration

or transfer the registration not to change, which can have a direct impact

the maximum price or the amount of, or conditions for reimbursement.



(10) a medicinal product or a food for special medical purposes can be

even without the proposal to lay down the conditions for reimbursement



and) if so required by the professional point of view or the point of view of safety associated with the

treatment with this medicine or food for special medical

purposes,



(b)) if the knowledge achieved in the framework of the research or the use of the

medicine or food for special medical purposes results in practice,

that medicine or food for special medical purposes has

a significant therapeutic value for certain groups of patients,

certain indications or clinical practice under certain conditions,



(c)) if it is necessary to ensure the effective and efficient

the use of the medicinal product or foods for special medical

purposes,



(d)) with respect to highly costly, the cost for the year are

at least one-tenth of the gross domestic product for 1

the person in the Czech Republic for the previous calendar year,



(e)) in cases where the limit exists and is applied in the

countries of the reference basket, or in other Member States

Of the European Union.



(11) the Institute provides for a medicinal product or a foodstuff for special

medical purposes in addition to the above terms and conditions of payment of the corresponding base

payment reference group and one other remuneration increased, where

This increased remuneration was appropriate on the basis of the evaluation of the active substances, medicinal

medicine or food for special medical purposes or dosage forms

for a selected indication or for a particular group of patients. For the determination of

the increased remuneration, the provisions for determining the reimbursement of medicinal products

medicines and foods for special medical purposes, by analogy.



(12) the amount of the reimbursement of medicinal products consisting of two or more medicinal

substances for which there is more than 1 active substance separately remunerated,

provides for the



and the sum of the payments for the usual) daily therapeutic dose of relevant

separately payable by active substances laid down pursuant to § 39 c of paragraph 1. 7,



(b)) of the highest producer price contained in the written agreement referred to in section

39A para. 2 (a). (b)), if the latter price is lower than the remuneration is calculated

According to subparagraph (a)),



(c) the amount of payment) contained in the written agreement under section 39 c of paragraph 1. 2

(a). (d)), if the payment is lower than the remuneration, calculated in accordance with subparagraphs

and) and (b)),



(d)) at the rate of the producer price recorded in any country of the European Union for the

each individual medicinal product with the same combination of active substances and

their content, if this price is lower than the remuneration calculated in accordance with

letters and), b) and (c))



(13) the amount of the reimbursement of medicinal products consisting of two or more medicinal

substances for which there is only 1 active substance separately paid, shall be adopted



and the price the manufacturer) found in any country of the European Union for the

each individual medicinal product with the same combination of active substances and

their content,



(b)) of the highest producer price contained in the written agreement referred to in section

39A para. 2 (a). (b)), if the latter price is lower than the remuneration is calculated

According to subparagraph (a)),



(c) the amount of payment) contained in the written agreement under section 39 c of paragraph 1. 2

(a). (d)), if the payment is lower than the remuneration, calculated in accordance with subparagraphs

a) and (b)).



(14) the Ministry of health shall lay down the implementing regulation



and) the rules and limits for increase or decrease of the remuneration referred to in paragraph 2

compared to the set basic remuneration having regard to the characteristics of the period

medicinal product or foods for special medical purposes in

compared to the other, in principle, therapeutically interchangeable medicinal

products or foodstuffs for special medical purposes,



(b)) the level of remuneration of a similar method of conversion of the product in accordance with paragraphs 5 to

7,



(c)) use of the procedures under section 39b to 39i for setting or changing the amount and


conditions of reimbursement of medicinal products consisting of two or more medicinal

substances,



d) procedure for the determination or changing the amount and conditions of payment of medical

medicines and foods for special medical purposes, in the form of liquid

non-split pharmaceutical forms,



(e) the method of determining the remuneration) of the medicinal products for which a

a request for a determination of the payment of the same amount for all the forces, regardless of the

the content of active substances,



(f) determining the conditions) rules for payment in the form of preskripčních and

restrictions and payment methods,



g) procedure for determining reimbursement of medicinal products including high

innovative products.



§ 39 c



(1) the Institute marshals the medicinal product in the context of proceedings under section 39 g to

reference group, where, in the course of the procedure proves that the given

reference group does not belong. The remuneration of the medicinal product shall be at the

the basis of the basic remuneration of the reference group to which the

preparation is classified. The basic remuneration is the payment for the usual daily

therapeutic dose of medicinal substances contained in medicinal products and

is the same as for the whole of the reference group. Reference groups are

the groups of medicinal products, in principle, therapeutically interchangeable with

similar or close to efficiency and safety and similar clinical

using the. The list of reference groups, provides for the Ministry of health

an implementing regulation.



(2) the basic remuneration in reference groups shall be



the lowest price of the manufacturer) attributable to the daily therapeutic dose

medicinal product or foods for special medical purposes

included in the reference group, found in any country of the European

the Union for medicine or food for special medical purposes

available in the Czech Republic; a medicine or food for

Special medical purposes is available on the market in the Czech Republic means

medicine or food for special medical purposes, which

share of the total sales volume, in principle, therapeutically interchangeable

medicinal products or foods for special medical purposes,

containing the same active substance, in the period amounted to at least 3%,

If this is not the first to third a similar medicine in the healing substance in order

by the time of application for the fixing of the amount and conditions of payment, or

the medicinal product in respect of which the manufacturer or pay the highest price was

concluded a written agreement; such medicinal products shall always be deemed

available on the market in the Czech Republic,



b) daily cost other therapy reduced the margin and

applied to value added tax, if a comparably efficient and cost-

effective compared with taking the medicinal product or food for

Special medical purposes under subparagraph (a)), and these facts are the Institute of

When the basic remuneration, taking into account the necessary

length of therapy medicinal product or a foodstuff for special medical

purposes and the necessary period of comparable treatment,



(c)) the highest producer price contained in the written agreement pursuant to § 39a para.

2 (a). (b)), if the latter price is lower than the remuneration, calculated in accordance with subparagraphs

a) and b), if the holder of the marketing authorisation of the medicinal product,

the importer or domestic manufacturer of foods for special medical purposes,

the importer or the submitter of a specific treatment program did not make in the

the last 2 years the administrative offense under § 39q para. 1 (b). (b)),



(d)) the remuneration included in the written agreement closed in the public interest

all health insurance companies with the holder of the marketing authorisation

of the medicinal product, the importer or domestic manufacturer of food for

Special medical purposes, if not committed in the last 2 years

the administrative offense under § 39q para. 1 (b). (c)), if the payment of the

lower than the remuneration, calculated in accordance with subparagraphs), b) and (c)), if the arrangement

closed for at least 1 year with at least 3 months ' notice for

all supplies of medicinal products or foods for special medical

the purpose of the market of the Czech Republic, and if its part of the commitment that the medicinal

product or foodstuff for special medical purposes for

the validity of this agreement available on the market in the United States, and the price for

the final consumer of such medicine or food for

Special medical purposes does not exceed the maximum possible reimbursement for the final

of the consumer.



(3) the basic remuneration in the reference in principle interchangeable groups

medicinal products whose therapeutic efficacy is low, do not use

the causal treatment of diseases, or are used to treat non-serious

disease is less than 60% of the remuneration referred to in paragraph 2.



(4) the provisions on reference groups on the medicinal product, or

food for special medical purposes, which cannot be classified in

reference group, or group of medicinal products or food for

Special medical purposes, in principle, therapeutically interchangeable, that

cannot be assigned to any reference groups, apply mutatis mutandis.



(5) in the event that, in the determination of remuneration under section 39b-39e was not in

some of the groups of active substances referred to in annex 2 of this Act,

regardless of the therapeutic interchangeability of at least 1 medicine

fully paid, the Department shall adjust the remittance decision so that the least expensive

medicinal product from a group of medicinal products has been fully assessed

paid.



(6) the Ministry of health may determine an implementing regulation

reference group, in which the health insurance fund may amount to be paid

medicinal products or foods for special medical purposes to enhance and

modify the conditions for reimbursement for the benefit of the patient above the level set

By the Institute. Health insurance fund is required to access when you deviate

modify the above terms and conditions of payment to all other medicinal products or

foods for special medical purposes listed in the reference group

as well.



(7) the basic remuneration reference groups will be established in the framework of the deep

or abbreviated revision of payments and is valid until the following revision changes

remittances. Similarly in the determination of the next higher remuneration pursuant to §

39B para. 11.



(8) unless otherwise provided by this Act, in proceedings for the setting or change of

the amount and conditions of payment to the payment made to the changes to the base

following the revision of the system used for the establishment or modification of the level of remuneration

all, in principle, therapeutically interchangeable medicinal products and food

for special medical purposes, the amount of the basic remuneration reference group

determined in accordance with paragraph 7; This does not apply if the applicant referred to in section

39f para. 2 (a). and) or (b)) was designed, the amount and conditions for reimbursement

more cost effective.



(9) in the case that was in accordance with section 39b para. 6 or 7 set

the first payment of a similar product in the reference group, which



and according to the law) was on pharmaceuticals registered as a generic medicine,

the basic payment established pursuant to paragraph 7 of 32%,



(b)) was not according to the law on medicinal products registered as a generic medicine,

the basic payment established pursuant to paragraph 7 of 15%,



(c)) was according to the law on medicinal products registered as a biological medicinal product

the product reduces the basic remuneration referred to in paragraph 7 by 15%.



(10) the reduction of the basic remuneration referred to in paragraph 9 shall be carried out according to the procedure

laid down in § 39p.



(11) the Ministry of health shall lay down the implementing regulation



and the required properties of the medicinal product) for the procedure under paragraph 2

(a). and)



(b) the determination of the basic details of the remuneration),



(c) the vesting period for the assessment of) the availability and price of the manufacturer

under section 39b and 39 c,



(d) the rules for the assessment of the presence) of the medicinal product, or

foods for special medical purposes on the market,



e) rules for the increase and decrease of the basic remuneration in the public interest,



f) assessment criteria of medicinal products or foods for particular

medical purposes, whose therapeutic efficacy is low, they are not

giving rise to the treatment of diseases, or are used to treat non-serious

disease,



g) the method of determining the typical daily therapeutic dose



(h) the procedure for determining the base) of the remuneration referred to in paragraph 5, including

the required properties, the least expensive of the medicinal product.



§ 39d



The principles for remuneration to the highly innovative products



(1) if it is in the public interest (section 17 (2)), the Institute shall decide on the amount and

conditions of temporary payment of highly innovative product that is

I know plenty of data on the cost effectiveness or results of your treatment

use in clinical practice, and that's only if warranted by the available

in the absence of enough information benefit highly innovative product for

treatment and if it satisfies the highly innovative product the other conditions for

the determination of remuneration and, if paid from public funds at least 2

countries of the reference basket. When the basic remuneration, the Institute shall proceed

pursuant to § 39 c apply mutatis mutandis.



(2) the amount and conditions of the temporary payment is fixed at 24 months and can be

fix it again, up to a further 12 months. For such other


determination of temporary payment, you must submit the results of reviews

laid down in paragraph 3, the application must be made no later than 6

months before the expiry of the period for which was the first temporary settlement

established. The second interim payment shall be determined pursuant to § 39 c of paragraph 1. 2 to 5,

the provisions of § 39 c of paragraph 1. 8 does not apply. Between the terms of payment of the highly

the innovative product is always filing for specialized work.



(3) The requirements for an application for a temporary payment shall apply section 39f of paragraph 1. 1,

5 to 11. The applicant is also required to demonstrate how the

shall ensure



and the interim evaluation of the therapy under consideration) highly innovative

with,



(b) impact, offers temporary payment) on the financial resources of the health

insurance,



(c) evaluate the cost-effectiveness of),



(d)) to cover costs on the rehabilitation of a patient with highly innovative

After the expiry of the period for which temporary settlement was established, until the

transferring a patient to another therapy.



(4) in proceedings for the determination of temporary payment and in proceedings relating to the determination of the amount and

conditions of payment after the expiry of the temporary payment, section 39 c of paragraph 1. 8 does not apply, and

The Institute provides for reimbursement under section 39 c of paragraph 1. 2 to 5.



(5) in the event of a breach of the undertaking referred to in paragraph 3, the Institute will not admit

considered highly innovative product second temporary cover.



(6) the Ministry of health shall lay down the implementing regulation

the elements of the undertaking referred to in paragraph 3, the conditions under which

specialised workplaces can be a highly innovative product, and

support criteria and procedures for the assessment, whether the medicinal product is

highly innovative, with the highly innovative product should always be

designed for the treatment of highly serious illnesses.



(7) a specialized institution, which may bring a highly innovative

the product on the basis of a special contract under § 15 para. 10, is required to

to provide, at the request of transmission of data related to assessing the effectiveness and

the position of the highly innovative product in clinical practice, health

the insurance company, and in promotional marketing authorisation holder

This medicinal product. The range of the data transmitted to health

the insurance company and the marketing authorisation holder of highly innovative

of the Ministry of health shall lay down the implementing

provision.



section 39e



Úhradová contest



(1) in order to ensure a fully covered by medicinal products and savings

resources health insurance Institute may enlist in a contest for the lowest

reimbursement of medicinal product (hereinafter referred to as "úhradová"), if its

the notice will ask the health insurance company. Úhradovou competition can be listed in the

the active substances and formulations, in which occur the healing

products from at least 3 marketing authorisation holders. In the reimbursement

the contest participants offer the lowest payment attributable to the usual

daily therapeutic dose and undertake to place on the market medicinal products

the corresponding request reimbursement of the competition so that their price for

the final consumer does not exceed the maximum possible reimbursement for

the final consumer.



(2) the Úhradová contest is carried out by means of the electronic auction. Electronic

the auction means the process of evaluation of the tenders, in which

the participant uses the electronic tools for the presentation of new

reduced tender values. A participant in the price competition is the holder of the

of the marketing authorisation that has fulfilled the conditions of qualification. Qualifications

shall mean verification of eligibility for fulfilment of the obligation of reimbursement of the competition.



(3) the request for invitation to tender the competition must always include



and affirmative representations of the Ministry of health) with an application on

invitation to tender competition,



(b)) the designation of the active substances and formulations, in the framework of which a notice of

reimbursement of the competition asks.



(4) Furthermore, the request typically contains



and the content of the active substance) in medicinal products, whose full

payment must be ensured, or úhradovou competitions required dose,

to be achieved by the unit of the pharmaceutical form of medicinal products

preparations or their division or times use (hereinafter referred to as

"the content"),



(b)) the minimum number of usual daily therapeutic dose in the package

medicinal products whose full remuneration must be úhradovou competitions

assured.



(5) the Institute shall notify the initiation of reimbursement of the contest within 30 days from the date of submission of the

the application in your Journal, and in a way allowing remote access.

The notification shall contain



and labelling of the active substance) and formulations, in the framework of which úhradová

competition prints,



(b) the number of the usual daily) of therapeutic doses of this active substance, and

pharmaceutical forms distributed on the Czech market for 18 months

prior to the initiation of reimbursement of the competition,



(c)) the conditions of qualification



(d)) the deadline by which it is possible to qualify to participate in the tender competition,

that is at least 15 days from the date of publication of the notice in the Gazette,



e) instruction on the course of the reimbursement of the competition,



(f) additional requirements arising from) the request referred to in paragraph 4.



(6) can qualify only the marketing authorisation holder of the medicinal

product available under section 39 c of paragraph 1. 2 (a). and) and containing the

the active substance in the dosage form in the application referred to in paragraph 3, which

for the last three years did not make the administrative offense under § 39q para. 1

(a). (d)). the condition of qualification for participation in the tender competition is further



specifications for medicinal products) the content that will be

placed on the Czech market in the case of winnings in the competition with the payment of the reimbursement

the corresponding decision in competition and a maximum reimbursement for the price for

the final consumer, not exceeding the maximum possible reimbursement for

the final consumer,



(b)) a written declaration of commitment to supply in the event of winning in the reimbursement

competition on the Czech market medicinal products referred to in point (a)) for the price for

the final consumer, not exceeding the maximum possible reimbursement for

the final consumer, and evenly over a period of 18 months from the date of

the enforcement of such a decision, and to the extent of at least half of the

the usual daily consumption of therapeutic doses in the medicinal substance, and

pharmaceutical form, distributed on the Czech market for 18 months

prior to the initiation of reimbursement of the competition.



(7) Department of the resolution decides that a person who or when prompted to

compensate for the lack of Administration did not fulfil the conditions of qualification, is not

participant. Against that order can be appealed.



(8) If a reimbursement is not participating in the competition at least 2 participants, Institute of

úhradovou contest by order of stops.



(9) the Institute participants reimbursement at least 7 days in advance of the competition shall notify the date

and the exact time of the implementation of the electronic auction. Notice under this

paragraph shall be delivered only a public decree in a manner allowing

remote access, and shall be deemed received on the tenth day after

off-hook. The notification also contains



and information on the number of participants) reimbursement of the competition,



b) opening auction value that corresponds to a valid basic pay

active substance and formulations for the usual daily therapeutic dose,



c) instruction on the course of the electronic auction,



(d)) information related to the used electronic means and other

technical information necessary for electronic communications in the context of the

electronic auctions,



(e) determining the minimum difference) for individual administration of decreasing auction

value, which corresponds to approximately 1% of the base payment for the usual daily

therapeutic dose of the drug substance and dosage form.



(10) electronic auction in the reimbursement of the contest takes place the day and time

provided by the Institute and notified the participants referred to in paragraph 9 and has only 1

bike. The Institute to issue a decision not to disclose the identity of the participants

reimbursement of the competition.



(11) electronic auction takes at least 30 minutes. Each administration, reducing

the auction value of 29. minute, extended the duration of the electronic auction

about another minute from this administration. Throughout the electronic auction is

The Institute is obliged to disclose information about the participants is currently the lowest

auction value.



(12) if the lowest auction value reached in electronic

the auction is at least 2% lower, than the opening value of the auction, the Department of

úhradovou contest by order of stops.



(13) the stopping of the reimbursement of the competition referred to in paragraphs 8 and 12, the Institute shall notify the

participants and make communication about it in their Journal and the way

allowing remote access. Against the resolution terminating the reimbursement

competition cannot be appealed.



(14) if the úhradová contest is not stopped, the Institute shall issue, within 7 days after

their electronic auction in reimbursement decisions, which

receives the lowest auction value (hereinafter referred to as "taken by the auction value").

The decision is delivered to the participants of the competition, and can be a "settlement against him

appeal. In the operative part of the decision, the Institute shall indicate the



and the list of participants) reimbursement of the competition,



(b) the designation of the party) offered the lowest auction value (hereinafter referred to as

the "winner"),



(c)) adopted the auction value



(d)) the designation of medicinal products requested content that will be put


on the Czech market with payment of the corresponding auction value received (hereinafter referred to as

"products"),



(e) the determination of the obligations of the winner) to supply medicinal products to the desired

the content, for which it was adopted the auction value at the price on the Czech market for

the final consumer, not exceeding the maximum possible reimbursement for

the final consumer, and evenly over a period of 18 months from the date of

enforceability of a judgment in the amount corresponding to at least half of the

the usual daily consumption of therapeutic doses in the medicinal substance, and

formulation of distributed on the Czech market for 18 months

prior to the initiation of reimbursement of the competition (hereinafter referred to as "the obligation of reimbursement

the competition ").



(15) in the preamble to the decision of the Institute shall, in particular,



and) list of people who meet the conditions for qualification in the reimbursement

the competition, on the grounds



(b) a summary of the course of the reimbursement) competition.



(16) following the entry into force of the decision on the reimbursement shall contest the

the result of the reimbursement of the competition notice, which shall be published within five days in a way

allowing remote access and in your Journal, and which contains the

information from the grounds of the decision in the tender competition.



(17) following the entry into force of the decision on the reimbursement Department of competition to 10

the days of initiating the procedure on changing the amount of remuneration and the conditions of medicinal products

that contain the same active ingredient and the same pharmaceutical form as the

received products. In this procedure, the Institute changed the amount of payment received

products according to accepted auction values and other medicinal products

changes the amount of payment according to 75% of the value of the auction, and received it on time

the validity of the tender competition, the violation of this obligation, or

to fulfill this commitment, the waiver. Conditions for reimbursement in this

control does not change. The parties are persons referred to in section 39f of paragraph 1. 2.

The first act in this control is the issue of the decision. The appeal against the

This decision does not have suspensory effect. The decision is enforceable on the day

enforceability of a judgment in the price competition.



(18) decision on the reimbursement shall be enforceable on the first day competition of the fifth

calendar month following the acquisition of its legal power.



(19) for the duration of the obligation of reimbursement of medicinal products, the competition

containing the active substance and the pharmaceutical form in which it was issued

the decision on reimbursement, paid in the amount provided for in paragraph 17;

enforceability of the terms and conditions of payment set out above to these medicinal products

in proceedings pursuant to § 39 g is hereby suspended.



(20) the provisions of paragraph 7 shall not prevent the initiation and conduct of the proceedings and issue

the decision to establish or change the amount and conditions of payment of medical

the products referred to in this paragraph, as well as perform an in-depth or

short review reference group, to which it belongs, including the

These medicinal products. Such a decision is enforceable on the expiry of

the period of validity of the reimbursement of the contest, is a violation of this commitment,

the obligation to observe this obligation to release, or under paragraph 25.



(21) from the date of enforcement of the decision on the reimbursement is the winner of the competition

obliged to fulfill the obligation of reimbursement of the competition. The Institute may winner

by a decision of exemption from the obligation to fulfil the obligation of reimbursement if

winner proves that there has been such and not caused by him in advance

unpredictable material change in the conditions under which you can no longer

reasonably required to fulfil the obligation of reimbursement of the competition. Such

the decision is enforceable in the first day of the calendar month following

After a month in which came into legal force. On the day of the enforcement of this

the provisions of paragraph 19 of the decision does not apply and the obligation of reimbursement

the competition is valid.



(22) in the case of an infringement of the obligation of reimbursement under section competition

39q first day of the next calendar month, with the provisions of the

paragraph 7 shall not apply and the commitment of the reimbursement of the competition will be cancelled.



(23) the next úhradovou competition can be in the same active ingredients and pharmaceutical

forms of launch soon after 10 months from the date of enforcement

the previous decision on the reimbursement. The inaugural auction value

auction value is received from the previous decision on the reimbursement.



(24) in the next contest for reimbursement listed medicines of the same

active substances and pharmaceutical forms is not the lowest auction value reached in

electronic auction of at least 2% lower than the opening auction value has

the former winner of the ability to deliver the Institute's proposal to extend the existing

the auction received value and its obligation of reimbursement for the period

the next 18 months. The proposal must be delivered to the winner's 30 calendar days after the

stop reimbursement of the competition, or at least 30 calendar days before

the expiry date of the reimbursement of the contest in the event that additional

úhradová competition has not been announced. For the submission of the proposal the provisions of the

paragraph 6 similarly. In this case the Department of his proposal without delay

will meet.



(25) in the case that after the period of validity of the tender competition the Institute of

Decides in deep or shortened revision amending the above terms and conditions

the remuneration received by the preparations so that the level of remuneration is less than the amount

the remuneration provided for in paragraph 5, the provisions of paragraphs 19 and 23,

does not apply and the commitment of the reimbursement of the competition will be cancelled. Such

the decision shall be enforceable pursuant to section 39 h of paragraph 1. 3.



section 39f



The request for the fixing of maximum prices and the request for the fixing of terms and conditions

payment of the



(1) an application for the determination of the maximum price or request for determination of the amount and

the terms of payment shall be submitted individually for each pharmaceutical form of the medicinal

product or foods for special medical purposes.



(2) an application for the determination of the amount and terms of payment may be made by



and) the marketing authorisation holder of the medicinal product, if the medicinal product

authorised ^ 42b), and the importer or domestic manufacturer of food

for special medical purposes,



(b)) or importer or domestic manufacturer of the medicinal product, if it imported

or produced medicinal product used in the territory of the Czech Republic in

under the specific treatment program or another promoter

a specific treatment program ^ 42b),



(c)) the health insurance fund.



(3) the request for the fixing of maximum prices may be made by persons referred to in

paragraph 2 (a) and (b)).) The persons referred to in paragraph 2 (a). (c)) can

application may be made only if the medicinal product or foodstuff for

Special medical purposes shall be subject to the regulation of the maximum price and its

the maximum price is higher than price calculated pursuant to § 39a para.

2, or the maximum price has not been determined.



(4) the Institute shall initiate the procedure for the fixing of maximum prices or determining the

the amount and conditions of payment, even ex officio, if the determination of the maximum

the price or the determination of the amount and terms of payment of the public interest.



(5) an application for reimbursement must contain



a) name or business name, identification number of the person if

granted, the address of the applicant,



(b) the name of the medicinal product) code assigned by the Institute, is a medicinal

product is authorised,



(c)), pharmaceutical form, package sizes, the method and route of administration,



d) for unregistered medicinal products or foods for particular

medical purposes, an indication of its composition, with an indication of the active substance

international non-proprietary name recommended by the World Health

Organization, where such name exists, the



e) therapeutic indications, for which the remuneration is being suggested,



f) quantifiable and genotypic expected results and the reasons

Pharmacotherapy, to be achieved by the inclusion of a medicinal product or

foods for special medical purposes into the system of payments of health

insurance for all indications, for which the remuneration is being suggested, laid down

on the basis of objective and verifiable criteria,



g) dosage, defined daily dose recommended by the world

the World Health Organisation and the usual therapeutic dose for

therapeutic indications, for which payment is required, the number of daily benefits in

packaging,



(h) the amount of payment) the proposed in Czech Crowns per therapeutic

the daily dose, the proposed additional conditions for reimbursement,



I) proposed the maximum price of the medicinal product or food for

Special medical purposes in Czech Crowns, if the medicinal product is subject to

price regulation the maximum price and the price has not been established,

price calculation in the event that the price of the medicinal product or food for

Special medical purposes is guided under the price regulations, where applicable,

the proposed market price, if the medicinal product or foodstuff for

Special medical purposes is not affordable.



(6) the applicant shall attach to the request



and the results of the clinical trials available), indicating the benefits with which

were carried out, farmakoekonomických study evaluation, in particular the analysis of

cost effectiveness and impact analysis on financial resources

health insurance (hereinafter referred to as "impact analysis"),



(b)) the differences in the summaries of product characteristics, if a product is in the Member

States of the European Union authorised the national registrations and individual

summaries are substantively different,




(c) a list of the States of the European Union), in which the medicinal product is

or food for special medical purposes, present, indicating the

the relevant trade name, manufacturer, price, amount and conditions of payment

out of public funds and an affidavit of the applicant, that is a

product or foodstuff for special medical purposes as referred to

conditions in individual countries, traded,



d) basic data on the costs of existing treatment options, or

Pharmacotherapy with an estimate of the impact of the medicinal product under consideration, or

foods for special medical purposes on the health resources

insurance; the estimated consumption and estimated the number of patients treated with

the medicine or food for special medical

purposes,



e) proposal to set higher remuneration under section 39b of paragraph 1. 11 the definition,

for that group of patients, or the indication is to be determined and its

in the preamble,



(f) the interim arrangement), health insurance companies, if they relate to the volume of

supply, prices or payments to the circumstances of the medicinal product, or

foods for special medical purposes, done in the public interest (section 17

paragraph. 2) with the holder of the authorisation, if it is to such an agreement by the manufacturer

empowered by, or with the manufacturer or importer of a medicinal product or

foods for special medical purposes,



(g) a copy of the decision on the specific) treatment program ^ 42b), unless

medicinal product is authorised.



(7) the structure of the data and the requirements of the documentation referred to in paragraphs 5 and 6

the Ministry of health shall lay down the implementing legislation.



(8) the applicant for a determination of the amount and conditions of payment is not obliged to submit

the supporting documents referred to in paragraph 5 (b). (f)) and paragraph 6 (a). a), b), (d))

and (e)), if the medicinal product or foodstuff under consideration for special

medical purposes is similar with the medicinal product, or

food for special medical purposes, which has already been in the Czech Republic

fixed remuneration, and, in principle, therapeutically interchangeable, and

the applicant does not request an increase in the basic remuneration or payment in different

indications. If the proposed use of the medicinal product or a foodstuff

for special medical purposes different from use in principle, therapeutically

assimilated to a medicinal product or foods for special medical

the purpose to which the applicant refers, or to be a medicinal product, or

food for special medical purposes being used with different objectives

Pharmacotherapy, in different doses or different therapeutic indications,

the provisions of the first sentence shall not apply.



(9) an application for the determination of the maximum price shall contain the details and attachments

in accordance with paragraph 5 (b). a) to (c)) and i) and pursuant to paragraph 6 (b). (c)), and (f)).

If the applicant at the same time asking for a determination of the amount of the remuneration,

a separate application to establish maximum prices only to requests for

remuneration shall be asking at the same time fixing the maximum prices.



(10) an applicant referred to in paragraph 2 (a). (c)) shall be attached to the request only

the supporting documents referred to in paragraph 6 (b). d) to (f)).



(11) the applicant who submitted the request for the fixing of maximum prices, or about

determining the amount and terms of payment, is entitled to mark some of the

the information contained in the request or in the annexes to the application in the subject

trade secret ^ 42d). For the subject of a trade secret pursuant to

This Act cannot be marked



and the trade name of the medicinal product), and the code allocated to the Institute when

medicinal product is authorised, or trade name of food for

Special medical purposes,



(b) identification of the applicant)



c) quantifiable and genotypic expected results and the reasons

Pharmacotherapy, to be achieved by the inclusion of a medicinal product or

foods for special medical purposes into the system of payments of health

insurance,



d) for unregistered medicinal products the indication of the composition

the active substance of the preparation, with mention of the international non-proprietary name

recommended by the World Health Organization, where such name

There are,



e) dosage, defined daily dose recommended by the world

the World Health Organisation and the usual therapeutic dose for

therapeutic indications, for which payment is required, the number of daily benefits in

the packaging referred to in paragraph 5,



f) results of available clinical trials, indicating the benefits with which

were carried out, farmakoekonomických study evaluation, in particular the analysis of

cost effectiveness and impact analysis referred to in paragraph 6,



g) trade names, price, amount and conditions for reimbursement from public funds

the method of payment or its limitations in the countries of the European Union, where there is a

the product traded in accordance with paragraph 6,



h) the comparison of the information contained in the summaries of product characteristics in accordance with

paragraph 6,



I) substantial part of the arrangements for the prices of the medicinal product or a foodstuff

for special medical purposes and their validity, contained in the

agreements with health insurance companies in accordance with paragraph 6,



j) basic data on the costs of existing treatment options, or

drug therapy, with an estimate of the impact on health insurance resources

the estimated consumption and estimated the number of patients treated with the

a medicine or food for special medical purposes.



(12) for the subject of a trade secret can be highly innovative

preparations to mark the selected part of the contractual arrangements entered into between the

the persons referred to in paragraph 2, that govern the impact of remuneration on offers

the financial resources of health insurance or that may have an impact on the

cost efficiency, including the data referred to in paragraph 11 (a). (c)),

(f)) and i).



§ 39 g



The procedure for the fixing of maximum prices and the procedure for determining the amount and terms and conditions

payment of the



(1) a party to the proceedings on the fixing of maximum prices and the procedure for the determination of the

the amount and conditions of payment are persons who have submitted an application, health

insurance companies, if they are not persons that made the request, the marketing authorisation holder,

in the case of an authorised medicinal product, importer or domestic manufacturer,

in the case of an unregistered medicine used in the approved

a specific treatment program, or a food for special medical

purposes.



(2) the Institute shall decide on the maximum price and the amount and terms of payment

no later than 75 days from the date on which the proceedings were initiated; in the case of

the common procedure for the setting of maximum prices and the determination of the amount and

the terms of payment shall be the period of 165 days.



(3) the Institute of the request of the person referred to in § 39f para. 2 (a). and) or (b))

granted when the proposed maximum price is less than the maximum price

the calculated pursuant to § 39a para. 2 to 6 or less is the proposed level of remuneration

than the amount of remuneration calculated according to § 39 c and adjusted in accordance with section 39b.



(4) in deciding on the amount and conditions of payment of the Institute of medicine

or food for special medical purposes provides for payment pursuant to § 39 c.

In determining the amount and terms of payment of the medicinal product, or

foods for special medical purposes, the payment of increases or decreases in

the basis of the assessment of the conditions laid down in section 39b para. 2 way

laid down in the implementing regulation.



(5) the parties to the proceedings are entitled to propose evidence and do other

15 days of the initiation of proceedings; This time limit may, by resolution of the Institute of

extended. Parties to the proceedings have the right to comment on the background for

decision within 10 days from the date of notification of the communication of their

discovery of documents for decision; This time limit may, by resolution of the Institute of

extended.



(6) if in the course of the procedure for the determination of the maximum price or the procedure for

determining the amount and terms of payment to changes in the data submitted, and

documentation, the applicant is obliged to immediately notify the Institute these changes.



(7) in proceedings relating to the fixing of maximum prices, in proceedings relating to the determination of the amount and

conditions of payment, as well as in proceedings on the amendment or revocation as set out

the maximum price or terms and conditions of payment set out above shall apply

the provisions on the management of a large number of participants in accordance with the administrative

order ^ 42e).



(8) the Institute collected price reference medicinal products and food

for special medical purposes and details of their availability and the presence of

shall be deemed correct if the party to the proceedings is not to the contrary.



(9) if the conditions of section 39b para. 5 and 6 and article 39f of paragraph 1. 8 and

If he fails, according to paragraph 10, the Institute shall decide within a period of 30 days from the

the initiation of proceedings. Will not issue a decision within the time limit under the first sentence, the

consider that sets the amount of and conditions for reimbursement in accordance with section 39b para. 5 and 6

or the maximum price in accordance with § 39a para. 4 and 5. Decision referred to in

the second sentence is enforceable in accordance with section 39 h of paragraph 1. 3. in proceedings under

the first sentence of the provisions of paragraphs 2, 4 and 5 shall not apply and the participants

control is given the opportunity to comment on the background to the decision referred to in

paragraph 10.



(10) the Institute proceedings pursuant to paragraph 9, where it stops within 10 days of its

begin the request for determining the amount and terms of payment does not meet the

the elements listed in section 39f of paragraph 1. 8, and at least one of the parties with

Thus, within 5 days of receipt of notice of termination detection

supporting documents for the issuance of the decision concerned give their consent. On the day following


the legal force of a resolution in the first sentence, the Institute shall initiate proceedings on the application for

determining the amount and terms of payment with the procedure laid down in paragraphs 1 to 8.



(11) the Agreement closed in the public interest under section 39 c of paragraph 1. 2 (a). (c))

or (d)), it is possible to negotiate a suspensory effect not later than the date of application

the decision establishing or changing the basic remuneration.



(12) the appeal authority is not bound by the reasons of the appeal in the case that the contested

decision cancelled because of its non-compliance with the legislation. In such a

case, the appellate body further by the opposition parties.



section 39 h



The decision on the fixing of maximum prices and the determination of the amount and the conditions of

payment of the



(1) the Institute shall establish the maximum price or decision shall lay down the amount and

conditions of payment, conditions are met for their determination as

of this Act. Medicine is paid in the amount specified by the sum of the

provided for remuneration, the maximum trade margins and taxes of the value added

values (hereinafter referred to as "the highest possible remuneration for the final consumer"),

However to the maximum of the above actually raised prices for the end

of the consumer. Set out the amount and conditions of payment shall not apply, if

health insurance shall proceed in accordance with § 39 c of paragraph 1. 6.



(2) if the decision is not issued within the time limits laid down in this Act,

can the person who filed the request for the fixing of maximum prices, pharmaceutical

medicine or food for special medical purposes on the market at a price

proposed in the application, and the enforceability of a judgment on the determination

the maximum prices.



(3) If the decision in the deep or shortened revision, the decision to

determination of the maximum price or the decision on the determination of the amount and the conditions of

the remuneration, as well as their modification or cancellation of the decision on appeal

resource, or the decision on examination procedure has the power to

15. day of the calendar month, including enforceable release of the nearest

the following list under § 39n para. 1. If it has power

15. day of the calendar month, shall be enforceable by issuing the second nearest

list referred to in paragraph 1(b). paragraph 39n 1.



(4) an appeal against a decision in deep or shortened revision,

the decision on the fixing of maximum prices or decisions fixing the amount of

and conditions of remuneration, as well as their modification or cancellation, and against

the decision in the review does not have suspensory effect. If such

the decision challenged by the appeal, or decomposition, is provisionally enforceable

in accordance with paragraph 3.



(5) the effects of a decision repealing the decision referred to in paragraph 4,

occur under paragraph 3 apply mutatis mutandis.



section 39i



Changes the maximum price and the amount and terms of payment



(1) the Institute shall decide on changing the specified maximum price or above, and

conditions of payment at the request of the person referred to in



and section 39f) para. 2 (a). a) to (c)), as regards the maximum price; persons

referred to in section 39f of paragraph 1. 2 (a). (c)) may submit an application only if that

the maximum price of the medicinal product or foods for special

medical purposes is higher than the price calculated pursuant to § 39a para. 2,



(b)) § 39f para. 2 (a). a) to (c)), as regards the determination of the amount and the conditions of

the remuneration.



(2) the Institute shall without delay initiate proceedings ex officio on the change set out above

and the conditions of payment of the medicinal product or foods for special

medical purposes, which does not correspond to the basic payment established pursuant to § 39 c

paragraph. 7, or the conditions for reimbursement of unsatisfactory conditions has the remuneration

laid down in deep or shortened revision. The first sentence shall not apply to

medicines and foods for special medical purposes for which the

payment in accordance with section 39 c of paragraph 1. 8 the second sentence. The Institute will initiate proceedings ex officio

official about changing the maximum prices if after the evaluation laid down by

maximum prices according to § 39 l finds that the maximum price is

higher than the maximum price that you would Institute established under section 39a, or

If it is clear that the maximum price of a similar product determined in accordance with

§ 39a para. 4 or 5 is higher than the maximum price that you would Institute

established pursuant to § 39a para. 2.



(3) the Institute shall decide on the reduction, or to modify the conditions of payment,

If this reduction is part of the measures approved by the Government in order to ensure

the financial stability of the health insurance system) 42f ^ ^. Reimbursement of medicinal products

products or foodstuffs for special medical purposes Institute adjusted in

extent necessary, gradually, from the groups covered by the general reference,

After the reference group, life-saving medicines.



(4) the Institute shall decide on the request of the person referred to in section 39f of paragraph 1. 2 (a). and)

or (b)) on the reduction of the maximum prices according to § 39 g of paragraph 1. 9.



(5) in proceedings about changing the process according to § 39 g of paragraph 1. 1 to 8 and section 39 h

by analogy. The requirements for an application for amendment of the maximum price or changes in the amount of

and the conditions of payment shall apply section 39f of paragraph 1. 1, 5 and 11. The applicant,

seeking a reduction in payment or tightening conditions of payment, may

ask the Institute about the abandonment of the submission of the particulars referred to in section 39f

paragraph. 6. the Institute a request, unless the particulars necessary to

the assessment of interest on the availability of effective and safe medical care.

An applicant who applies for a reduction in the maximum price, it may request the Institute of

the abandonment of the submission of the particulars referred to in section 39f of paragraph 1. 6 (a). (c)).



§ 39j



Cancellation and termination of the maximum price and the amount and terms of payment



(1) If a medicine or food for special medical

the purposes are not made available on the Czech market for more than 12 months, the Institute can

to revoke a specified maximum price or amount and conditions

reimbursement at the request of the person referred to in section 39f of paragraph 1. 2 (a). and) or (b)), or from the

ex officio, and the maximum price or the cancellation of the above terms or conditions

remuneration is not contrary to the interest of the security of the availability of effective and

safe health care.



(2) the Institute may decide to revoke the above terms and conditions of payment



at the request of the person) and referred to in section 39f of paragraph 1. 2 (a). and) or (b)),



(b) at the request of the person) referred to in section 39f of paragraph 1. 2 (a). (c)), if provided for in

the amount and conditions of payment are not in accordance with this Act and the

compliance cannot be achieved by changing the maximum price or amount and conditions

payment, or



c) ex officio, if it is not a medicine or food for

Special medical purposes, suitable for use in clinical practice, and the holder of the

registration of the medicinal product or the importer or the domestic

manufacturer of foods for special medical purposes, evidence to the contrary.



(3) the Institute may decide to revoke the above terms and conditions of payment can

the official, provided this is not contrary to the public interest, if the person on whose

the request was granted by a decision of the administrative offense under § 39q

paragraph. 1, will not ensure the fulfilment of the obligations under paragraph 39d paragraph. 3 or fails to comply with

the obligation provided for in § 39 para. 1 (b). and) or (b)) or in § 39 para.

2. the decision to cancel the payment to that person may Institute for up to 3 years

Disable submission for determination of the amount and terms of payment of the medicinal

medicine or food for special medical purposes, in connection with the

This person committed an administrative offense.



(4) the Institute shall decide on cancellation of the specified maximum price or above, and

the conditions of remuneration referred to in paragraphs 1 to 3 within 75 days from the

the date on which proceedings were initiated. In proceedings for annulment provided for maximum

prices and conditions of payment, the amount shall be treated according to section 39 g of paragraph 1. 1 to 8

and section 39 h. The requirements for an application for revocation of the maximum price or

the cancellation of the above terms and conditions of payment shall apply section 39f of paragraph 1. 1 and section 39f of paragraph 1. 5

(a). a) to (c)), and (e)) apply mutatis mutandis.



(5) the maximum prices of proprietary medicinal products and food

for special medical purposes, for which the price is according to the decision of the

issued under the price regulation ^ 23 c) decided to cancel a regulation

the maximum price, the effective date of this decision.

The maximum price of the medicinal product or foods for special medical

the purpose of the enforceability of the decision expires on the date of the cancellation of the above terms and conditions

the remittance of this medicine or foods for special medical

purposes.



(6) the maximum price and the amount and terms of payment of the authorised

products expire on the date when the registration has been cancelled or allowed to lapse

the medicinal product or the marketing authorisation for the medicinal product

lost its validity, if it was not yet decided on the progressive download

medicinal product out of circulation; If it was possible to its gradual withdrawal from the

circulation, the amount and conditions of payment and the maximum price shall cease the expiry of

the deadline for the implementation of this download. For unregistered medicinal

the maximum price and the amount of products and conditions for reimbursement shall cease on the date of

a specific treatment program has been terminated; This does not apply, if it was with the

implementation of a specific treatment program for an identical pharmaceutical

product is reissued in a period of 6 months from the date of their

the validity of the prior agreement.



§ 39 k



Extraordinary extension of time



In the case of an extremely large number of requests for an increase in the maximum prices may

Institute of the period referred to in section 39 g of paragraph 1. 2 extend the resolution of 60 days, and


It only once. The applicant and the persons referred to in section 39f of paragraph 1. 2 (a). a) and

(b)), unless the applicant notifies the Department of extension of time prior to its

the end of the.



§ 39 l



A thorough revision of maximum prices or payments



(1) the Institute shall regularly evaluate at least once in 5 years, if specified

maximum prices do not exceed the limits laid down by law, the amount of

the basic remuneration, the amount of remittance compliance for all in principle, therapeutically

substitute medicinal products or foodstuffs for special medical

the purpose of the basic remuneration, consistency and effectiveness of the conditions laid down

reimbursement and compliance set out above and the terms of reimbursement of medicinal products and

foods for special medical purposes with this Act, and in particular

meet the expected results and the reasons, the effectiveness of the pharmacotherapy

determination of reference groups, the amount of the basic remuneration, conditions of payment,

evaluation of the clinical and cost effectiveness and comparison with the original objectives

pharmacotherapy.



(2) the Institute shall regularly evaluate the data obtained from its own activities and from the

third parties and observed situation maximum prices or reimbursement.



(3) on the basis of the information collected under paragraphs 1 and 2 of the Institute handles

the audit report, including the proposal on the adjustment of the reference groups and proceed

under paragraph 4 of the setting, modification or deletion of the maximum price or

the amount and conditions of payment of medicines and foods for special

medical purposes.



(4) a thorough revision of maximum prices or payments (hereinafter referred to as

"thorough revision") is done in the common procedure for the whole reference

a group within the period specified under section 39 g of paragraph 1. 2. In-depth review can be

self initiate and lead and to those medicinal products or

foods for special medical purposes for which it is proceeding on the

establishing, changing or cancelling the maximum price or amount and conditions

payment, or a shortened revision.



§ 39 m



The provision of information



(1) following the entry into legal force of the decision on the fixing of maximum prices, or

the decision on the determination of the amount and conditions of payment is the person on whose application

the decision was made (hereinafter referred to as "the holder") shall

without delay



and the Institute of information) to provide eligible affect the conditions for

a fixed maximum price or the amount and conditions of payment under section 39b of paragraph 1.

2 (a). a), c) and (f)) to (i)),



(b)) meet the Institute addressed letters rogatory relating to information referred to in point (a)

and)



(c) to inform the Department about the change) information necessary for interoperability

Of the Institute with the holder (for example, phone, fax, address

electronic mail).



(2) the person on whose application the decision on determination of the maximum

price or the decision on the determination of the amount and conditions of payment, which came into

legal force before 31 December 2006. in January 2010, the Institute is required to submit the data in

extent provided in § 39f para. 5 and 6 to 31. by 1 January 2013 and every

5 years. The person on whose application the decision on determining the

the maximum price or the decision on the determination of the amount and conditions of payment,

which came into force after 31 December 2006. January 2010, is required to submit to the Institute

data to the extent provided in section 39f of paragraph 1. 5 and 6 to 31. January 2018 and then

every 5 years.



(3) the obligation of notification under paragraphs 1 and 2 apply to health

insurance companies likewise.



§ 39n



Publication of information



(1) the Institute publishes on the first day of the calendar month a list that

exposes the electronic notice board. The list contains



and) for medicinal products and foods for special medical purposes

covered by the general health insurance scheme, for which the Institute shall decide on the amount and

conditions of payment, their full list along with the amount of the advertised price

the manufacturer, or the maximum set prices on the grounds, as the maximum

prices were established, with the amount and the terms of payment on the grounds, as above

and conditions for reimbursement laid down, with the highest possible remuneration for the final

consumers on the grounds, as it was calculated, and with the amount of the balance due

in the limit of pensionable service under section 16b, para. 1,



(b)) the basic payment reference groups on the grounds, as the base

the remuneration laid down, together with a full listing of medicinal products and food

for special medical purposes listed in reference groups,



(c)) the maximum prices of medicines and foods for special medical

the purposes for which the Institute shall act only on the maximum price together with a full

listing of medicines and foods for special medical purposes and with the

the rationale, as the maximum prices were established.



(2) the Institute shall regularly publish in the electronic notice board to 20. the date of

calendar month the draft list referred to in paragraph 1. In the penultimate

day of the calendar month, you can draft the list. Institute of

evaluates the expression and performs the repair. On the evaluation of the proposal for repair

list of Institute who filed a proposal, not inform.



(3) in the case of detection of defects in the amount of the maximum price or the highest possible

payment for the final consumers of the medicinal product in the list referred to in

paragraph 1 or update it promptly removes defects Institute.



(4) the Institute once a year, inform the Commission of the European Union



and) list of medicinal products and food for special medical purposes,

the maximum prize was established in the period under review, indicating the

the amount of the



(b)) the list of medicinal products, and foods for special medical purposes

of which the maximum price increased in the period considered, under

the amount of the



(c)) the updated list of medicines and foods for special

medical purposes covered by health insurance; the list contains

a full list of them along with the amount and the terms of payment on the grounds, as

the amount and conditions of payment has been established.



(5) the Institute will allow, at the request of the legal entity or natural person to inspect

the documentation submitted with the request for the fixing of the maximum

prices and fixing the amount of remuneration and the terms and conditions which it was taken during the

the procedure for the fixing of maximum prices or determining the amount and terms and conditions

the remuneration. When submitting the application data marked as the subject of the business

the secret of the Institute does not provide or otherwise disclose.



(6) if the applicant subsequently publish some information that

described under section 39f of paragraph 1. 11 for the subject of business secrets, cannot be

This information will continue to be considered for the subject of a trade secret; about

the applicant is obliged to inform the Institute.



(7) the information considered to be the subject of a trade secret pursuant to this

the law may Institute to provide on-demand administrative authorities for the

needs assessment of price controls, the fixing of maximum prices and the amount and

the terms of payment of, or in connection with their administrative, control or

sanctioning activities, as well as courts and law enforcement authorities. On

demand also provides this information to the Commission of the European Union.



§ 39o



Service in proceedings under part six



In a proceeding for the establishment, amendment or repeal of the maximum price or above, and

the terms of payment in the deep or shortened revision, in proceedings on appeal

resource or in review, all of the document served

only a public decree in a way allowing remote access.

The document shall be deemed to have been delivered on the fifth day after posting.



§ 39p



Abridged revision of maximum prices or payments



(1) the Institute conducts the proceedings ex officio or at the request of the person referred to

in section 39f of paragraph 1. 2 (a). (c) the revision of the maximum reduced) prices or

payments (hereinafter referred to as "shortened revision") in the event that the projected savings

health insurance resources in the reference group is greater than 30

0000 0000 CZK per year, or 5 0000 0000 CZK in the case of high level of remuneration

an innovative product.



(2) if the Department finds that in some of the groups of medicinal substances

referred to in annex 2 of this Act is not even 1 medicine fully

paid, shall forthwith initiate ex officio the abridged revision of all

reference groups containing active substances referred to in the relevant

the Group of annex 2 of this Act and a decision modifies the remuneration so that

in accordance with section 39 c of paragraph 1. 5 was the least expensive medicine

belonging to this group are fully paid.



(3) the Institute shall without delay initiate the shortened revision on the basis of the written

agreement under section 39 c of paragraph 1. 2 (a). c) or (d)) in the case that

the estimated savings in health insurance funds in the reference

the group is at least 20 0000 0000 CZK per year.



(4) the Institute shall without delay initiate the shortened review in the case that there has been a



and) violation of written agreement under section 39 c of paragraph 1. 2 (a). (c))

the basic payment reference group was established in the amount of such

the written agreement, or



(b)) violation of written agreement under section 39 c of paragraph 1. 2 (a). (d))

the basic payment reference group was established by such

the written agreement.



(5) the decision in the proceedings referred to in paragraphs 1 to 4 and § 39 c of paragraph 1. 9 Department of

to 50 calendar days from the date of initiation of the proceeding. Parties to the proceedings

they are entitled to propose evidence and make other suggestions 10 calendar days

from the date of initiation of the proceeding, and this period may Institute by resolution


extended. In the management of the revision of the maximum prices or

tender, the provisions of section 39 g of paragraph 1. 5 does not apply. A shortened revision under

paragraphs 1 to 4 and pursuant to section 39 c of paragraph 1. 9 it is possible to take place only at

in principle, therapeutically interchangeable group of medicinal products and

foods for special medical purposes, in which took place the first revision

the system of payments; otherwise, the Institute shall proceed pursuant to section 39 l short

revision pursuant to § 39 c of paragraph 1. 9 shall be carried out from the base of the remuneration conversion

set out under section 39 c of paragraph 1. 7 and the conditions of payment are maintained.



(6) a shortened revision is done in the common procedure for the whole reference

the Group of. A shortened revision can be separately to initiate and lead and to those

medicinal products or foods for special medical purposes,

which is proceeding for the establishment, amendment or repeal of maximum prices

or the amount of the remuneration, terms and conditions, or depth of the revision.



§ 39q



Administrative offences



(1) legal or natural person has committed the administrative business

offense, if the breach



and submitted pursuant to section). 6 (a). (e)),



(b) a written agreement) pursuant to § 39 c of paragraph 1. 2 (a). (c)), which was

fixed basic remuneration reference groups,



(c) a written agreement under paragraph) 39 c of paragraph 1. 2 (a). (d)), which was

fixed basic remuneration or reference groups



(d) the obligation of reimbursement) the competition under section 39e.



(2) for the administrative offence referred to in paragraph 1 shall be fined



and the $ 10 0000 0000), in the case of an administrative offence referred to in paragraph 1 (b). and)

(c)),



(b)) for a third of annual turnover in the context of the active substances and

the dosage form in the Czech Republic, up to 100 0000 0000 Czk in the case

on administrative offence pursuant to paragraph 1. (d)).



(3) a legal or natural person-entrepreneur for the administrative offence

does not match, if it proves that made every effort, which was

may be required to prevent a breach of duty.



(4) in determining the amount of the fine to take account of the seriousness of the administrative

offense, in particular, the way a criminal offence and its consequences, and

circumstances in which it was committed, and if it is a repeated

violation of this law.



(5) the responsibility for the administrative offence shall cease, if the administrative authority about him

has commenced proceedings in 2 years, when aware of it, but not later than 5

years from the date on which it was committed.



(6) administrative offences referred to in paragraph 1 dealt with the Institute. The fine exacted

the Customs Office. Income from fines is the State budget revenue.



PART SEVEN



section 40



Health insurance companies



(1) the health insurance these health insurance companies:



and general health insurance company), United States, ^ 43)



b) departmental, sectoral, enterprise or any other insurance company. ^ 44)



(2) the health insurance companies are required to pay the providers, or

other entities referred to in § 17 paragraph 2. 7, who, in accordance with this

by law are written by paid to the insured services, such services provided in

time limits negotiated in the contract pursuant to § 17 para. 1. If it is not between

the health insurance company and provider of contract negotiated, and if they are

health insurance pursuant to this Act are required to provided by health

service pay, be paid in the same time limits as the providers,

which health insurance company concluded a contract pursuant to § 17 para. 1.



(3) the health insurance fund shall provide health providers under contract

services a remuneration of $ 100 for each day on which it was in the period from

1 January to 31 December 2004. December 2014, provided its inpatient care

the insured person, the insured person, for each such day, being in

which the insured person was adopted to provide inpatient care and day on

which has been providing bed care ended, counts as one day

(hereinafter referred to as ' the compensation '). Health insurance compensation calculated from

data on inpatient care provided to the provider of the reported 31. March

2015 and the recognized sickness insurance fund.



(4) the Compensation referred to in paragraph 3 shall be granted in the form of monthly advances with

subsequent billing. The basis of the advance shall be calculated as one-twelfth of the

the total regulatory charges for in-patient care, that the provider was

obliged in 2013 for this care select and choosing this regulatory

fee health insurance company has reported. In the month of July 2014 will pay

health insurance provider, seven times higher than the base backup,

not later than 31 December 2006. July 2014. The monthly advance in August to

December 2014, the health insurance fund shall pay to the provider of the base

backup not later than on the last day of each such calendar

of the month. Expense report monthly prepayments and calculated the compensation of health

the insurance company performs up to 30. from 1 June 2015.



(5) the health insurance fund shall decide on applications of its insured persons about

the issue of permits under the coordination regulation. The request must be

shows what health services insured person intends to draw instead of their

drawing and estimated time of their usage. Health insurance company

authorisation in accordance with the coordination regulation shall only be granted if they are for

his release conditions stipulated coordination ^ 52) regulations.

If there is reason to fear that the required health service cannot be

the insured person due to his State of health and the probable course of the

the disease is granted on the territory of the United States in a timely manner and there is no danger of

delay, the health insurance company to issue a permit under the coordination

regulation without delay.



(6) the health insurance fund shall provide to the insured at his request a refund

costs pursuant to § 14 para. 2 to 5 not later than the last day of the month

following the acquisition of the decision pursuant to § 53 para. 1.



(7) the health insurance companies are obliged to ensure their insurance policy holders



and the local availability of paid services). The local availability of means

reasonable distance of the place of provision of paid services due to the

place of residence or the place of residence of the insured person. Local

availability is expressed by the coastdown time. Local availability

emergency medical services provided by law, governing health

emergency service. The coastdown time shall, for the purposes of this Act, the

time in whole minutes, which corresponds to the effective availability of places

means of transport which is proportional to the speed of land

communication and is in accordance with the law governing the operation of the road

roads. Driving time determined by the Government, by regulation,



(b) the availability of paid services) time. The time availability of the means

ensuring the provision of urgent and acute covered services within

corresponding to their urgency. The deadline for expressing time availability

the planned paid services provides for government regulation.



(8) the health insurance companies are required to issue free of charge to its insureds

insurance card or replacement document. Pass or replacement document

a person with limited legal capacity shall issue the relevant health insurance

guardian, guardian or guardian. Insurance card

or replacement document contains name, last name, or title,

force and the number of the insured person, which is, in the case of citizens of the United States

your social security number. Health insurance lead in information systems data

of their insured individuals needed to implement the public health

insurance under the number of the insured person.



(9) insurance card or replacement document can contain in addition to the data

to identify a policyholder in written form also similar information in

electronic form. For the issue of a replacement document capable to bear the

information in electronic form has health insurance are entitled to the reimbursement of

the cost of its acquisition. On the card of the insured or on the replacement

the document can be stored even more data on insured persons, if so determined by the

the law. Additional data can be stored on the ID card of the insured person or

the replacement document, if the insured person agrees with the appropriate

health insurance company.



(10) health insurance lead



and a list of providers); This list, which does not contain data

referred to in point (b)), is required to disclose any health insurance company

manner allowing remote access,



(b) an overview of the medical workers) paid service

each of the providers in the breakdown of doctor, dentist,

pharmacist and healthcare worker engaged in allied health

occupation according to the law on the paramedical professions, who

show your health insurance company made to medical procedures according to the list

medical procedures with point values (hereinafter referred to as the "recipient"); for

to this end, they are required to disclose health insurance providers

for the past quarter, and at the latest within 30 days, a list of individual

holders of performances on the last day of the quarter, giving the name,

last name, title, social security number and category of the wearer power according to the

list of medical procedures with point values; This provider

the obligation to fulfil even if health insurance shall notify only those

the changes that have occurred since the previous report.



(11) health insurance companies give the initiative to cancel the Trade Office

trade licence entrepreneurs because of non-compliance


entrepreneurs pay a premium on health insurance premiums.



(12) the health insurance fund is a user-maintained in reference data

basic population register about subjects who are its

the insured person, to the extent



and) surname,



(b) the name or names),



(c) the address of the place of stay)



(d)) of the date, place and County of birth; for the data subject, who was born in

abroad, the date, place and the State where he was born,



(e)) of the date, place and County of death; in the case of the death of the data subject outside the territory

The United States, date of death, place and the State on whose territory the death

has occurred.



(13) the health insurance fund is a user of the data kept in the registry

social security numbers of natural persons who are its beneficiaries in

the range of



and) the name or names, first and last name,



(b) the social security number),



(c)) in the event of the original social security number, personal identification number,



(d)) the day, month and year of birth.



(14) the data needed by health insurance under paragraphs 12

and 13, may use, only if they are necessary for the performance of its responsibilities.

Use of data from the population register and the register of birth

numbers for health insurance is free.



(15) the health insurance fund shall collect data relating to the administrative

proceedings in matters relating to compensation of the costs for health services pumped

insured persons in other Member States of the European Union, in particular, the



and) proceedings initiated on the reimbursement of costs pursuant to § 14 para. 2 to 4, of the

their number, place of their drawing and about how it was in the individual

proceedings decided



(b)) proceedings initiated for the granting of prior consent, about the number of

and, as was decided in the respective proceedings,



(c)) the amounts that were in accordance with § 14 para. 2 to 4 are replaced by the insured.



(16) the data collected in accordance with paragraph 3 shall be communicated to health insurance

in anonymised form at the request of the Ministry of health.

The Ministry of health provides this information to the European Commission in the

her deadlines.



§ 41



the title launched



(1) the health insurance fund used for the purposes of proceedings under section 53 of the

the basic data of the population register to the extent



and) surname,



(b) the name or names),



(c) the address of the place of stay)



(d)) of the date, place and County of birth; for the data subject, who was born in

abroad, the date, place and the State where he was born,



(e)) of the date, place and County of death; in the case of the death of the data subject outside the territory

The United States, date of death, place and the State on whose territory the death

has occurred; If it is issued the Court's decision on the Declaration of death, day,

that is the decision, listed as the day of death or the date on which the entity

data declared dead have survived, and the date of acquisition of legal power of this

the decision,



f) nationality, or more of State citizenship.



(2) the health insurance fund used for the purposes of proceedings under section 53 of the

the information system of the population register data in the range



and) the name or name, last name, or changing them, native

last name,



(b)) date of birth,



(c)) place and County of birth; for the citizen, who was born in a foreign country, location and

State where he was born,



(d) the social security number) and its amendments,



e) nationality, or more of State citizenship,



(f) the address of the place of residence), including previous address space

permanent residence,



(g)) the beginning of permanent residence or cancellation date data on the place of

permanent residence or the date of their permanent residence in the territory of the United

Republic,



h) date of final court decision on the approval of the Treaty on

agent or representative office of a member of the household including the Court that

contract or agency has approved, the date of the decision

Court on the restriction of incapacitation, the name or names, surname and maiden

the number of the guardian; If no guardian identity number allocated,

the date, place and County of birth, and the guardian, who was born in

abroad, the place and the State where he was born, is the guardian of the legal

the person, the name and address of the registered office,



I) name or name, last name and social security number of the father, mother,

or other legal representative; in the event that one of the parents or

another legal representative or guardian does not have a social security number, his name,

where appropriate, the name, surname and date of birth; If other regulatory

the representative of the child's legal person, the name and address of the registered office,



j) family status and due date changes



spouse's social security number); If the husband is a natural person who does not have

assigned a social security number, his name or names, the surname of the husband and

the date of his birth,



l) social security number of the child,



m) date, place and County of death; in the case of the death of a citizen outside the United

Republic, the date, place and the State on whose territory the death occurred,



n) day, who was in the Court decision on the Declaration of death listed

as the day of death, or as a day that did not survive,



o) day, who was in the Court decision about declared missing listed

as the day when the effects of the Declaration of the nezvěstnosti occurred, and the date of acquisition

the decision of the Court about the declared missing.



(3) the health insurance fund used for the purposes of proceedings under section 53 of the

the information system of the foreigners to the extent information



and) the name or names, surnames, their change, maiden name,



(b)) date of birth,



(c)) the place and State of birth,



(d) the social security number) and its amendments,



e) country of citizenship or nationality,



(f)) the type and address of the place of stay,



g) number and valid permission to stay,



(h) the beginning of the stay, if applicable) date of the termination of the stay,



I) limitation of incapacitation,



j) administrative or judicial expulsion and the period for which it is not allowed to enter

on the territory of the Czech Republic,



k) marital status, date and place of its changes, the name or names,

the surname of the husband and his social security number; in the case that the social security number was not

allocated, date of birth,



l) the name or names, the family name of the child and his social security number; in

If the social security number was not assigned, date of birth,



m) the name or names, the surname of the father, mother or any other

legal representative or guardian and their social security number; in the case that

one of the parents or other legal representative or guardian does not have native

the number of his name, where applicable, the name, surname and date of birth,



n) date, place and County of death; in the case of deaths outside the United

the Republic, the State on whose territory the death occurred, or the date of death,



o) day, who was in the Court decision on the Declaration of death listed

as the day of death or the date on which the stranger declared dead survivors



p) day, who was in the Court decision about declared missing listed

as the day when the effects of the Declaration of the nezvěstnosti occurred, and the date of acquisition

the decision of the Court about the declared missing,



q) the name or names, and last names



1. an adult dependent child of a foreigner,



2. minor aliens who had been strangers, or his or her spouse

by decision of the competent authority entrusted into foster care, or

that was a stranger, or his spouse acquired or whose guardian

or the husband of his guardian is a foreigner,



3. the lone stranger 65 years or older, regardless of age of the alien,

that you cannot take care of himself for health reasons, in the case of

family reunification with a parent or child who are aliens,



4. an alien who is a dependent direct relatives in the ascending or

descending line or such relatives of the husband of a citizen of the European Union,



5. the parents of a minor alien and his or her social security number; in the case of foreigners,

who do not have assigned a social security number, name, or name, surname and

date of birth.



(4) the health insurance fund used for the purposes of proceedings under section 53 of the registry

social security numbers of individuals who have been granted social security number,

However, they are kept in information systems referred to in paragraph 2

or 3, the data in the range



and) the name or name, surname, maiden name, if applicable



(b) the social security number) and its amendments,



(c)) date of birth,



d) place and County of birth, for physical persons born abroad of a place and

State of birth.



(5) the data which are kept as reference data in the principal registry

of the population, shall be used from the information system of the population register or

information system for foreigners only if they are in the shape of the previous

the current state.



(6) of the provided data that can be used in a particular case only

such data, which are necessary for the performance of the task.



section 41a



Classification of acute care and a reference network providers



(1) for the purposes of rationalization of the functioning of the system of public health

insurance in the area of acute care Institute of health information

and statistics of the Czech Republic (hereinafter referred to as the "Institute of health

information ") creates and annually updates the list of groups

in acute care hospitalizations related to diagnosis (hereinafter referred to as

"the group"), their relative cost, marshaling rules

hospitalizations into groups and methodologies related to reporting

paid services provided in acute care. The current data and

methodology in the first sentence it passes the Institute of health information


The Ministry of health always within 90 days before the end of the calendar

of the year. Rules for the classification of hospitalizations into groups leading the Institute

health information in a computer program, which the Ministry of

health care provides at the same time with the data referred to in the second sentence.



(2) the Ministry of health data and methodologies referred to in paragraph 1 sentence

the second published on its website and, upon request, free of charge

It provides in particular for the purposes of the reporting of covered services acute

care health insurers, providers and other entities

a computer program referred to in paragraph 1, the sentence of a third.



(3) for the purposes of the transmission of information to the national registry of covered services

According to the law on health services health insurance information

the provider reported acute care services covered by the

processes in the computer program referred to in paragraph 1, third sentence.



(4) to ensure the development of the Marshal hospitalizations in acute

inpatient care to groups may Institute of health information to conclude

the contract with the provider of the transmission of information on costs

hospital admissions. The Department of health will publish a list

providers with whom the contract has been concluded, according to the first sentence in the

Journal of the Department of health.



Review



§ 42



(1) the health insurance fund shall control the use and provision of paid

services and the health insurance bill, in terms of volume

and quality, including compliance with the prices with providers and policy holders.



(2) control activities are carried out through information data in the

the scope of the law and the activities of the inspection of doctors. Other control

the activities carried out by healthcare professionals who are eligible for health care

audit activities (hereinafter referred to as "qualified persons"). Health insurance companies

the implementation of control activities through access to

A central repository of electronic prescriptions under the Special

the law ^ 44a).



(3) the revision shall be considered substantiation of the therapeutic process doctors with a special

regard to its progress, and the prescription of medicinal products, food

for special medical purposes and medical devices, and on the

the assessment of the needs of the Spa sanatorium rehabilitation care as part of the

therapeutic care. Review by doctors and other professionals on

check whether



and paid services) provided correspond to the borne vyúčtovaným services

health insurance,



(b)) have been accounted for only those performances, medicines and food for

Special medical purposes and medical devices which is a health

the insurance company have to pay,



(c)) and the type of covered services range corresponds to a State of health

of the insured person.



If the check shows the unlawfulness or incorrectness of the statement

covered services, health insurance does not pay for such services. If

check shows that the insured person has been prescribed for the medicinal product in

contrary to the conditions laid down in the decision of the Institute about the amount and

conditions of payment and health insurance this medicine

care providers pay, has the appropriate health

the insurance company the right to reimbursement of the amount paid for such a medicinal product

provider, where he was a medicine prescribed to you.



(4) to fulfil the tasks referred to in the preceding paragraphs are revision

doctors and healthcare professionals who are authorized to enter into health care

device. The performance of the activities of the medical and professional staff must not

disrupt the treatment carried out performance. The provider provides health

insurance company necessary assistance in the exercise of control, in particular presents

required documents, communicates information, and provides an explanation. Access to the

medical documentation allows only physicians to review or

specialists; These workers have access to health care

the documentation only to the extent the corresponding control.



(5) Review the doctors carrying out control activities in the field, in particular

where the acquired specialization.



(6) Review the doctors carrying out control activities in employment

relation to the health insurance company, which is contracted on the basis of

the selection procedure.



(7) the review doctors undertake monitoring activities with your provider,

of which are employees, owners, co-owners, operators, members of the

statutory authority, or where by reference to their relationship to the

the controlled persons or to the subject of checks are reasonable doubt

about their impartiality. Revision doctors are obliged to immediately after

what becomes aware of facts indicating their bias,

tell your health insurance company, for which they perform the inspection

activity.



§ 43



(1) the health insurance fund shall be subject to the control of the State authorities of the Czech

of the Republic.



(2) health insurance leads a personal account of the insured person as overview

expenditure on paid services provided to that insured person and paid

regulatory charges under section 16a and supplements for partially paid for by the active

medicines and foods for special medical purposes that are

count towards the limit under section 16b, para. 1. Upon request of the insured person is

health insurance shall in writing without undue delay and free of charge

provide once a year in the form of statement of personal account data on

covered services paid for the insured person during the period of the past

12 months including regulatory charges paid pursuant to section 16a and

supplements for partly paid for medicines and foods for special

medical purposes during this period, the following information, if applicable, for the number of months

that the insured person during the last 12 months for this health

insurance companies insured. Health insurance is required on request

of the insured person to provide remote access to his personal account. If you can to

the insured person, his legal representative, a guardian or guardian a written

consent may be made available to this personal account as well as doctor

of the insured person.



PART EIGHT



FINES AND SURCHARGES TO THE FUSE



§ 44



(1) for failure to comply with the notification obligation referred to in article 10, the competent

health insurance save policyholders a fine up to $ 10,000 and

employers of up to 200 000. Failure to comply with the notification

the obligation by the employer to impose a fine only to the employer.



(2)



cancelled



(3) upon repeated failure to comply with the notification obligation may be imposed

a fine of up to twice the amount of the fine imposed.



(4) when the failure to fulfil obligations to be subject to preventive

inspection under section 12 (a). (e)) or in breach of its obligations under section 12

(a). I) to), or if the insured is prematurely released from inpatient

care for the continuing gross violations of internal regulations of the provider

inpatient care, the relevant health insurance save policyholders

a fine up to $ 500. Health insurance company may impose a fine on

up to $ 5000 to the insured that the provision covered by the

the services proved her identity card of the insured person, although at that time it

the insured person was not. A fine may be imposed within one year from the date of

appropriate health insurance company has found a violation of or failure to perform

obligations, but within three years from the date on which the acts of infringement or

failure to fulfil obligations has occurred.



(5)



cancelled



(6) the financial penalty is receiving health insurance, which it imposed.



§ 45



(1) the health insurance fund may charge a premium to the fuse

employers, which has occurred in the past calendar year to

a recurrence of accidents at work or occupational diseases in the same

causes ^ 45) and, consequently, to increase the cost of health services,

with the exception of those accidents at work or occupational diseases, the

the cause is detected or occurring threat to animals or

natural elements or due to infringement of third parties.



(2) the health insurance fund shall be levied to the employer referred to in paragraph

1 Premium contributions up to 5% of the market share, driven by

insurance for all employees.



(3) payment of premiums, premium assessment for the calendar year can be

post by 30. June of the calendar year following the

the year in which the facts referred to in paragraph 1. Premium on

premiums shall be paid in one lump sum on behalf of the health insurance companies.



(4) employers are required to send the competent health insurance company

^ 46) copy records on accidents at work, and at the same time for the past

calendar month, not later than the fifth day is always the following month.

Failure to comply with this obligation, the competent health insurance company

Save the employer a fine up to 100 000 CZK.



(5) providers, who are entitled to the recognition of occupational diseases,

are required to send a copy of the report, the competent health insurance company

occupational diseases.



(6) as regards maturity increases to premiums, the method of payment,

its recovery, forfeiture and return of overpaid on the costs of premiums,

proceed as with the premium.



§ 45a



(1) the health insurance fund is committing an administrative offense, by



and) shall not disclose contract and payment of covered services pursuant to §


Article 17(1). 9 or its amendment or modification,



(b) does not result in a list of the providers) pursuant to § 40 paragraph 2. 10 (a). and)

or such a list will not disclose,



(c) an overview of the health of workers does not keep) providing paid

for each service providers pursuant to § 40 paragraph 2. 10 (a). (b)),



(d) does not provide their insureds the provision) covered services, including

their local and temporal availability pursuant to § 46 para. 1, or



e) in violation of § 52 para. 2 enters into a contract for the provision and payment of

paid services to the applicant without the recommendation of the conclusion of such an agreement in

the selection procedure.



(2) an administrative offense shall be fined in the



and 100 000 CZK), in the case of an administrative offence referred to in paragraph 1 (b). (b)) or

(c)),



(b)) 1 0000 0000 CZK in the case of an administrative offence referred to in paragraph 1 (b). (e)),



(c) Eur 10 0000 0000), in the case of an administrative offence referred to in paragraph 1 (b). and)

or (d)).



(3) the health insurance fund for the administrative offence does not match, if the

demonstrates that he made every effort, that it was possible to require that

breach of legal obligations.



(4) in determining the amount of the fine to take account of health insurance

the severity of the administrative offense, in particular, to the manner of its perpetration, and his

consequences and the circumstances under which it was committed.



(5) the liability of the insurer for the administrative offence shall cease, if the

administrative authority about him has not initiated proceedings within 1 year from the date on which it

learned, but not later than within 3 years from the date on which it was committed.



(6) administrative offences referred to in paragraph 1 dealt with the Ministry of

the health sector.



(7) the Fines collected and enforced by the authority that is saved.



(8) income from fines is the State budget revenue.



section 45b



cancelled



PART NINE



NETWORK OF PROVIDERS OF HEALTH CARE SERVICES



§ 46



(1) the health insurance fund is required to ensure the provision of paid

services to its affiliated persons, including their regional and time availability.

This obligation through providers with which it has concluded

contract for the provision and payment of covered services. These providers

form a network of providers, health insurance companies (hereinafter referred to as

the "network").



(2) before entering into a contract for the provision and payment of covered services,

the selection procedure takes place. Selection procedure does not take place



and care providers),



(b) if the provider) is paid by the prison service, services



(c)) in cases of extension of medical provider network Contracting

emergency services,



(d)) in the conclusion of a new contract for the provision and payment of covered services,

If this is a contractual relationship with the same body and at the same time

There is no extension of the scope of the provided covered services,



e) in the case of highly specialized care provided, provider

which was to provide such medical care is granted under the law on

health services the health status of the Centre of highly specialized

care, or



f) when concluding the contract and payment of covered services according to

§ 17 para. 8.



(3) in the event of a change of legal form provider that has an

contract for the provision and payment of covered services, and in the case where the

the founder of the limited liability company is a natural person, that has

a contract for the provision and payment of covered services, whose

permissions to the provision of health services as natural person ceases to exist

When you grant permission to provide these health services as

limited liability company, the selection process takes place only when the

When the extension of the scope of the provided covered services.



(4) the venue of the selection procedure may suggest a health insurance company,

applicant, or a municipality. Applicant means the provider of authorised

provide health care in the field, or the natural or

legal person who intends to provide health services and is able to

the time limit set in the notice of the selection procedure to meet the requirements for

provision of health services in the field of health care.



§ 47



(1) the tender announced by the way in the place of the usual regional office in

the capital city of Prague, Prague City Hall (hereinafter referred to as "regional

the Office "). The local jurisdiction of the regional office shall be the place of the provision of

health services. Tender for the provision of beds and Spa

hospital rehabilitation care announced by the Ministry of health.



(2) the tender must include:



and paid services and range) specifically defined area for which they have

be provided, and the health insurance companies, if the health

the undertaking by the applicant selection process



(b)) the time within which to submit a tender; This time limit shall not be shorter than

30 working days,



(c) the place for filing of the application),



(d)), from which the time limit is necessary to ensure the provision of health services,

which are the subject of the tender.



§ 48



(1) the Principal shall for each tender to the Commission. Members of the Commission

they are:



and a representative of the regional authority), in the case of a tender, organized

the regional authority, or a representative of the Ministry of health, in the case of

the tender launched by that Ministry,



(b) a representative of the relevant Chamber) established by law of the Czech Medical Chamber,

The Czech dental Chamber and the Czech Chamber of pharmacists or representatives

professional organization in the case where there is no appropriate Chamber,



(c) a representative of the competent sickness insurance fund),



(d)) the expert for health services to be provided by the applicant;

When it operates in the field of health services support company, is

a member of the selection board, the representative of the company.



(2) the members of the Commission could not be persons for whom taking into account their relationship

the candidates are doubts about their impartiality, and relatives

those persons.



(3) the membership of the Commission is indispensable. The members of the Commission are covered by

obligation of professional secrecy on all the facts which are

learn in the context of the selection process. Provide information on the

the fact that the person participated in the selection process, the members of the Commission

not considered a breach of the confidentiality obligations under

a special law.



§ 49



(1) the activities of the Commission, chaired by its President, who is the representative of the regional

the Office, in the case of a tender, the promoter's Regional Office,

or a representative of the Ministry of health, in the case of a selection procedure,

the promoter is the Ministry of health.



(2) the Commission is quorate if the majority

all members of the Commission. The decision is taken, if voted for him

an absolute majority of present members of the Commission. In the event of a tie

a representative of the casting vote, the competent health insurance company. About hearing

the Commission, the progress and outcome of the selection procedure, the Commission shall,

which shall be signed by the Chairman and the members of the Commission by all present. The entry shall

contain the names of the members of the Commission and the determination of the application, stating the order

the number of obtained votes. The President of the Commission shall transmit the registration vyhlašovateli

immediately after the end of the meeting of the Commission. The activity of the Commission ends.



(3) the costs associated with the announcement of the selection procedure and activities of the Commission

paid by the announcer. The costs associated with participation in the tender shall be borne by

the tenderer.



§ 50



(1) tenders shall be notified within the time limit set by the vyhlašovateli pursuant to § 47

paragraph. 2 (a). (b)). The candidate is required to demonstrate that it meets, or is in the

the period laid down in the tender, able to meet the prerequisites for

the provision of paid services in the field of health care, which

is the subject of the tender.



(2) the applicant shall be invited to meetings of the announcer of the selection board (hereinafter referred to as

"the Commission"). Applicants whose application has formal defects that

the candidate does not remove the time limit set by the organising body, returns

announcer application, stating the reasons.



§ 51



(1) when assessing applications for members of the Commission shall take into account, in particular, to the network

health insurance companies in the field and to the reputation of the applicant, to

experience in the relevant field, to disciplinary measures imposed by

under the Act on the Czech Medical Chamber, the Czech dental Chamber and

The Czech Chamber of pharmacists, to ethical approach to patients to complain

on the provision of health services. The members of the Commission also considered the intent of the

the applicant to the provision of paid services in the field of health care, which

is the subject of the tender, and its ability to meet the prerequisites for

provide covered services within the period specified in the notice of the selection

control.



(2) after examination of applications the Commission shall determine the order of candidates.



§ 52



(1) the Principal is obliged to publish the outcome of the selection procedure including the

the number of votes referred to in § 49 paragraph 1. 2.



(2) the health insurance fund shall take into account the results of the selection procedure when

the conclusion of contracts for the provision of and payment of covered services. The result of the

the selection procedure shall not confer the right to contract with health

the insurance company. Health insurance company is authorized to enter into a contract with

the applicant only where the conclusion of such a contract in the selection

recommended control.



(3) the conclusion of the contract with the tenderer in the tender


recommended that this candidate may submit an application for a declaration of a new

the selection procedure in the same scope and territory again after 3

months from the date of publication of the result of such a tendering procedure.



(4) if the conclusion of the contract with the tenderer in the tender

recommended, can this candidate again to request the publication

competition or to apply to the already renowned for the selection

tender for the scope, territory and a health insurance company, for which it was

the conclusion of the contract and payment of covered services recommended to

After the expiration of 3 months from the date of publication of the result of such a selection

control.



PART TEN



THE PROVISIONS OF THE COMMON



§ 53



Decision making



(1) on the decision-making of health insurance companies in matters relating to

granting of prior informed consent under section 14b, authorisation by the

the co-ordination regulation, the reimbursement of costs pursuant to § 14 para. 2 to 4,

the price increases to premiums, fines, and the likely amount of the premium and the

disputed cases in matters of premium payments, penalties, refunds

the excess on the insurance and reduce the prepaid insurance premiums are subject to the General

regulations on administrative proceedings, ^ 47) unless otherwise provided by this Act. In

administrative application proceedings shall be decided whether or not in the insured person's

disputed cases about payment of amounts under section 16b; to the design of the insured person

shall be accompanied by proof of payment of regulatory charges that are counted

in the limit under section 16b and evidence of payment of the fees for part

paid for medicines and foods for special medical purposes,

that will be included in the limit under section 16b, from which it follows that

limit under section 16b has been exceeded. Health insurance companies make decisions on

matters increases to premiums, fines and in contentious cases

premium payments and penalties payment acreage. The appeal against the

the payment of the insurance premium assessment in matters does not have suspensory effect.



(2) the outstanding premiums and penalties may prescribe to the health insurance company

a statement of the arrears payment also. Statement of arrears must contain



the premium payer), which show arrears,



(b) the amount of the arrears by status) the payer's account of premiums on a specific day

based on the data reported by the payer or of the checks

carried out by the health insurance premiums of likely,

If it was fixed, and the finance charge calculated on that date,



(c)), the date on which the amount of the arrears was detected,



(d)), the competent health insurance account numbers, on which must be

arrears paid



e) instruction on the enforceability,



f) instruction on the objections,



(g)) the health insurance companies, which issued a statement of arrears, and

the date of issue. Statement of arrears shall be provided with an official stamp and

signed with the name, surname and the functions of an authorized person.



(3) a statement of arrears shall be enforceable on the day of its delivery. A statement of the

arrears shall be served on the same way as credit assessment.



(4) Against the statement of arrears can be health insurance company, which the statement

arrears has released, filed within 8 days from receipt of written comments, if

the payer does not agree with the existence of debt premiums on the insurance and finance charge memos

or its amount. The reason for the opposition is the payer of insurance shall in

objections noted.



(5) the health insurance fund on the basis of the objections within 30 days of their

delivery issues a decision, which the statement of arrears either confirm, if the

the amount of the arrears is fixed correctly, or cancelled. If health

the insurance company decides about the objections within the time limit referred to above, shall cease to be a statement of the

arrears of force.



(6) the health insurance fund may cancel the arrears on its own statement

initiative.



(7) The procedure for issuing the statement of arrears are not subject to the General provisions

on the administrative proceedings.



(8) the Enforceable decision on the matters referred to in paragraph 1 and

enforceable statements of arrears are heading for court ^ 47a) or

^ 47) administrative enforcement.



(9) the administrative execution of the decision on the matters referred to in paragraph 1 shall be

health insurance credit assessment issued at first instance

the proceedings; This applies to statements of arrears.



(10) on the appeal against the decision of the health insurance fund referred to in paragraph 1

shall be decided by the arbitration authority of the health insurance companies. The arbitration body shall be composed

one representative of the health insurance companies, one representative of the Ministry of

the health sector, one representative of the Ministry of labour and Social Affairs,

one representative of the Ministry of finance, which shall designate three representatives from

its members, the Board of health insurance, and three representatives of that

shall designate from among its members, the Supervisory Board of health insurance company. The arbitration body

It is able to pass resolutions if more than two thirds of the present members. To

the validity of the decision should be by an absolute majority of the members present. To

the first meeting shall convene the members of the arbitration body Director of health

the insurance company. At this first meeting, members of the arbitration body shall elect

from among their number a President who continues to convene and conduct

the arbitration body.



(11) in the performance of the functions of a member of the arbitration body may be granted

the reward, which is decided by the Board of health insurance companies.



(12) decide if arbitration body in the first instance shall apply mutatis mutandis

the provisions of the code of administrative procedure of decompilation.



(13) the Final decision of the health insurance companies referred to in paragraph 1 are

subject to review by the Court in accordance with the specific legislation.



§ 53a



(1) the health insurance fund may remove the hardness of which would

occurred when prescribing penalties, the amount of which does not exceed 20 000 CZK to date

delivery hardness removal requests.



(2) the arbitration body may remove the hardness that would arise in the

the imposition of fines, assessment surcharges to premiums or prescription of penalties,

the amount of which exceeds the 20 000 CZK.



(3) the removal of hardness in accordance with paragraph 1 or 2, you cannot decide

If



and insurance premiums) the payer not pay health insurance contributions payable

to the date of issue of the decision on immunity, increases to the premiums or

finance charge memo



(b)) to the payer of insurance was filed insolvency ^ 47b)



(c)) the payer of insurance entered into liquidation.



(4) for a waiver of premiums, fines, surcharges or penalties shall be decided

at the written request of the payer of the insurance or other authorized persons

(hereinafter referred to as "the applicant"). An application may be made to the acquisition of legal power

the decision, which was fine, levied a surcharge to premiums

or the prescribed penalty; If new facts have emerged that

through no fault of the applicant could not apply to the time of the acquisition of the legal

the power of this decision may be lodged within three years of legal

the power of this decision.



(5) The procedure for the remission of fines, surcharges, premiums or periodic penalty payments

not covered by the General rules of administrative procedure. ^ 47)

removal of hardness is the decision final.



§ 53b



The delivery of a public decree



(1) the health insurance fund shall apply in proceedings pursuant to § 53 para. 1 delivery

a public decree in the case where it is not known residence or registered office of the

party to the proceedings, or in the event that the party does not stay on

the place of his residence, registered office or the address for service of that insurance company

He said.



(2) service of a public decree makes health insurance so that

be posted at the headquarters for a period of fifteen days in place of the usual way

notification of location of documents with its precise indication; notification

also be posted at the headquarters of the locally applicable organizational unit

health insurance companies that document served. The last day of the period

in the first sentence shall be considered the date of delivery.



§ 53 c



In carrying out the obligations arising from this Act, and the Special

law, ^ 17) are compulsory subjects entitled social security numbers of the persons

Alternatively, a different number of the insured person.



§ 54



cancelled



section 55



Reimbursement of costs of paid services incurred as a result of an unlawful

behaviour towards the insured person



(1) the health insurance fund has against a third party the right to claim

the cost of paid services that incurred as a result of culpable

infringement of the third party against the insured person. Replacement according to

the first sentence is receiving health insurance funds.



(2) for the purposes of reimbursement of paid services referred to in paragraph 1 are

providers are required to notify the relevant accident and health insurance

other damage to the health of the people, which are written by paid services if they have

reasonable grounds for believing that an injury or other damage to health caused by

conduct legal or natural persons. The obligation of notification have

the authorities of the police of the Czech Republic, the Prosecutor's Office and the courts.

The obligation of notification under this paragraph shall be implemented within 1 month from the date of

When the one who announces the fact he learned about it.



(3) for the purposes of reimbursement of paid services referred to in paragraph 1 are

public health authorities are required to provide on request

competent health insurance company reports on the results of epidemiological and

other investigations which are carried out by these authorities shall be obliged to

the specific legislation.



(4) for the purposes of reimbursement of paid services referred to in paragraph 1 are


labour inspection authority and the authorities of the State mining authority required to provide

upon request, the competent health insurance company the results of the investigations into the causes

deadly, heavy and bulk of work accidents and occupational diseases.



(5) for the purposes of reimbursement of paid services referred to in paragraph 1 shall

information referred to in the preceding paragraphs, provided free of charge.



(6) the health insurance fund may waive recovery of all or part of the above

reimbursement of the costs referred to in paragraph 1,



and) if enforcement of the recovery of the costs associated with special or

nepoměrnými, or



(b)) if it is likely that the costs of enforcement outweigh the proceeds.



The waiving of recovery of part or all of the amount of reimbursement of costs pursuant to

paragraph 1 is not a legal right.



(7) in determining the amount of the refund of the costs from its enforcement of the health

the undertaking referred to in paragraph 6 shall refrain, shall take into account health insurance

in particular, how the damage occurred, and to the personal circumstances and property

the person who caused the injury.



(8) for the purposes of a claim for reimbursement of the costs referred to in paragraph 1

not employees of health insurance company secrecy

established by a special law, and it's about the facts decisive for

claims and against persons in respect of which, or through which the

the claim alleges.



section 55a



Relationship to international treaties



Provisions of this Act shall not apply where an international treaty to which the

Parliament gave its assent, which the Czech Republic is bound and which was

published, provides otherwise.



section 55b



For the regional authority or municipality of the village with

extended jurisdiction under this Act are transferred

the scope of the.



PART ELEVEN



TRANSITIONAL AND FINAL PROVISIONS



§ 56



(1) for dependent children, pursuant to § 7 para. 1 (b). and until 31 December 2008).

December 1998, and university students older than 26 years old. This provision

does not apply after the date of interruption of studies to students who study at the

the high school had been interrupted.



(2) For those receiving pensions from pension insurance pursuant to § 7 para. 1

(a). (b)) shall be treated as beneficiaries of pensions granted also after 31 December 2006. December

1992 according to the regulations of the Czech Republic or the Slovak Republic, if they

a pension was calculated taking into account the period of employment before 1. January

1993 the employer established in the territory of the Czechoslovak Socialist

Republic or the Czech and Slovak Federal Republic.



(3) where regulations uses the term "general health

insurance "means" public health insurance ".



§ 57



Shall be deleted:



1. the law of the Czech National Council No. 550/1991 Coll., on general health

insurance, as amended by Act of the Czech National Council No. 592/1992 Coll., Act

The Czech National Council No. 10/1993 Coll., Act of the Czech National Council No. 15/1993

Coll., Act No. 166/1993 Coll., Act No. 333/1993 Coll., Act No. 241/1994

Coll., Act No. 58/1995 Coll., Act No. 160/1995 Coll., Act No. 145/1996

Coll. and Constitutional Court of the Czech Republic No. 206/1996 Coll.,



2. The Ministry of finance Decree No. 273/1993 Coll., laying down the

method of making and using departmental funds, industry, corporate, and

other health insurance companies,



3. The Ministry of finance Decree No. 269/1993 Coll., laying down the

more detailed conditions for the creation and use of the Reserve Fund of the general health

the insurance company.



PART TWELVE



CHANGE AND THE ADDITION OF RELATED LAWS



§ 58



The Czech National Council Act No. 553/1991 Coll. on general health

the insurance company of the Czech Republic, as amended by the Act of the Czech National Council.

593/1992 Coll., Act of the Czech National Council No. 10/1993 Coll., Act No.

60/1995 Coll. and Act No. 149/1996 Coll., shall be amended and supplemented as follows:



1. In article 7 (2). 1 (b). and at the end of a comma) be replaced by a semicolon and

connect with these words: "the basic Fund covers the costs of further

the activities of the insurance company pursuant to section 5 (b). d),".



2. In article 7 (2). 1 (b). (c)) at the end of attached these words: ";" Special-purpose

You cannot create pools of basic resource or reserve fund ".



§ 59



The Czech National Council Act No. 280/1992 Coll., on departmental, disciplinary,

corporate and other health insurance companies, as amended by the law of the Czech

the National Council No. 10/1993 Coll., Act of the Czech National Council No. 15/1993 Coll.

Act No. 60/1995 Coll. and Act No. 149/1996 Coll., amending and supplementing

as follows:



1. in article 13, paragraph 2 is deleted.



2. In article 16(1). 2 at the end of this sentence connects:



"The special funds of the basic resource cannot be created or reserve

Fund. ".



3. in article 16, paragraph 4 shall be deleted.



4. § 17 para. 1 reads as follows:



"(1) the health insurance fund is used to pay for health care

paid for by the general health insurance scheme and is made up of payments

insurance premiums. From the Fund the costs of further activity

employee insurance companies according to § 13 para. 1 (b). d).".



5. in paragraph 22 of part five shall be inserted, which including the title reads as follows:



"PART FIVE



HEDGE FUND



§ 22a



(1) this Act establishes a hedge fund (the "Fund"), which

is a legal entity. The Fund is recorded in the commercial register. Fund

He is not a fund within the meaning of such a law.



(2) the Fund is used to pay for the health care provided by healthcare professionals.

devices to the insured employee insurance destroyed by 6

paragraph. 6 (a). and), in cases where they were not on the date of completion of the liquidation, the

employee insurance companies met all due accounts receivable

health care facilities, and in cases where an employee and the insurance company has

several lenders and is not able to for a long period to meet its debts,

or if it is předlužena.



(3) Any employee of an insurance undertaking shall be obliged to contribute to the Fund.

The annual contribution of employee insurance companies in the Fund is 0.5% of the average

the annual expenditure of the basic Fund employee insurance. The contribution to the

The Fund is an employee and the insurance company is obliged to pay for the previous

calendar year not later than 31 December 2006. January of the current year. The Fund may

to invest funds in government securities, securities

securities guaranteed by the State or in vouchers the Czech National Bank.



(4) the Fund is managed by a Board of Directors. Members of the Management Board shall be appointed by

the Minister of health. Members of the Board are appointed for a period

five years, and it repeatedly. As a member of the Management Board does not belong

the reward.



(5) the details of the activities of the Fund adjusts the Fund rules, issued by the

The Ministry of health.



section 22b



(1) the Fund shall provide reimbursement of medical devices based on its

request, the conditions are fulfilled according to § 22a para. 2. the Fund shall have the right

to review the lawfulness of the provision of health care, which has to pay;

the provisions of this law and other laws regarding

staff employee of the insurance undertaking shall not apply.



(2) the remuneration shall be as follows:



and) with regard to claims arising in respect of the provision of health care

general practitioner and general practitioner for children and adolescents, in the amount of 80%

the amount owed, but not more than 200 Czk per person



(b)) in respect of claims arising from the title of the provision of out-patient

health care specialists, in the amount of 80% of the outstanding amount, no more than

However, 900 Eur per insured person,



(c)) in respect of claims arising from the title of the provision of hospital

care, amounting to 80% of the outstanding amount, but not more than 1200 Czk per

the insured person,



(d)) with respect to claims arising from the title on the basis of dispensing

a prescription, in the amount of 80% of the outstanding amount, but not more than 700 CZK

one of the insured person.



(3) the right of medical equipment on the reimbursement from the Fund shall become statute-barred

the expiry of five years from the date laid down in paragraph 1.



(4) in the event that the resources of the Fund are not sufficient to pay the law

provided for payments, will provide the remaining part of the necessary cash

resources to Fund the State in the form of returnable financial assistance. In such a

the case increases the employee's contribution to the Fund from the insurance

the year following the granting of a loan to double the percentage of the

referred to in § 22a para. 3. in the year following the repayment of repayable

financial assistance to post reduced to the percentage referred to in §

22A paragraph 2. 3.



section 22 c



Fund becomes a creditor of health insurance rights

medical equipment from the Fund. ".



section 60



The Czech National Council Act No. 592/1992 Coll., on premiums for General

health insurance, as amended by Act of the Czech National Council No. 10/1993 Coll.

the Czech National Council Act No. 15/1993 Coll., Act No. 166/1993 Coll.,

Act No. 333/1993 Coll., Act No. 42/1994 Coll., Act No. 241/1994 Coll.

Act No. 58/1995 Coll. and Act No. 149/1996 Coll., amending and supplementing

as follows:



1. in article 15, paragraph 2. 1 at the end of this sentence connects:



"Arrears of premiums, the amount in the aggregate does not exceed one

complied and one insurance company of $ 50, you cannot recover them. ".



2. section 18, the following paragraph 4 is added:



"(4) if not prescribed penalty does not exceed in the aggregate $ 100 for one

calendar year. ".



3. section 28b, the following paragraph 4 is added:



"(4) in accordance with the provisions of § 15 para. 1 and § 18 para. 4 insurance proceeds


even in the case of periodic penalty payments, which should be assessed by the insurance company or enforce the day

the effectiveness of these provisions, however, until the date of their effectiveness so

failed to do so. ".



PART THIRTEEN



§ 61



The effectiveness of the



This Act shall take effect on 1 January 2000. April 1997, with the exception of article 15, paragraph 2.

10 the first sentence, and article 59 paragraph 5 which enter into force on 1 January 2000. January

1998.



Zeman in r.



Havel, v. r.



Klaus r.



Annex 1



LIST OF MEDICAL PROCEDURES FROM A HEALTH INSURANCE COMPANY OR

COVERED ONLY UNDER CERTAIN CONDITIONS



List of abbreviations and symbols

---------- ------------------------------------------------------------------------------

Mark, Explanation

symbol

---------- ------------------------------------------------------------------------------

ODB expertise



CAT health category performance in terms of payment of health insurance

-symbols N, Z, W-see below



The performance marked in column n KAT symbol "N"-health performance significantly

nehrazený of health insurance, the exception may be the previous

to enable the audit trail for the insured's doctor, due to its

serious medical condition (or special health need)



W marked in column performance KAT symbol "W"-health performance fully

paid from health insurance only when certain conditions or

maximum reimbursable limit frequencies, you do not need the approval of the revision

doctor



Of performance in the column marked "Z" symbol KAT-health performance fully

paid health insurance only under certain conditions and after approval by

the review by a doctor



DG. diagnosis



sequence. No serial number power

---------- ------------------------------------------------------------------------------

---------- ----------------------------------------------------------------------------

ODB Name

---------- ----------------------------------------------------------------------------

001 General practical medicine



002 practical medicine for children and adolescents



014 Dentistry General-General dentist-dentist



015 Orthodontics



201 rehabilitation and physical medicine



401 occupational medicine



404 Dermatovenereology



504 vascular surgery



601 plastic surgery



603 of gynaecology and obstetrics



605 Oral and maxillo-facial surgery



606 Orthopedics



701 Otorhinolaryngology



705 Ophthalmology



706 Urology



808 forensic medicine



809 diagnostic radiology



903 clinical speech therapy



911 General nurse



999 Universal care-without binding on the expertise

----------- ---------------------------------------------------------------------------



List of medical procedures from public health insurance company

or covered only under certain conditions

-------------- ------------------------------------------------------ -------------------------------------

Sequence. ODB Name Health Condition of payment performance KAT

No.

-------------- ------------------------------------------------------ -------------------------------------

1.001 Health educational činnostN



2.002 Disabled educational activity N



3.014 Sealing fissures-tooth N



4.014 Koferdam-one jaw N



5.014 alveolár bone Trephination N



6.014 Augmentation, guided tissue regeneration and implant a N

in dentistry



7.014 Makeshift bridge made in N



8. Fix the fixed compensation in 014 surgery N



9.015 Professional consultations at the request of orthodontic patient N



10. Reconstruction and 504. iliaca int. and other feats of N

for vascular impotence



11.603 Rekanalizace the fallopian tube after previous sterilization N



12.701 Indirect laryngoscopy with instillation of drug to the larynx N



13. The implantation of penile prostheses 706 N



14.706 cock-kavernosometrie N



15.706 Kavernosografie N



16. the types of preventive examinations-903 detect N

in the field



17. The investigation carried out at the workplace 001 racing doctor W performance will be paid if the

jenezbytný to determine the

the epidemiological situation in the workplace



18.014 Injectable anesthesia W performance will be paid except

intraligamentární anesthesia



19.014 Comprehensive examination by a doctor of the provider in the field of Watts power will be paid only when the

the takeover of the insured person to the dentist care

upon registration of the insured person



20.014 Review oral hygiene-prophylaxis W Paid twice a year



21.014-prophylactic removal of tartar W Paid once a year



22.014 Local fluoridation with drying W Paid when the product

with aminofluoridem without carrier



23.014 Fill permanent teeth (regardless of the number of Watts Paid only when you use

faces, including the reconstruction of the nedózovaného amalgam)

in the scope of the entire set of teeth, when you

use samopolymerujícího

composite only to the extent

the canine teeth, including



24.014 Composite fill the permanent tooth (without Watts Paid for children up to the age

regardless of the number of faces, including 18 years in the range of the canines, including

reconstruction of the muzzle and the completion of the plastic)



25.014 endodontic treatment W Paid when you use

the registered material

method of the central pin



26.014 Transitional splint without preparation-per tooth W Paid when you use

self-polymerizing

composite resin



27.014 Temporary splint with the preparací-per tooth W Paid when you use

self-polymerizing

composite resin



28. Determination of the long-term rehabilitation 201 W Paid once during treatment

plan on the basis of past rehabilitation Conference



29. The investigation in the workplace of the insured person 401 W Performance will be paid only

in terms of risks of professional examination for indication

damage to threatened, suspicious or

This ongoing professional disability



30.601 Reshaping and tightening odstálého ears W Full payment to 10 years of age

a child over 10 years of health

the insurance company will not refund the



31.701 agravaci tests and simulation of W in the case of proven simulation

nehrazen



32.705 Applications contact lenses W performance will be paid after the operation

cataracts



33.808 Consultation findings the Court doctor W performance will be paid, if it is

nažádost doctor

necessary to explain the award

for the particular case



34. A comprehensive assessment of health 911 W Performance will be paid only on

the status of an insured person in his environment, the recommendation of a medical practitioner

upon receipt of the insured person to

doctor indicated the temporary or

long-term nursing care

in the home



35. check of the insured person in the 911 Targeted home environment W performance will be paid after the previous

indication of general practitioner,

that can be a one-off or

expressing a specific frequency

visits to a specific period



36.911 Nursing intervention is simple in a home environment W performance will be paid after the previous

indication of general practitioner,

that can be a one-off or

expressing a specific frequency

visits to a specific period



37.911 Comprehensive care ošetřovatelsky W Performance-intensive will be paid after the previous

or non-moving the insured person in a domestic environment the indication of a medical practitioner,

that can be a one-off or

expressing a specific frequency

visits to a specific period



38.999 Psychotherapy support-performed by doctor nepsychiatrem W performance will be paid only on one

the insured person once a year


in a single scope after detailed

registration in the medical

documentation



39.999 to interview the doctor with the family will be paid on the Watts power one

insured persons under the age of 15 years

no more than twice per year,

in adults once a year after

detailed registration in the medical

documentation



40.999 Educational interview doctor with a sick or family W Paid only when health

the indication of a reasoned in writing

vezdravotnické documentation

and legitimized by the signature of the edukovaného

or his legal representative



41.999 Consultation doctor Watts power provider paid only if it is on

specialized outpatient care practitioner's request



42.403 Proton radiotherapy of performance will be paid only if it was done

on the basis of the indications of a provider that

mástatut Center of highly specialized

health care in the field of Oncology awarded

According to the law on health services.



43.404 Epilation á 30 minutes of performance will be paid only

for dg. E00-E07 (disorders of the thyroid

gland, hormonal disorders),

E10-E14 (diabetes mellitus),

E20-E35 (diencefalohypofyzární

disorders)



42.601 correction of congenital anomalies of the auricle of the small

and the surrounding area (bone growths)



45.601 Xanthelasma of



46.601 Operation ptózy face-upper, dolníZ



47.601 Operation ptózy face-total (smas of

lifting)



48.601 Operations hard and soft nose for the function of the

malfunction



49. Rinoplastika-601 soft nose of



50.601-Rinoplastika sedlovitý nose (L-graft, including collection)



51. Rinofyma of 601



52. gigantomastie Operation of 601



53.601 Ablation with preserving the areola of the breast



54. The reconstruction of the areomamilárního complex of 601



55.601 Capsulotomy implant from housing



56.601 breast implant removal with kapsulektomií from



57. The implantation of tissue Expander and 601 of



58.605 chin augmentation bone, cartilage or prosthesis of



60.605 Subperiosteal implant-one jaw of the



61. the Chin Correction of 605



62.606 Osteotomy of the hip



63.606, shortening of the long bones Extending from the



64.701 of Septoplasty



65. Laser iridotomy 705 of the Performance is paid when you perform

1 St 3 times, when most

another implementation is to be paid

require the consent of the review a doctor



66.705 Dermatoplastika one eyelid, or from

blepharochalasis-exize from one eyelid

+ fat removal and fold



67.705 Laser coagulation of the retina of the Performance is paid when you perform

1 St 5 times, when most

another implementation is to be paid

require the consent of the review a doctor



68.705 plastic surgery of the skin of the eyelid of the Rotary

the caudate lobe or offset



69. thermotherapy Transurethral prostate of 706



70.706 cock-intrakavernózní injection of vasoactive substances from



71. the vas deferens-706 Ligature vazektomie from

-------------- ------------------------------------------------------ -------------------------------------



Annex 2



LIST OF GROUPS OF ACTIVE SUBSTANCES



--------- --------------------------------------------------------------------------------------

The number of the name of a group of substances

Group

--------- --------------------------------------------------------------------------------------

1 protivředová of the drug from a group of Proton pump inhibitors, oral administration



2 agents, oral administration



3 from the Group setronů antiemetics



4 anti-inflammatory drugs with inflammatory intestinal inflammation, oral administration



5 anti-inflammatory drugs for inflammation in the bowel, rectal application



6 micronized multienzymové pancreatic preparations



7 insuliny short-acting



8 insuliny intermediate acting



9 insuliny long-acting



10 oral antidiabetics of biguanides group



11 oral agents from a group of sulphonylurea



12 vitamin D and its analogues, oral administration



13 vitamin D and its analogues, parenteral administration



14, oral administration of calcium salts



15 salt potassium oral



16 antithrombotika of vitamin K antagonist



17 antithrombotika of a group of heparin



18 antithrombotika acting through the anti-Xa (low molecular weight

heparins and similar drugs)



19-in addition to aspirin anti-platelet agents



20 antifibrinolytics, oral administration



21 antifibrinolytics, parenteral application



22 antihemorrhagics (vitamin K), oral administration



23 coagulation factor VIII



24 coagulation factor IX



25 iron salts, oral administration



26 iron salts in combination with folic acid, oral administration



27 iron salts, parenteral application



28 erythropoietin and other drugs with a similar mechanism of action



29 substituents plasma and plasma proteins (albumin)



30 substituents plasma and plasma proteins (other)



31 total parenteral nutrition (components for the systems all in one)



32 by solutions has the solution



33 intravenous glucose solutions



34 solutions for peritoneal dialysis



35 solutions for haemodialysis



36 cardiac glycosides, oral administration



37 class I and III antiarrhythmics, oral administration



38 adrenaline



39 nitrates and molsidomin for chronic oral administration of



40 nitrates for emergency treatment



41 antiadrenergic agents, antihypertensives-oral



42 drug for pulmonary hypertension



43 diuretics lower the effect of oral administration of diuretickým,



44 diuretics with high effect, oral administration



45 diuretics with high effect, parenteral application



potassium-sparing diuretics, 46 oral administration



47 selective beta blockers, oral administration



48 vápníkového channel blockers from the Group dihydropyridinů Active 24 hours, more than 3 months

oral administration of



49 other calcium channel blockers, oral administration, acting

less than 24 hours



50 other groups of calcium channel blockers, oral administration, acting

more than 24 hours



51 ACE-inhibitors acting for more than 24 hours



52 drugs affecting the renin-angiotensin system, with the exception of the ACE-inibitorů



Statin lipid lowering medicines from a group of 53



lipid lowering medicines from a group of 54 Fibrates



55 antifungals for topical use



56 antipsoriatics for topical use



57 antibiotics for topical use



58 corticosteroids used for topical therapy-the weak and moderate

1. and 2. generation



59 corticosteroids used for topical therapy-the weak and moderate

3. and 4. generation



60 corticosteroids used for topical therapy-a strong and very strong

1. and 2. generation



61 corticosteroids used for topical therapy-a strong and very strong

3. and 4. generation



62 active substances against acne for topical use



63 gynecological antifungals, antibiotics and chemotherapeutics for topical

the use of the



64 of the drug rising tone of the uterus



65 drugs reducing the tone of the uterus



66 prolactin inhibitors



67 male sex hormones



68 female sex hormones of estrogen, oral administration group



69 female sex hormones of estrogen, parenteral application group



70 female hormones from a group of progestins



71 gonadotropins and other ovulation stimulants



72 other sex hormones, androgens and modulators



73 urinary antispasmodics



74 drugs used in benign prostatic hyperplasii



75 front lobe of the pituitary hormones and their analogues



the rear lobe of the pituitary gland 76 hormones and their analogues



77 the hypothalamus hormones and their analogues



78 total use of corticosteroids, oral administration



79 total use of corticosteroids, parenteral application



80 thyroid hormones



81 of antithyroid drugs



82 glucagon



83 homeostatika calcium




84 tetracycline antibiotics, oral administration



85 Penicillins with wide range and combination of Penicillins, including inhibitors

betalactamases, oral administration



sensitive to Penicillins, betalaktamáze 86, oral administration



87 different lactam antibiotics, oral administration



88 sulfonamides and trimethoprim, oral administration



89 macrolide antibiotics, oral administration



90 linkosamidová antibiotics, oral administration



91 aminoglycoside antibiotics



92 quinolone chemotherapy, oral administration



93 imidazolová and nitrofuranová chemotherapy, oral administration



94 antimycotics for systemic use, oral administration



95 antimycobacterials



System 96 antivirals for treatment of herpes, cytomegalovirových infections

and some other viral infections, oral administration



97 antiretroviral therapy



98 immunoglobulins, normal human



99 human tetanus immunoglobulin



100 human immunoglobulins against the hepatitis



101 other human specific immunoglobulins



from a group of alkylating antineoplastic 102 substances, oral administration



from a group of alkylating antineoplastic 103 substances, parenteral application



104-folic acid analogues antimetabolites, oral administration



105-folic acid analogues antimetabolites, parenteral application



106 antimetabolites-purine and pyrimidine analogs, oral administration



107 antimetabolites-purine analogues, parenteral application



108 antimetabolites-pyrimidine analogues, the other the application paths



109 of vinca alkaloids and analogues



110 podofylotoxinu derivatives, oral administration



111 podofylotoxinu derivatives, the other the application paths



112 taxanes



113 anthracyclines and their derivatives



114 cytotoxic antibiotics



115 Platinum antineoplastic agents



116-tyrosine kinase inhibitors, antineoplastic agents, oral administration



117 antineoplastic agents-monoclonal antibodies



118 a cytostatic effect of hormonal medicines, parenteral administration



119 antagonists of hormones-anti-estrogens, oral administration



120 antagonists of hormones-antiandrogens, oral administration



121 aromatáz inhibitors



122 interferons used in Oncology



123 the interferons and glatiramer acetate are used in neurology



124 interferons used in Hepatology



125 immunosuppressive drugs-m-TOR, oral administration



126 immunosuppressive drugs-calcineurin inhibitors, oral administration



127 of immunosuppressive drugs, TNF-alpha inhibitors



128 nonsteroidal anti-inflammatory drugs, oral administration



129 nonsteroidal anti-inflammatory drugs, rectal



130 Central muscle relaxants, oral administration



131 anti-gout agents, oral administration



132 Drugs acting on bone mineralisation-bisphosphonates, oral administration



133 local anesthetics of the amide hydrolysis group



134-strong opioid analgesic oral



135-strong opioid analgesics, transdermal application



136 analgesics-morphine, parenteral administration



137 analgesics-weak opioids, oral administration



138-strong opioid analgesics for the treatment of breakthrough pain



139 analgesics-antipyretics, oral administration



140 antimigraine preparations



141 antiepileptics from a group of barbiturates



142 antiepileptics, oxazolidinů of the Group of hydantoinátů and sukcinimidů



143 antiepileptics from a group of benzodiazepines and karboxamidů



144 antiepileptics from the Group derivatives of fatty acids



145 anticholinergic antiparkinsonian



146 dopaminergic antiparkinsonian levodopa from the Group and their derivatives



147 of the dopamine agonist antiparkinsonian group



148 antiparkinsonian acting on MAO or COMT



149-classical antipsychotic Neuroleptics, class I, oral administration



150-classical antipsychotic Neuroleptics, II. class, oral administration



151 low potential antipsychotic drugs seizures, oral administration



Antipsychotics-152 and dopamine receptors of serotonin antagonists



153 Antipsychotics-multireceptoroví antagonists



154 lithium



155 antipsychotic drugs, Neuroleptics parenteral applications-depot preparations



156 anxiolytics, oral administration



157 anxiolytics, rectal



158 antidepressants non-selectively inhibits the reuptake of Monoamines,

oral administration of



159 antidepressants-selective serotonin acting on one transmiterový

system, the oral administration of



160 antidepressants-selective serotonin acting on two transmiterové

systems, oral administration



161-the oral administration of Central stimulants



162 drugs for the treatment of Alzheimer's disease (cholinesterase inhibitors)



163 parasympatomimetika, oral administration



164 of the drug used in the treatment of dizziness, oral administration



165 antimalarial drugs



166 anthelmintic



167 nasal corticosteroids including hypoallergenic



168 inhaled sympathomimetics



169 inhaled corticosteroids



170 inhaled anticholinergics



171 antileukotrieny, oral administration



172 non-sedating antihistamines



173 ophthalmologicals-antibiotics



174 ophthalmologicals-chemotherapy



our 175-antivirals



176 ophthalmologicals-corticosteroids



177 ophthalmologicals-nonsteroidal anti-inflammatory drugs



178 antiglaukomatika of a group of sympathomimetics and parasympatomimetik



179 antiglaukomatika from the Group of beta blockers



180 antiglaukomatika of a group of prostaglandins and prostanoidů



181 mydriatika and cykloplegika



our 182-antialergika



183 therapeutic extracts standardized allergens, neinjekční administration



184 therapeutic extracts standardized allergen injection



185 basic antidotes



186 antidotes used in the treatment of chemotherapy, oral administration



187 antidotes used in the treatment of chemotherapy, parenteral administration



188 defined mixture of amino acids without phenylalanine



189 defined mixture of amino acids amino acids (except without the selected

phenylalanine) for other metabolic disorders



190 individually prepared radiopharmaceutical for diagnosis



191 individually prepared radiopharmaceutical therapy



192 of packed products



193 trombocytární preparations



194 products from plasma



195 leukocyte preparations

--------- --------------------------------------------------------------------------------------



Annex 3



THE LIST OF MEDICAL DEVICES



SECTION AND



List of abbreviations and symbols



In the list of medical devices which are not fully from the resources

health insurance and in the list of medical devices covered by

health insurance funds in the provision of out-patient

health services have used abbreviations and symbols the following meaning:



and) group

1 bandages, plasters

2 AIDS for incontinence

3 Ostomy AIDS

4 orthopaedic prosthetic devices mass produced

5 orthopaedic prosthetic devices individually made

6 compression stockings and girdles

7 disability including trolleys accessories

8 hearing aid accessories

9 glasses and optical AIDS

10 AIDS respiratory and inhalation

11 tools for diabetics

12 compensatory aids for the disabled

13 on unspecified equipment

14 compensatory aids for the visually impaired

15 compensatory aids for the hearing impaired

16 orthopedic shoes

17 tools for laryngektomované



(b)) the abbreviation

DB decibel

DPT diopters

K. t. compression class

PVC (polyvinyl chloride)

SRT verbal threshold of clarity



(c) specialisation and marking abbreviations) special focus sites

ALG Allergology and Clinical Immunology

CHR surgery

DIA Endocrinology and diabetology

DRV dermatovenereology

FON foniatrie

GER Geriatrics

J16 surgeries with the activity of angiologickou and lymfologickou

NEU Neurology, Child Neurology

OHM Oncology and Hematology

OPH ophthalmology

ORP prosthetics

ORT orthopedics

OTO Otorhinolaryngology

PED paediatrics, practical medicine for children and adolescents

PRL general practical medicine

REH, rehabilitation and physical medicine

S3 owning Company ENT doctor certificate entitling to

to regulation and the issue of hearing aids financed by public funds

health insurance

S4 ophthalmic surgeries for the dispensing of special optical AIDS

S5 special health insurance scheme for the approval of the review a doctor

TRA Traumatology

TRN Pneumology and phthisiology

TVL sports medicine

URN in urology and Nephrology



SECTION B



The list of medical devices which are not fully public health

insurance in the provision of out-patient health services

----------------- ----------------------------------------------------------------------------------

Item Group name of the species (kind of) medical device Note



----------------- ----------------------------------------------------------------------------------

1 1 patches with the exception of hypoalergických

patches



2 1 patch for corns



plena 3 2 PVC



4 2 pads PVC




5 4 shoe tennis



6 4 brace sports



stroller accessories-7 7 worktop



8 7 of the pram accessories-storage basket



9 7 the stroller accessories-raincoat



10 7 accessories to the cart-job board



11 7 accessories to the trolley-raincoat



12 7 electric trolleys accessories-control for escorts



diagnostic strips on 13 11 determination of cholesterol



14 12 chodítkům accessories that are beyond the scope of their functions



15 13 eye dropper



16 13 Rod eye



17 13 breast pump



18 13 finger technical rubber



19 13 bed health



20 13 intrauterine device



21 13 pillow including coating



22 16 neortopedické insoles



23 repair medical devices in addition to wheelchairs and strollers and individually manufactured

Orthopedic and prosthetic products and repair jacks and positioning beds

----------------- ----------------------------------------------------------------------------------



SECTION C



The list of medical devices covered by public health

insurance in the provision of out-patient health services

----------------- ------------------------------------------ -------------------------------------------------------------------------------

Item Group name of the species (kind of) the restriction of the limitations of the above remuneration

medical

resource

----------------- ------------------------------------------ -------------------------------------------------------------------------------

1 1 resources for classic healing max. size 10 x 10 cm 100%; Max. 4 Eur per 1 piece; And



2 1 non-wovens max. size 10 x 10 cm. 100%; Max. 50 € per 100 pieces; And

Max. 100 PCs per month;



3 1 resources for moist wound healing max. dimension 12x12cm; 100%; Max. 160 CZK per 1 piece; And

After prescription of the CHR, DIA, DRV,

GER, INT, JI6; the prescription

possible to delegate to the PRL; When

treatment of longer than 3 months after the

the approval of the review a doctor



Hypo-allergenic patch 4 1 to 18 years of age, only for stomiky and 100%; Max. 30 € per pack; And

diabetics

elastic bandage 5 1 max. size 14 cmx 5 m 100%; Max. 50 Eur per 1 piece; And



6 1 bandage sterile hydrophilic max. size 12 cmx 5 m 100%; Max. 15 CZK per 1 piece; And



flexible hose wrap 7 1 100%; Max. 30 Eur per 1 piece; And



8 1 tampons coil max. 1 000 pieces per year; After 100%; Max. 70 CZK per 1 000 PCs; And

prescription of DIA



9 1 cotton cellulose max. 500 g 100%; Max. $ 50 per 500 g; And



10 2 absorption means for max. 150 PCs per month 100%; Max. 450 CZK per 150 PCs; And

incontinent-inserts

for light incontinence



11 2 absorption means for max. 150 PCs per month 100%; Max. 900 CZK/150 SC; And

medium incontinence

-shaped diapers



12 2 absorption means for max. 150 PCs per month 100%; Max. 1 700 CZK/150 SC; And

severe incontinence-

diaper



13 2 absorbent fixation devices max. 24 PCs per year 100%; Max. 190 CZK per 24 PCs; And

for a fee the diapers



14 2 condoms urine max. 30 PCs per month 100%; Max. 700 CZK for 30 DC; And



urine collection bags, 15 2 max. 10 PCs per month 100%; Max. 500 CZK per 10 PCs; And



colostomy pads 16 3 max. 10 PCs per month 100%; Max. 3 000 CZK for 10 PCs; (B)



Ileostomy pads 17 3 max. 15 PCs per month 100%; Max. 4 500 € for the 15 DC; (B)



18 3 washers urostomy max. 15 PCs per month 100%; Max. 4 500 € for the 15 DC; (B)



19 3 caps Ostomy max. 30 PCs per month; 100%; Max. 3 100 CZK for 30 DC; (B)

After the approval of the review a doctor



20 3 Stoppers Ostomy max. 30 PCs per month; 100%; Max. 3 100 CZK for 30 DC; And

After the approval of the review a doctor



21 3 systems colostomy max. 60 PCs per month 100%; Max. 4 000 CZK for 60 PCs; (B)

two piece closed-bags



22 3 systems colostomy max. 60 PCs per month 100%; Max. 7 500 CZK for 60 PCs; (B)

one-piece closed-bags

(including support)



Ileostomy systems 23 3 max. 30 PCs per month 100%; Max. 9 000 CZK for 30 DC; (B)

one-piece drain-bags



Ileostomy systems 24 3 max. 30 PCs per month 100%; Max. 8 500 CZK for 30 DC; (B)

one-piece drain-bags

(including support)



urostomy two-piece systems 25 3 max. 30 PCs per month 100%; Max. 5 500 CZK for 30 DC; (B)

-bags



urostomy systems 26 3 max. 30 PCs per month 100%; Max. 9 000 CZK for 30 DC; (B)

one-piece-bags

(including support)



27 3 retaining straps and a max. 2 PCs per year; after the approval of 100%; Max. 600 CZK per 2 PCs; And

resources for stomiky review a doctor



Ostomy irrigation systems 28 3-max. 2 sets including accessories 100%; Max. 2 800 CZK per 2 sets; And

sets and accessories per year; After the approval of the review

doctor



Ostomy-29 3 systems to the max. 1 system (10pcs pads 100%; Max. 13 000 CZK per 1 system; And

a temporary stoma kontinenci 60 PCs sealed bags and 15 PCs

device for temporary kontinenci

Stoma) per month; after approval

the review by a doctor



Ostomy-drain washers 30 3 max. 10 PCs per month; 100%; Max. 3 000 CZK for 10 PCs; (B)

After the approval of the review a doctor



Ostomy-drainage systems 31 3 max. 30 PCs per month; 100%; Max. 8 500 CZK for 30 DC; (B)

one-piece-bags after the approval of the review a doctor

(including support)



Ostomy-drainage systems 32 3 max. 30 PCs per month; 100%; Max. 7 000 CZK for 30 DC; (B)

two-piece-bags after the approval of the review a doctor



Ostomy-resources 33 3 100%; And

filling out and buffer



Ostomy-resources thickening 34 3 max. 30 PCs per month; 100%; Max. 360 CZK for 30 DC; And

for ileostomiky



Ostomy resources 35 3-cleaning 100%; Max. 350 Czk per month; And



36 3 Remover pads 100% Ostomy; Max. 300 € per month; And



Ostomy-resources trade 37 3 100%; Max. 1 000 CZK per month; And



38 3 resources-Ostomy deodorant after the approval of a revision doctor 100%; Max. 350 Czk per month; And



series-produced orthosis 39 4 max. 1 piece per year; after prescription of 100%; And

ORT, ORP, REH, CHR, NEU, TRA, TVL



40 4 sleeve one max. 8 PCs per year 100%; And



41 4 Jockstrap max. 2 PCs 100% per year; Max. 130 CZK per 2 PCs; And



Breast epitéza 42 4 max. 1 PC for 2 years; 100%; Max. 1 800 CZK per 1 piece; And

After prescription of the CHR, OHM, PRL



43 4 self-adhesive breast epitéza max. 1 PC for 2 years; at 100%; Max. 3 000 CZK per 1 piece; And

the lymphatic swelling; After the prescription

Ohm, J16



epitéza postoperative breast 44 4 max. 1 DC in rámci1 operations; 100%; Max. 500 CZK per 1 piece; And

After prescription of the CHR, OHM



45 4 compression bra max. 1 piece per year; at 100%; Max. 1 300 CZK per 1 piece; And

the lymphatic swelling;

After prescription of the CHR, OHM



46 5 brace individually made after prescription of ORP, ORT, REH, 100%; And

CHR, NEU, and after approval by the review

doctor



epitéza 47 5 individually made max. 1 PC for 2 years; 100%; And

After prescription of the CHR, ORP, ORT

and after the approval of the review a doctor



upper and lower dentures 48 5 max. 1 PC for 2 years; 100%; And

limbs-basic design after prescription of ORP, REH, ORT



49 5 modular prosthesis for upper and a max. 1 PC for 2 years; 100%; And

the lower limbs that are after prescription of ORP, REH, ORT

constructed of modular and, after approval by the review a doctor

preparations and reports, including

tensile prostheses for upper limbs




50 5 prostheses myoelektrické, max. 1 DC in 5 years (in the case of 100%; And

the loss of both upper limbs, disability of both limbs 1 pair per

or unilateral amputation with 5 years); After prescription of ORP, REH,

functional disabilities second ORT and after approval by the review

upper limb doctor S5



51 6 compression elastic max. 2 pairs per year; After 100%; Max. 820 CZK per 2 pairs; And

stockings leg II. Prescribing PRL to T, CHR, INT, DRV,

J16



52 6 compression elastic max. 2 pairs per year; After 100%; Max. 900 CZK per 2 pairs; And

stockings leg III. K. T prescription CHR, INT, DRV, J16



53 6 compression elastic max. 2 pairs per year; After 100%; Max. 2 000 CZK per 2 pairs; And

stockings leg IV. K. T prescription CHR, INT, DRV, J16



54 6 compression elastic max. 2 pairs per year; After 100%; Max. 1 050 CZK per 2 pairs; And

stockings polostehenní II. Prescribing PRL to T, CHR, INT, DRV,

J16



55 6 compression elastic max. 2 pairs per year; After 100%; Max. 1 200 CZK per 2 pairs; And

stockings polostehenní III. K. T prescription CHR, INT, DRV, J16



56 6 compression elastic max. 2 pairs per year; After 100%; Max. 2 600 CZK per 2 pairs; And

stockings polostehenní IV. K. T prescription CHR, INT, DRV, J16



57 6 compression elastic max. 2 pairs per year; After 100%; Max. 1 200 CZK per 2 pairs; And

stockings thigh II. Prescribing PRL to T, CHR, INT, DRV,

J16



58 6 compression elastic max. 2 pairs per year; After 100%; Max. 1 200 CZK per 2 pairs; And

stockings thigh III. K. T prescription CHR, INT, DRV, J16



59 6 compression elastic max. 2 pairs per year; After 100%; Max. 3 000 CZK for 2 pairs; And

stockings thigh IV. K. T prescription CHR, INT, DRV, J16



60 6 compression elastic max. 2 PCs per year; after prescription of 100%; Max. 700 CZK per 2 PCs; And

stockings thigh with PRL, CHR, INT, DRV, J16

at the waist (II). K. T



61 6 compression elastic max. 2 PCs per year; after prescription of 100%; Max. 750 CZK per 2 PCs; And

stockings thigh with the CHR, INT, DRV, J16

at the waist (III). K. T



62 6 compression elastic max. 2 PCs per year; after prescription of 100%; Max. 800 CZK per 2 PCs; And

stockings thigh with the CHR, INT, DRV, J16

at the waist (IV). K. T



63 6 compression elastic max. 2 PCs per year; after prescription of 100%; Max. 1 900 CZK/2 DC; And

tights Womens PRL, CHR, INT, DRV, J16 and after

II. A. T. the approval of the review a doctor



64 6 compression elastic max. 2 PCs per year; after prescription of 100%; Max. 2 000 CZK per 2 PCs; And

tights Womens CHR, INT, DRV, J16 and after

III. A. T. the approval of the review a doctor



65 6 compression elastic max. 2 PCs per year; after prescription of 100%; Max. 2 000 CZK per 2 PCs; And

tights Womens CHR, INT, DRV, J16 and after

IV. A. T. the approval of the review a doctor



66 6 compression elastic max. 1 piece per year; after prescription of 100%; Max. 950 CZK per 1 piece; And

pantyhose CHR, INT, DRV, J16 and after

maternity (II). K. T. the approval of the review a doctor



67 6 compression elastic max. 1 piece per year; after prescription of 100%; Max. 1 300 CZK per 1 piece; And

pantyhose CHR, INT, DRV, J16 and after

maternity III. and (IV). K. T. the approval of the review a doctor



68 6 arm shoe assy II. K.T. Max. 2 PCs per year; after prescription of 100%; Max. 1 000 CZK per 2 PCs; And

CHR, INT, DRV, J16, OHM



69 6 arm shoe assy (III). Max. 2 PCs per year; after prescription of 100%; Max. 1 000 CZK per 2 PCs; And

and (IV). K. T. CHR, INT, DRV, J16, OHM



70 6 compression elastic max. 2 PCs per year; after prescription of 100%; Max. 4 000 CZK per 2 PCs; And

stockings and girdles II., III. CHR, INT, DRV, J16 and after

and (IV). K. t.-individually approve the review a doctor

made up of technology

circular knitting



71 6 compression elastic max. 2 PCs per year; after prescription of 100%; Max. 15 000 CZK per 2 PCs; And

stockings and girdles II., III. J16, and after approval by the review

and (IV). K. t.-individually doctor S5

made up of flat knitting technology



ankle and knee 72 6 piece piece max. 2 PCs per year; after prescription of 100%; Max. $ 260 for 2 PCs; And

II. and III. K. T. CHR, ORT, REH, PRL, DRV, J16



73 6 aid for donning max. 1 piece per year; after prescription of 100%; Max. 300 CZK per 1 piece; And

compressive elastic, CHR, INT PRL, DRV, J16

stockings II., III. and (IV). K. T.



74 7 stroller health max. 1 SC in 3 years; After 100%; Max. 21 000 CZK

prescription REH, ORT, NEU and 1 SC; And

the approval of the review a doctor



75 7 health-stroller accessories max. 1 SC in 3 years; After 100%; Max. 5 000 CZK per 1 piece; And

prescription REH, ORT, NEU and after

the approval of the review a doctor



76 7-core trolley mechanical max. 1 DC in 5 years; After 100%; Max. 9 EUR per 1 piece; And

prescription REH, ORT, NEU, INT

and after the approval of the review a doctor



mechanical-lightweight trolley 77 7 max. 1 DC in 5 years; After 100%; Max. 19 EUR per 1 piece; And

prescription REH, ORT, NEU, INT

and after the approval of the review a doctor



78 7 truck mechanical-active max. 1 DC in 5 years; After 100%; Max. 21 000 Eur per 1 piece; And

prescription REH, ORT, NEU, INT

and after the approval of the review a doctor



a mechanical trolley 79 7-baby max. 1 DC in 5 years; After 100%; Max. 21 000 Eur per 1 piece; And

prescription REH, ORT, NEU and after

the approval of the review a doctor



80 7 truck mechanical-special max. 1 DC in 5 years; After 100%; Max. 55 EUR per 1 piece; And

having regard to the degree and severity of prescription REH, ORT, NEU and after

the approval of the review of disability by a doctor



81 7 truck mechanical accessories max. 1 DC in 5 years; After 100%; And

prescription REH, ORT, NEU, INT

and after the approval of the review a doctor



82 7 leather gloves for wheelchair users max. 2 pairs per year 100%; Max. 300 CZK per 2 pairs; And

(mechanical)



83 7 trolley electric cars max. 1 DC in 7 years; After 100%; Max. 136 EUR per 1 piece; And

-for operation usually prescription REH, ORT, NEU, INT

in the exterior, and after the approval of the review a doctor



84 7 trolley electric cars max. 1 DC in 7 years; After 100%; Max. 115 EUR per 1 piece; And

-the standard for light traffic prescription REH, ORT, NEU, INT and

usually in the Interior, after approval by the review doctor S5



85 7 cart electric-accessories max. 1 DC in 7 years; After 100%; And

prescription REH, ORT, NEU, INT

and after the approval of the review a doctor



86 7 repair truck mechanical, after the approval of a revision doctor 90%

the power and the health of the stroller



87 8 hearing aid for aerial lines max. 2 DC in 5 years; from 0 to 100%; Max. 10 600 CZK per 2 PCs; And

-for moderate 7 years; After prescription of the FON

hearing loss from 30 dB to

59 dB SRT



88 8 hearing aid for aerial lines max. 2 DC in 5 years; from 0 to 100%; Max. 11 600 CZK per 2 PCs; And

-for heavy and very heavy for 7 years; After prescription of the FON

hearing loss from above 60 dB

SRT above, remnants of the hearing, deafness



89 8 hearing aid on bone conduction-max. 2 DC in 5 years; from 0 to 100%; Max. 22 000 CZK per 2 PCs; And

hearing loss in the double-sided 7 years; After prescription of the FON

abnormality of the ear canal and, after approval by the review a doctor

and middle ear with severe conversion

hearing loss, chronic

discharge of mucus membranes,

kofochirugických operations

intractable allergies to

fitting, bad effect

hearing aids on air management



90 8 hearing aid for aerial lines max. 2 DC in 5 years; from 7 to 100%; Max. 10 600 CZK per 2 PCs; And

-for moderate, 18 years of age; After prescription of FON, OTO

hearing loss from 30 dB to S3

59 dB SRT





91 8 a hearing aid for aerial lines max. 2 DC in 5 years; from 7 to 100%; Max. 11 600 CZK per 2 PCs; And

-for heavy and very heavy for 18 years; After prescription of FON, OTO

60 dB hearing loss from SRT, S3

the remains of the hearing loss, deafness



92 8 hearing aid on bone conduction-max. 2 DC in 5 years; from 7 to 100%; Max. 6 800 CZK per 2 PCs; And

hearing loss in the double-sided 18 years; After prescription of the FON

abnormality of the ear canal and the review and approval by a physician

the middle ear with severe conversion

hearing loss, chronic

effluent from the middle ear, the States

After kofochirugických

operations, intractable

allergies on the fitting,

the bad effect of hearing aids on the

air management



hearing aid for air max 93 8. 1 DC in 5 years; from 18 years of age; 100%; Max. 2 700 CZK per 1 piece; And

leadership-for moderate after prescription of FON, OTO S3

hearing loss from 40 dB to 59 dB SRT



hearing aid for air max 94 8. 1 DC in 5 years; from 18 years of age; 100%; Max. 3 900 CZK per 1 piece; And

leadership-for severe after prescription of FON, OTO S3

hearing loss from 60 dB to

79 dB SRT



hearing aid for the air max 95 8. 1 DC in 5 years; from 18 years of age; 100%; Max. 5 100 CZK per 1 piece; And

leadership-for very severe after prescription of FON, OTO S3

conductive hearing loss, loss of

80 dB SRT, remnants of the hearing, deafness



the bone conduction hearing aid 96 8-max. 1 DC in 5 years; from 18 years of age; 100%; Max. 6 800 CZK per 1 piece; And

hearing loss in the double-sided after prescription of FON, OTO S3 and after

anomaly of the ear canal and the approval of the review a doctor

the middle ear with severe conversion

hearing loss, chronic

effluent from the middle ear, the States

After kofochirugických

operations, intractable

allergies on the fitting,

the bad effect of hearing aids



97 8 batteries to the SoundBridge converts max. 4 PCs in 5 years; After 100%; Max. 80 EUR for 4 PCs; And

prescription of FON, OTO S3



98 8 optician adapter to the suspension max. 1 DC in 5 years; After 100%; Max. 90 Eur per 1 piece; And

the SoundBridge converts the prescription of FON, OTO S3



99 8 ear fitting-individually made max. 2 PCs in 1 year; from 18 years of age; 100%; Max. 700 CZK per 2 PCs; And

After prescription of FON, OTO S3



100 8 ear fitting-individually made max. 1 DC in 5 years; from 18 years of age; 100%; Max. 350 CZK per 1 piece; And

Max. 2 DC in 5 years-only for

Deafblind; After the prescription after

Fon, OTO S3



101 8 ear fitting protective-max. 1 PC for 2 years; from 18 years of age; 100%; Max. 250 CZK per 1 piece; And

individually made States with otevřenýmstředouším; After

prescription of OTO, and after approval by

the review by a doctor



102 8 ear fitting-series-produced max. 1 DC in 5 years; After 100%; Max. 20 Eur per 1 piece; And

prescription of FON, OTO S3



103 9 eye glasses max. 3 pieces per year-up to 6 years; 100%; Max. 300 Eur per 1 piece

Max. 1 piece per year-from 6 to 15

years of age; two glasses during refractive

a defect of the nad +-3 DPTdo distance; After

prescription OPH



104 9 eye glasses max. 1 SC in 3 years-15 years; 100%, max. 150 CZK per 1 piece; And

two-glasses when the refractive defect

NAD +-3 DPT into the distance; After

prescription OPH



105 9 lens eyewear spherical, a toric max. 3 times per year-up to 6 years; 100%; And

Max. Once a year-from 6 to 15 years of age;

Max. once every 3 years-15 years;

without changing the correction; epileptikům,

jednookým-always hardened;

After the prescription OPH



106 9 lens eyewear lenticular max. 3 times per year-up to 6 years; 100%; And

Max. Once a year-from 6 to 15 years of age;

Max. once every 3 years-15 years;

without changing the correction; NAD +-10

DPT; up to 3 years for afakie; After

prescription OPH



107 9 lens eyewear vysokoindexová max. 3 times per year-up to 6 years; 100%; And

Max. Once a year-from 6 to 15 years of age;

Max. once every 3 years-15 years;

without changing the correction; myopia over

-10 DPT; Central

the field of view; After the prescription OPH

and after the approval of the review a doctor



108 9 lens bifocal glasses, max. 2 x per year-up to 6 years; 100%; And

Franklin, zatavovaná, max. Once a year-from 6 to 18 years of age;

vybrušovaná, silicate, plastic without changing the correction; strabismus;

afakie; After the prescription OPH; from

18 years old nehrazeno



109 9 lens eyewear prismatická max. 3 times per year-up to 6 years; 100%; And

Max. Once a year-from 6 to 15 years of age;

Max. once every 3 years-15 years;

without changing the correction; diplopia;

strabismus; After the prescription OPH



prismatické 110 9 foil-soft, hard max. 3 times per year-up to 6 years; 100%; And

Max. Once a year-from 6 to 15 years of age;

Max. once every 3 years-15 years;

without changing the correction; diplopia;

strabismus; After the prescription OPH



111 9 lens glasses plastic-spherical, a toric max. 2 x per year-up to 6 years; 100%; And

Max. Once a year-from 6 to 15 years of age;

Max. once every 3 years-15 years;

without changing the correction; from 15 years old

+-10 DPT; up to 15 years over +-3

DPT; After the prescription OPH



112 9 absorption layer on the lens max. 3 times per year-up to 6 years; 100%; And

Max. Once a year-from 6 to 15 years of age;

Max. once every 3 years-15 years;

without changing the correction; afakie,

pseudoafakie, diseases and defects

coherent světloplachostí; After

prescription OPH



113 9 lens eyewear hyperokulární max. 2 x per year-up to 18 years of age; 100%; And

Max. once every 3 years-from 18 years of age;

without changing the correction; After the prescription

And after the approval of the PBC review

doctor



soft contact lens 114 9 max. 2 x per year-up to 15 years; 100%; And

Max. Once a year-15 years;

without changing the correction; refraction; above the

+-10 DPT; afakiealespoň

astigmatism in one eye,

anisometropie irregularis, 3 DPT

and more; After the prescription OPH



115 9 lens hard contact max. 2 x per year-up to 15 years; 100%; And

Max. 1 x every 2 years-15 years;

without changing the correction; Keratoconus

astigmatism irregularis, within 15

years for afakie; After the prescription OPH

and after the approval of the review a doctor



hard contact lens-116 9 max. 2 x per year-up to 15 years; 100%; And

individually made max. 1 x every 2 years-15 years;

without changing the correction; Keratoconus

astigmatism irregularis; up to 15

years for afakie; After the prescription OPH

and after the approval of the review a doctor



117 9 lens contact max. 2 x per year-up to 15 years; 100%; And

stenopeutická, color, therapeutic max. Once a year-15 years;

without changing the correction; only serious

disease of the cornea, the iris or

combination; After the prescription OPH

and after the approval of the review a doctor



118 9 Occluder gel, náplasťový, plastic, after 100% prescription OPH; And



119 9 dalekohledový system at a distance of max. 1 DC in 7 years; After 100%; Max. 8 EUR per 1 piece; And

even at the close, with accessories for the prescription OPH S4a after approval

the review by a doctor



120 9 Magnifier magnifying asferická 4 x + max. 1 DC in 5 years; After 100%; Max. 1 500 CZK per 1 piece; And

prescription OPH S4a after approval

the review by a doctor




Magnifier magnifying sphere to 121 9 4 x max. 1 DC in 5 years; After 100%; Max. 100 CZK per 1 piece; And

prescription OPH



122 9 prosthesis eye glass max. 2 PCs per year; after prescription of 100%; Max. 800 CZK per 1 piece; And

OPH



Acrylic prosthesis eye 123 9-max. 2 SC in 3 years; After 100%; Max. 2 000 CZK per 1 piece; And

individually made prescription OPH and after approval

the review by a doctor



124 10 applicators aerosol preparations by prescribing a THORN, ALG, OTO, 100%; Max. 500 CZK per 1 piece; And

PED; from 18 years after the

the review by a doctor



125 10 inhaler compressor max. 1 DC in 5 years; After 100%; Max. 4 500 CZK per 1 piece; And

prescription of THORN, ALG, OTO and after

the approval of the review a doctor



126 10 inhaler ultrasound max. 1 DC in 10 years; After 100%; Max. 4 500 CZK per 1 piece; And

prescription of THORN, ALG, OTO and after

the approval of the review a doctor



127 10 oxygen concentrator after the prescription after the approval of the 100% of TRNa; And

the review by a doctor



128 10 resources for the application of max. 1 PCs. for 2 years; After 100%; Max. 300 CZK per 1 piece; And

powder inhaled forms of pharmaceuticals prescription according to of the prescriber

restrictions on pharmaceuticals



CPAP device after 129 10 prescription THORN, NEU and after 100%; Max. 40 EUR per 1 piece; And

approval of a revision doctor S5



130 10 appliance BPAP after prescription of THORN, NEU and after 100%; Max. 60 EUR per 1 piece; And

approval of a revision doctor S5



131 10 spirometer personal after prescription of THORN, ALG and after 100%; Max. 300 CZK per 1 piece; And

the approval of the review a doctor



132 10 nebulizer to inhaler (attachment) max. 1 PC for 2 years; After 100%; Max. 600 CZK per 1 piece; And

prescription of THORN, ALG, OTO and after

the approval of the review a doctor



133 11 insulin insulin Pen applicator-max. 1 SC in 3 years; Max. 2 PCs 100%; Max. 1 500 CZK per 1 piece; And

for 3 years when the concurrent application

two types of insulin; After

prescription of DIA



134 11 applicator insulin to application max. 1 SC in 3 years; After 100%; Max. 1 200 CZK per 1 piece; And

syringe prescription DIA



135 11 applicator blood sampling using the lancet max. 1 DC in 5 years; After 100%; Max. 250 CZK per 1 piece; And

prescription of DIA



-blood glucose meter for diabetics 136 11 max. 1 DC in 10 years; After 100%; Max. 1 000 CZK za1 SC; And

treated with intenzifikovaným prescription of DIA and after approval

the insulin regimen (3 doses of the review a doctor

daily or insulin pump),

for unstable diabetics with

2 doses of insulin per day



137 11 needles to injection syringes after prescription of the DIA 100%; Max. 120 € per 100 pieces; And

the application of insulin



138 11 insulin Pen needle to the max. 200 PCs per year; After 100%; Max. 530 CZK per 200 PCs; And

prescription of DIA



139 11 needles for pens neinzulínovým max. 100 PCs per year; After 100%; Max. 270 € per 100 pieces; And

prescription of DIA



140 11 set to application syringe after prescription of DIA (100%; Max. € 370 100 PCs; And

with a fixed needle)



141 11 lancets for blood sampling max. 100 PCs per year; After 100%; Max. 300 CZK per 100 PCs; And

prescription of DIA



142 11 strips diagnostic glucose on the determination of max. 400 pieces per year; After 100%; Max. 3 200 CZK per 400 PCs; And

prescription of DIA



Max. 1 000 pieces per year; for 100%; Max. 8,000 CZK per 1 000 PCs; And

patients treated with intenzifikovaným

the insulin regimen or

insulin pump; After

prescription of DIA and after approval

the review by a doctor



Max. 1 800 PCs per year-up to 18 years of age 100%; Max. 14 400 CZK per 1 800 SC; And

and for pregnant diabetics; After

prescription of DIA and after approval

the review by a doctor



143 11 insulin pump max. 1 piece or set of 2 for 4 100%; Max. 100 EUR per 1 piece or 1 set; And

years; After prescription of the DIA and after

approval of a revision doctor S5



144 11 sets of metal infusní to the insulin pump after prescription of the DIA 100%; Max. 160 CZK per 1 set; And



145 11 sets infusní nonstick after prescription after approval of 100% DIAa; Max. 300 CZK per 1 set; And

the insulin pump review by a doctor



injection syringe to 146 11 application of insulin after prescription of the DIA 100%; Max. 230 € per 100 pieces; And



147 12 crutches max. 1 pair every 2 years 100%; Max. 400 CZK per 1 pair; And



crutch forearm 148 12 max. 1 pair or 1 piece in 2 years 100%; Max. 300 CZK per 1 piece; And



149 12 Walker max. 1 DC in 5 years; After 100%; Max. 7 000 CZK per 1 piece; And

prescription REH, NEU, ORP, ORT

and after the approval of the review a doctor



150 12 stick max. 1 DC for 3 years 100%; Max. 130 CZK per 1 piece; And



151 12 bed positioning with the possibility of the power max. 1 DC in 10 years; After 100%; Max. 30 EUR per 1 piece; And

setting the prescription REH, ORT, NEU and after

approval of a revision doctor S5



Chair of the 152 12 max. 1 DC in 5 years; After 100%; Max. 4 000 CZK per 1 piece; And

prescription REH, ORT, NEU, PRL, GER



153 12 TOILET attachment max. 1 SC in 3 years; After 100%; Max. 1 200 CZK per 1 piece; And

prescription REH, ORT, NEU, PRL, GER



154 12 seat in the tub and the shower max. 1 DC in 5 years; After 100%; Max. 2 000 CZK per 1 piece; And

prescription REH, ORT, NEU, PRL, GER



the pointing device 155 12 max. 1 DC in 10 years; After 100%; Max. 60 EUR per 1 piece; And

prescription REH, ORT, NEU and after

the approval of the review a doctor



156 12 accessories for your pointing device max. 1 DC in 10 years; After 100%; Max. 10 EUR per 1 piece; And

prescription REH, ORT, NEU and after

the approval of the review a doctor



157 12 lifter mechanical, electric, max. 1 DC in 10 years; After 100%; Max. 30 EUR per 1 piece; And

hydraulic prescription REH, ORT, NEU and after

the approval of the review a doctor



158 12 bed positioning with the option max. 1 DC in 10 years; After 100%; Max. 15 000 CZK per 1 piece; And

the mechanical setting of the prescription REH, ORT, NEU and after

the approval of the review a doctor



159 13 wig max. 1 piece per year; after prescription of 100%; Max. 1 EUR per 1 piece

OHM, DRV, INT



160 13 pad Anti-decubitus max. 1 SC in 3 years; After 100%; And

prescription REH, ORT, NEU and after

the approval of the review a doctor



161 13 helmet protection max. 1 PC for 2 years; After 100%; Max. 2 500 CZK per 1 piece; And

prescription REH, NEU, dogs and after

the approval of the review a doctor



catheter for intermittent catheterisation 162 13 max. 150 PCs per month; After 100%; Max. 7 500 CZK per 150 PCs; And

-covered prescription URL and after approval by

the review by a doctor



163 13 catheter for intermittent catheterization max. 150 PCs per month; After 100%; Max. 2 300 CZK per 150 PCs

-non-prescription URL and after approval by

the review by a doctor



164 14 stick white Braille max. 3 PCs per year; after 100%; And

prescribing PRL OPH,



165 14 compensatory aids for the blind max. 1 DC in 7 years; After 100%; Max. 2 000 CZK per 1 piece; And

prescribing PRL OPH, and after

the approval of the review a doctor



166 15 induction set Amps max. 1 DC in 7 years, after 100%; Max. 1 000 CZK per 1 piece; And

prescription of FON, OTO S3



167 15 compensatory aids for hearing max. 1 DC in 7 years; After 100%; Max. 2 000 CZK per 1 piece; And

the affected prescription of FON, OTO S3 and after


the approval of the review a doctor



168 16 orthopedic shoes for kids-max individually. 3 pairs per year; After 100%; Max. $ 60 for 3 pairs

made prescription REH, ORT, ORP and after

the approval of the review a doctor



169 16 orthopedic shoes for Kids-series-max. 3 pairs per year; After 100%; Max. 3 000 CZK for 3 pairs

manufactured prescription REH, ORT, ORP and after

the approval of the review a doctor



170 16 orthopedic shoes-max. 1 pair every 2 years; After 50%

individually made-simple prescription REH, ORT, ORP



Orthopedic shoes-171 16 max. 1 pair every 2 years; After 90% of

individually made-prescription REH, ORT, ORP

more complex and very complex



172 16 shoes for diabetics max. 1 pair every 2 years; After 100%; Max. 1 000 CZK per 1 pair

prescription of DIA and after approval

the review by a doctor



173 16 insert orthopedic-max. 1 pair every 2 years; After 100%; Max. 100 € for 1 pair

individually made prescription REH, ORT, ORP



174 16 insert orthopedic-max. 2 pairs per year; After 100%; Max. 600 CZK for 2 pairs

individually made-the children's prescription of REH, ORT, ORP



175 16 insert orthopedic-special max. 2 pairs per year; after 80%

prescription REH, ORT, ORP



176 17-a noble metal cannula of max. 3 PCs per year; and 18 years; After 100%; Max. 10 500 EUR for 3 PCs; And

prescription of OTO, FON and after

the approval of the review a doctor



177 17-a noble metal cannula of max. 2 DC in 5 years; from 18 years of age; 100%; Max. 4 000 CZK per 2 PCs; And

After the prescription of OTO, FON



178 17-a cannula of max. 3 PCs per year; and 18 years; After 100%; Max. 10 500 EUR for 3 PCs; And

Silicone paediatric prescription of OTO, FON and after

the approval of the review a doctor



179 17-a cannula silicone max. 2 PCs per year; from 18 years of age; After 100%; Max. 4 000 CZK per 2 PCs; And

prescription of OTO, FON and after

the approval of the review a doctor



180 17 electric breast pump, mechanical max. 1 DC in 5 years; After 100%; Max. 4 000 CZK per 1 piece; And

prescription of OTO, and after

the approval of the review a doctor



181 17 breast pump accessories-max. 150 PCs per year; After 100%; Max. 1 000 CZK per 150 PCs; And

suction catheters for the prescription of OTO, and after

the approval of the review a doctor



182 17 accessories for tube tracheostomické max. 1 x per year; After the prescription 100%; Max. 2 000 CZK per

Oto, FON 1 Pack complete accessories; And



183 17 voice prosthetics accessories max. 1 x per year; After the prescription 100% max. 12 500 CZK per 1 Pack complete

Oto, FON and approval review accessories; And

doctor



elektrolaryng 184 17 max. 1 DC in 10 years; After 100%; Max. 15 500 Eur per 1 piece; And

prescription of FON, and after approval by

the review by a doctor



185 17 battery to elektrolaryngu max. 1 PC for 2 years; 100%; Max. 700 CZK per 1 piece; And

After the prescription FONa after approval

the review by a doctor

----------------- ------------------------------------------ -------------------------------------------------------------------------------



Symbols of reimbursement limits



And-remuneration of the prices for the final consumer healthcare

resource in the implementation of the least economically challenging depending on the degree of

and severity of disability (hereinafter referred to as "economically at least

challenging variant of "); the price of the least economically challenging variants

medical device detects the health insurance market.



(B) remuneration of prices-economically at least challenging variations of the entire

the system of medical devices Group No. 3 of this

section.



Annex 4



LIST OF DENTAL PRODUCTS



List of abbreviations and explanatory notes



List of dental products contains the individually carved

dental prosthetic and orthodontic apparatus of compensation, rehabilitation

and medical equipment.



Payment of health insurance is established for dental products

by way of derogation for persons:



and) to 18 years (codename dental products begins with a digit

7)



(b) over 18 years of age) (codename dental products begins

the numeral 8)



For each dental products to their lists:



1. identification code



2. the name of the



3. dental alloy, using a numeric symbol alloy designed for

the making of the dental product in the basic version



4. the category of orthodontic products, using symbols to indicate

the category of the product and the amount of the remuneration of the orthodontic health

the insurance company



5. preskribční restrictions, if treatments and fabrication of dental

the product may only be carried out by a doctor specialist, the symbol P



6. payment of health insurance



a) in its entirety, the symbol and



(b)) of the amount indicated in Eur

------------------------------------------------------------------

Dental alloys for dental products

in the basic version

------------------------------------------------------------------

Dental Symbol

alloy

------------------------------------------------------------------

1 chrome-nickel alloy

for ceramic and resin

facets

------------------------------------------------------------------

2 stříbrocínová, stříbroměděná

replacement alloy

------------------------------------------------------------------

3 chromkobaltová,

chromkobaltmolybdenová

alloy for skeletons

------------------------------------------------------------------



The price for the cam Orthotics used dental alloys included in price

delivery of the product. For a fixed price for the used Orthotics

Dental alloy added to the price of the dental product.



Health insurance shall be borne by the making of cast to partial reinforcement

a removable compensation with simple retention elements (products with codes

82001, 82002, 72001, 72002). Price cast reinforcement will be added to the price

delivery of the product. In the article "repair or adjustment of the scanning

apparatus with the imprint "(code 86081 and 76081) is not included in the price

orthodontic screw. In the case of the use of the screw with its price

added to the price of the dental product.



Health insurance dental precious metal alloys used in the

cases:



1. reconstruction of the clinical crowns of teeth in children under 15 years of age,



2. reconstruction of the clinical crowns of teeth for congenital or hereditary disorders

the formation of hard dental tissues,



3. fabrication of fixed compensation for missing teeth at birth or

hereditary disorders of tooth development and eruption,



4. fabrication of fixed refunds when the total reconstruction of the mandibular skusů

anomalies, which can no longer improve orthodontic treatment,

but where prosthetic by modifying the dentition can be achieved by improving the function of

the lingual apparatus,



in the amount of at least 400 CZK per 1 gram of gold in the pure metal.



The life of dental products



Health insurance covers:



-once every two years in resin jacket Crown made of plastic and

composite plastic,



-every five years other fixed prosthetic replacements,



-every three years, removable partial and total compensation,



If the auditing physician health insurance company decides otherwise.



The exception are:



-the Crown of the mantle made of plastic (codes 71111, 71112)



-the Crown of the mantle of composite plastic material (71113, 71114 codes),



-Crown protective sheath cast (code 71103)



-protective jacket crowns minted (code 71104)



-removable partial refunds (72001-72152 codes),



-removable total refunds (codes 72201-75445)



which health insurance shall be borne by persons under 18 years of age without restriction.



Health insurance shall stipulate that:



-lost or negligent treatment of a destroyed stomatologicko-prosthetic

compensation, medical and rehabilitation equipment, orthodontic devices,



-removal of defects, which are covered by the legal warranty

----------------------------------------------------------------------------------------------------

Categorization for reimbursement of orthodontic products

health insurance company



Mark

the distinguishing criteria categories Above

payment of the

----------------------------------------------------------------------------------------------------

and) clefts lip, jaw and palate, congenital defects, and overall system


orthodontic disease manifestations, without depending on the age of full payment

----------------------------------------------------------------------------------------------------

(b)) 1. hypodontia of four or more permanent teeth in one jaw out of teeth

wisdom

2. reverse bite incisors and individual

3. a protrusion defect with incizálním step seven or more millimeters

4. the open bite in the range of all permanent incisors, two and more

millimeters

5. retention, palatal position and agenze of the standing of the Studio. In children under

18 years of the lack of space for permanent canine tooth, five millimetres and more

6. the retention of the standing of the upper lateral incisor

7. deep bite with traumatisation of gingiva

8. cross bite with forced the leadership of the lower jaw

9. nonokluze at least two pairs of antagonists, including wisdom teeth

in one lateral segment

without depending on age except as specified in point 5. 80% of the

calculated prices

standard. product

----------------------------------------------------------------------------------------------------

(c)) the other anomalies of the teeth and bite in children under 18 years of age 50%

calculated prices

standard. product

----------------------------------------------------------------------------------------------------

(d)) other anomalies of the teeth and bite for persons over 18 years of age shall stipulate

----------------------------------------------------------------------------------------------------



Decisive for the inclusion of the patient to the appropriate category under the

the gravity anomaly is the diagnosis in the patient file at the beginning of

orthodontic treatment. This classification is valid until the end of the treatment, including

the retention phase. Improvement of the anomalies in the course of treatment with categorization

does not change.



Model and x-ray the patient file must be stored in the

the clinic for three years after the end of treatment.



Lifetime orthodontic appliances is given in therapeutic effectiveness

These apparatuses according to treatment plans.



Orthodontic products are paid by the health insurance company only to those Contracting

medical facilities, where these products exhibits:



-dentist with a license for the field of orthodontics,



-dentist licensed general dentist and with the certificate, SHALL BE for the

the scope of orthodontics.



Dental products-persons under 18 years of age



+-----+---+------------------------------+--------+-----+-----+-----------+

| Code | STRANG | The name of the dental product | Dental | Kat | OME | Payment |

| | | | alloy | | | insurance company |

+-----+---+------------------------------+--------+-----+-----+-----------+



Separate the production phase



70001 | | Study model with imprint | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

70002 | | Analysis of models in okludoru | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

70004 | | Diagnostic remodeling | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

70011 | | A functional fingerprint of the upper jaw | | | | (I)

| | in individual spoon | | | |

------+---+------------------------------+--------+-----+-----+------------

70012 | | A functional fingerprint of the lower jaw | | | | (I)

| | in individual spoon | | | |

------+---+------------------------------+--------+-----+-----+------------

70013 | | The imprint of the jaw Anatomy | | | | (I)

| | in individual spoon | | | |

------+---+------------------------------+--------+-----+-----+------------

70021 | | Registration of the face Tanner | | | | (I)

| | ARC | | | |

------+---+------------------------------+--------+-----+-----+------------

70031 | | Reconstruction of mezičelistních | | | | (I)

| | skusovými relations templates | | | |

------+---+------------------------------+--------+-----+-----+------------

70041 | | Registration of functional positions | | | | (I)

| | mandible | | | |

------+---+------------------------------+--------+-----+-----+------------

70051 | | Modelling of black-pillar | | | | (I)

| | | | | |

------+---+------------------------------+--------+-----+-----+------------

70061 | | Milling-pillar | | | | (I)

| the bridge construction or ' | ' | | | |



Reconstruction of the Crown



71041 | | The inlay of the root, one channel | 2 | | | (I)

| direct, aluminium | | | | |

------+---+------------------------------+--------+-----+-----+------------

71042 | | The inlay of the root, one channel | 2 | | | (I)

| indirect, aluminium | | | | |

------+---+------------------------------+--------+-----+-----+------------

71051 | | The inlay of the root, two canals | 2 | | | (I)

| direct, aluminium | | | | |

------+---+------------------------------+--------+-----+-----+------------

71052 | | The inlay of the root, two canals | 2 | | | (I)

| indirect, aluminium | | | | |

------+---+------------------------------+--------+-----+-----+------------

71061 | | Root inlay, three and more | 2 | | | (I)

| ducts, direct, | aluminium | | | |

------+---+------------------------------+--------+-----+-----+------------

71062 | | Root inlay, three and more | 2 | | | (I)

| |, indirect, aluminium ducts | | | |

------+---+------------------------------+--------+-----+-----+------------

71071 ' | | Aesthetic plastic bezel | | | | (I)



Crown of the refund



71101 | | Crown steel, sheath | 1 | | | (I)

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

71102 | | Crown steel, sheath | 1 | | | (I)

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

71103 | | Crown protective sheath | | | | (I)

| | aluminium | | | |

------+---+------------------------------+--------+-----+-----+------------

71104 | | Crown protective sheath | | | | (I)

| | embossed | | | |

------+---+------------------------------+--------+-----+-----+------------

71111 | | Crown sheath of plastic | | | | (I)

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

71112 | | Crown sheath of plastic | | | | (I)

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

71113 | | Crown sheath | | | | 693.0-

| from composite plastic, | | | | |

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

71114 | | Crown sheath | | | | 745.0-

| from composite plastic, | | | | |

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

71121 | | Crown bevelled-plastic, | 1 | | | (I)

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

71122 | | Crown bevelled-plastic, | 1 | | | (I)

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

71123 | | Crown bevelled-| | | | 1014.0-

| preparation of composite plastic, | | | | |

| | in | | | |

------+---+------------------------------+--------+-----+-----+------------

71124 | | Crown bevelled-| | | | 1066.0-

| preparation of composite plastic, | | | | |

| | schůdková | | | |

------+---+------------------------------+--------+-----+-----+------------

71131 | | Crown skeleton, armovaná | | | | (I)

| |-plastic | | | |

------+---+------------------------------+--------+-----+-----+------------

71132 | | Crown bevelled-| | | | 1014.0-

| | metal-ceramics | | | |



Fixed bridges abutment design of bridges



71201 | | Crown steel, sheath | 1 | | | (I)

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

71202 | | Crown steel, sheath | 1 | | | (I)

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

71211 | | Crown bevelled-plastic, | 1 | | | (I)

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

71212 | | Crown bevelled-plastic, | 1 | | | (I)

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

71221 | | Crown bevelled-| | | | 942.0-

| preparation of composite plastic, | | | | |

| | in | | | |

------+---+------------------------------+--------+-----+-----+------------

71222 | | Crown bevelled-| | | | 994.0-

| preparation of composite plastic, | | | | |

| | schůdková | | | |

------+---+------------------------------+--------+-----+-----+------------

71231 | | Crown bevelled-| | | | 942.0-

| | metal-ceramics | | | |


------+---+------------------------------+--------+-----+-----+------------

71251 | | The root CAP, one | | | | 597.0-

| | Canal | | | |

------+---+------------------------------+--------+-----+-----+------------

71252 | | The root CAP, two ducts | | | | 662.0-

------+---+------------------------------+--------+-----+-----+------------

71253 | | The root CAP, three and more | | | | 753.0-

| | Canal | | | |



Connection pilířových construction



71301 | The bridge-| | 1 | | | (I)

------+---+------------------------------+--------+-----+-----+------------

71302 | The bridge, a faceted-| | 1 | | | (I)

| |: plastic | | | |

------+---+------------------------------+--------+-----+-----+------------

71303 | The bridge, a faceted-| | | | | 598.0-

| composite plastic | | | | |

------+---+------------------------------+--------+-----+-----+------------

71312 | The bridge, a faceted-| | | | | 598.0-

| | metal-ceramics | | | |

------+---+------------------------------+--------+-----+-----+------------

71321 | | Support the caliper individually | | | | (I)



| |-crafted | | | |

------+---+------------------------------+--------+-----+-----+------------

71322 | | Support the caliper prefebrikovaný | | | | (I)



Adhesive refunds



71501 | | Adhesive bridge, one | | | | (I)

| | mezičlen-plastic | | | |

------+---+------------------------------+--------+-----+-----+------------

71502 | | Adhesive bridge, more | | | | (I)

| | mezičlen-plastic | | | |

------+---+------------------------------+--------+-----+-----+------------

71531 | | Adhesive aluminium splint-| | | | (I)

| | to 6 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

71532 | | Adhesive aluminium splint-| | | | (I)

| and more teeth | 7 | | | |



Temporary fixed refunds, repairs of fixed refunds



71601 | | A makeshift protective Crown | | | | (I)

| | | | | |

------+---+------------------------------+--------+-----+-----+------------

71611 | | A makeshift protective bridge | | | | (I)

| |-up to 6 plastic teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

71612 | | A makeshift protective bridge | | | | (I)

| |-plastic 7 + teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

71621 | | Fix fixed refunds | | | | (I)

| |-new bearing bezel | | | |

------+---+------------------------------+--------+-----+-----+------------

71631 | | Fix fixed refunds | | | | (I)

| |-bearing joining | | | |



Partial dentures dental defect



72001 | Partial removable replacement | | | | | (I)

| with simple retention | | | | |

| |-to elements 6 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

72002 | Partial removable replacement | | | | | (I)

| with simple retention | | | | |

| |-7 elements and more teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

72011 | Partial removable replacement | | 3 | | | 2010.0-

| with cast anchor elements |-| | | |

| | to 6 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

72014 | Partial removable replacement | | 3 | | | 2146.0-

| with cast anchor elements |-| | | |

| and more teeth | 7 | | | |

------+---+------------------------------+--------+-----+-----+------------

72021 | Partial removable replacement | | 3 | | | 2490.0-

| |-stabilises the bottom with cast | | | |

| |-7 connection bracket and more | | | |

| | teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

72022 | Partial removable replacement | | 3 | | | 2502.0-

| upper bunk with cast | | | | |

| |-7 plate and more teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

72041 | | Baby cam replacement | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

72104 | | The top skeleton replacement-| 3 | | | (I)

| | 2 anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

72105 | | The top skeleton replacement-| 3 | | | (I)

| | 3 or more anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

72106 | | The top skeleton replacement-| 3 | | | (I)

| | nesponové anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

72114 | | The lower compensation-skeleton | 3 | | | (I)

| | 2 anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

72115 | | The lower compensation-skeleton | 3 | | | (I)

| | 3 or more anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

72116 | | The lower compensation-skeleton | 3 | | | (I)

| | nesponové anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

72141 | | Aluminium splint pickup-| 3 | | | (I)

| | to 6 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

72142 | | Aluminium splint pickup-| 3 | | | (I)

| and more teeth | 7 | | | |

------+---+------------------------------+--------+-----+-----+------------

72151 | | Aluminium splint fixed-up to 6 teeth | 3 | | | (I)

------+---+------------------------------+--------+-----+-----+------------

72152 | | Aluminium fixed splint-| 3 | | | (I)

| and more teeth | 7 | | | |



The total dentures



72201 | | The total remuneration of the top | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

72203 | | The total remuneration of the top with cast | 3 | | | 3125.0-

| | top bunk | | | |

------+---+------------------------------+--------+-----+-----+------------

72204 | | The total remuneration of the top hybrid | | | | 2707.0-

------+---+------------------------------+--------+-----+-----+------------

72211 | | The total replacement of the bottom | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

72212 | | The total replacement of the bottom with cast | 3 | | | 3177.0-

| | Base | | | |

------+---+------------------------------+--------+-----+-----+------------

72213 | | The total compensation of the lower hybrid | | | | 2759.0-



Repairs and adjustments to the casting, rebaze

72301 | | Fix-tooth vypadlého | | | | (I)

| from refunds | | | | |

------+---+------------------------------+--------+-----+-----+------------

72311 | | Fix on the model-cracked | | | | (I)

| broken replacement | | | | |

------+---+------------------------------+--------+-----+-----+------------



72320 | | Fix or edit the retention | | | | (I)

| compensation elements, | | | | |

------+---+------------------------------+--------+-----+-----+------------

72331 | | Edit-extension of the base | | | | 537.0-

| |-up to 4 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

72332 | | Edit-extension of the base | | | | 600.0-

| |-5 or more teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

72341 | | Fix wireframe-| | | | (I)

| joining, scoring | | | | |

------+---+------------------------------+--------+-----+-----+------------



72351 | | Edit-rebaze partial | | | | 353.0-

| dentures unhashed | | | | |

------+---+------------------------------+--------+-----+-----+------------

72352 | | Edit-rebaze partial | | | | 940.0-

| | dentures bearing | | | |

------+---+------------------------------+--------+-----+-----+------------

72353 | | Edit-rebaze total | | | | 405.0-

| without the fingerprint | | | | |

------+---+------------------------------+--------+-----+-----+------------

72354 | | Edit-rebaze total | | | | 1122.0-

| refund with fingerprint | function | | | |

| | framing | | | |



Reconstruction of the refund



73001 | | Obturátor floor with partial | | | | (I)

| resin replacement | | | | |

------+---+------------------------------+--------+-----+-----+------------

73002 | | Obturátor floor with partial | 3 | | | (I)

| skeleton replacement | | | | |

------+---+------------------------------+--------+-----+-----+------------

73003 | | Obturátor floor with a total || | | | (I)

| replacement teeth | | | | |

------+---+------------------------------+--------+-----+-----+------------


73011 | Partial refund | poresekční | | | | (I)

| | top JAWS | | | |

------+---+------------------------------+--------+-----+-----+------------

73012 | Partial refund | poresekční | | | | (I)

| the upper jaw with the Chamber, | | | | |

------+---+------------------------------+--------+-----+-----+------------

73021 | Partial refund | poresekční | | | | (I)

| | lower jaw | | | |

------+---+------------------------------+--------+-----+-----+------------

73032 | | Total poresekční recovery | | | | (I)

| | lower jaw | | | |



Rehabilitation and therapeutic AIDS



74001 | | Fusing resin | | | | (I)

| the occlusal splint | | | | |

------+---+------------------------------+--------+-----+-----+------------

74011 | | Fixed resin nákusná | | | | (I)

| |-splint | | | |

------+---+------------------------------+--------+-----+-----+------------

74012 | | Fixed skeletovaná nákusná | 3 | | | (I)

| |-splint | | | |

------+---+------------------------------+--------+-----+-----+------------

74021 | | Sensing resinous nákusná | | | | (I)

| |-splint | | | |

------+---+------------------------------+--------+-----+-----+------------

74022 | | Nákusná cam skeletovaná | 3 | | | (I)

| |-splint | | | |

------+---+------------------------------+--------+-----+-----+------------

74031 | | Cover of postoperative plate | | | | (I)

| | Kiliánova Board | | | |

------+---+------------------------------+--------+-----+-----+------------

74032 | | Carrier transplant | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

74033 | | Cover plate for newborns | | | | (I)

| with cleft palate | | | | |

------+---+------------------------------+--------+-----+-----+------------

74034 | | Oklusní surgical splint-| | | | (I)

| | bimaxilární plate | | | |

------+---+------------------------------+--------+-----+-----+------------

74035 | | N t brace | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

74036 | | Strut plate to support | | | | (I)

| orbital trash | | | | |

------+---+------------------------------+--------+-----+-----+------------

74041 | | Rozvolňovač the oral closure | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

74042 | | Spring gag | | | | (I)



Orthodontic products



76001 | | Orthodontic diagnostic | | | P | (I)

| documentation models | | | | |

------+---+------------------------------+--------+-----+-----+------------

76010 | | Simple functional sensing | | and | P | (I)

| | device (monoblocks, propulsor) | | | |

------+---+------------------------------+--------+-----+-----+------------

76011 | | Simple functional sensing | | (b) | P | 1289.0-

| | device (monoblocks, propulsor) | | | |

------+---+------------------------------+--------+-----+-----+------------

76012 | | Simple functional sensing | | (c) | P | 806.0-

| | device (monoblocks, propulsor) | | | |

------+---+------------------------------+--------+-----+-----+------------

76013 | | Moderately complex functional devices | | and | P | (I)

| | (klammt, balters) | | | |

------+---+------------------------------+--------+-----+-----+------------

76014 | | Moderately complex functional devices | | (b) | P | 1770.0-

| | (klammt, balters) | | | |

------+---+------------------------------+--------+-----+-----+------------

76015 | | Moderately complex functional devices | | (c) | P | 1106.0-

| | (klammt, balters) | | | |

------+---+------------------------------+--------+-----+-----+------------

76016 | | Complex functional removable appliance | | and | P | (I)

| | (fránkel, bimler, lehnam, | | | |

| | hansa-platte) | | | |

------+---+------------------------------+--------+-----+-----+------------

76017 | | Complex functional removable appliance | | (b) | P | 2450.0-

| | (fránkel, bimler, lehnam, | | | |

| | hansa-platte) | | | |

------+---+------------------------------+--------+-----+-----+------------

76018 | | Complex functional removable appliance | | (c) | P | 1532.0-

| | (fránkel, bimler, lehnam, | | | |

| | hansa-platte) | | | |

------+---+------------------------------+--------+-----+-----+------------

76020 | | Positioner | | and | P | (I)

------+---+------------------------------+--------+-----+-----+------------

76021 | | Positioner | | (b) | P | 3258.0-

------+---+------------------------------+--------+-----+-----+------------

76022 | | Positioner | | (c) | P | 2036.0-

------+---+------------------------------+--------+-----+-----+------------

76030 | | Simple plate cam | | and | P | (I)

| |-up to 4 devices elements (wire., | | | |

| | 1 screw) | | | |

------+---+------------------------------+--------+-----+-----+------------

76031 | | Simple plate cam | | (b) | P | 1043.0-

| |-up to 4 devices elements (wire., | | | |

| | 1 screw) | | | |

------+---+------------------------------+--------+-----+-----+------------

76032 | | Simple plate cam | | (c) | P | 652.0-

| |-up to 4 devices elements (wire., | | | |

| | 1 screw) | | | |

------+---+------------------------------+--------+-----+-----+------------

76033 | | A complex plate removable appliance | | and | P | (I)

------+---+------------------------------+--------+-----+-----+------------

76034 | | A complex plate removable appliance | | (b) | P | 1323.0-

------+---+------------------------------+--------+-----+-----+------------

76035 | | A complex plate removable appliance | | (c) | P | 827.0-

------+---+------------------------------+--------+-----+-----+------------

76036 | | Obtain canopy sunshades | | and | P | (I)

------+---+------------------------------+--------+-----+-----+------------



76037 | | Obtain canopy sunshades | | (b) | P | 965.0-

------+---+------------------------------+--------+-----+-----+------------

76038 | | Obtain canopy sunshades | | (c) | P | 603.0-

------+---+------------------------------+--------+-----+-----+------------

76040 | | Fixed device to extend | | and | P | (I)

------+---+------------------------------+--------+-----+-----+------------

76041 | | Fixed device to extend | | (b) | P | 1933.0-

| | midpalatal suture | | | |

------+---+------------------------------+--------+-----+-----+------------

76042 | | Fixed device to extend | | (c) | P | 1208.0-

| | midpalatal suture | | | |

------+---+------------------------------+--------+-----+-----+------------

76050 | | Laboratory-made nábradek | | and | P | (I)

------+---+------------------------------+--------+-----+-----+------------

76051 ' | | Laboratory-made nábradek | | (b) | P | 709.0-

------+---+------------------------------+--------+-----+-----+------------

76052 | | Laboratory-made nábradek | | (c) | P | 443.0-

------+---+------------------------------+--------+-----+-----+------------

76070 | | Laboratory prepared | | and | P | (I)

| intraoral | arc | | | |

------+---+------------------------------+--------+-----+-----+------------

76071 | | Laboratory prepared | | (b) | P | 542.0-

| intraoral | arc | | | |

------+---+------------------------------+--------+-----+-----+------------

76072 | | Laboratory prepared | | (c) | P | 339.0-

| intraoral | arc | | | |

------+---+------------------------------+--------+-----+-----+------------



76080 | | Repair or adjustment of the scanning | | | | (I)

| a simple apparatus (lom |, | | | |

| wire Element | 1) | | | |

------+---+------------------------------+--------+-----+-----+------------

76081 | | Repair or adjustment of the scanning | | | P | (I)

| apparatus bearing the ' | ' | | | |



Dental products-persons older than 18 years of age



+-----+---+------------------------------+--------+-----+-----+-----------+

| Code | STRANG | The name of the dental product | Dental | Kat | OME | Payment |

| | | | alloy | | | insurance company |

+-----+---+------------------------------+--------+-----+-----+-----------+



Separate the production phase



80001 | | Study model with imprint | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

80002 | | Analysis of models in okludoru | | | | 132.0-

------+---+------------------------------+--------+-----+-----+------------

80004 | | Diagnostic remodeling | | | | 156.0-

------+---+------------------------------+--------+-----+-----+------------

80011 | | A functional fingerprint of the upper jaw | | | | (I)

| | in individual spoon | | | |

------+---+------------------------------+--------+-----+-----+------------

80012 | | A functional fingerprint of the lower jaw | | | | (I)

| | in individual spoon | | | |

------+---+------------------------------+--------+-----+-----+------------


80013 | | The imprint of the jaw Anatomy | | | | (I)

| | in individual spoon | | | |

------+---+------------------------------+--------+-----+-----+------------

80021 | | Registration of the face Tanner | | | | 156.0-

| | ARC | | | |

------+---+------------------------------+--------+-----+-----+------------

80031 | | Reconstruction of mezičelistních | | | | 190.0-

| | skusovými relations templates | | | |

------+---+------------------------------+--------+-----+-----+------------

80041 | | Registration of functional positions | | | | 300.0-

| | mandible | | | |

------+---+------------------------------+--------+-----+-----+------------

80051 | | Modelling of black-pillar | | | | 84.0-

| | | | | |

------+---+------------------------------+--------+-----+-----+------------

80061 | | Milling-pillar | | | | 105.0-

| the bridge construction or ' | ' | | | |



Reconstruction of the Crown



81041 | | The inlay of the root, one channel | 2 | | | 350.0-

| | direct | | | |



Reconstruction of the Crown



81042 | | The inlay of the root, one channel | 2 | | | 596.0-

| indirect, aluminium | | | | |

------+---+------------------------------+--------+-----+-----+------------

81051 | | The inlay of the root, two canals | 2 | | | 369.0-

| direct, aluminium | | | | |

------+---+------------------------------+--------+-----+-----+------------

81052 | | The inlay of the root, two canals | 2 | | | 666.0-

| indirect, aluminium | | | | |

------+---+------------------------------+--------+-----+-----+------------

81061 | | Root inlay, three and more | 2 | | | 429.0-

| ducts, direct, | aluminium | | | |

------+---+------------------------------+--------+-----+-----+------------

81062 | | Root inlay, three and more | 2 | | | 770.0-

| |, indirect, aluminium ducts | | | |



Crown of the refund



81101 | | Crown steel, sheath | 1 | | | (I)

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

81102 | | Crown steel, sheath | 1 | | | (I)

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

81111 | | Crown sheath of plastic | | | | (I)

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

81112 | | Crown sheath of plastic | | | | (I)

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

81113 | | Crown sheath | | | | 693.0-

| from composite plastic, | | | | |

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

81114 | | Crown sheath | | | | 745.0-

| from composite plastic, | | | | |

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

81115 | | Crown sheath ceramic, | | | | 745.0-

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

81121 | | Crown bevelled-plastic, | 1 | | | 561.0-

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

81122 | | Crown bevelled-plastic, | 1 | | | 592.0-

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

81123 | | Crown bevelled-| | | | 561.0-

| preparation of composite plastic, | | | | |

| | in | | | |

------+---+------------------------------+--------+-----+-----+------------

81124 | | Crown bevelled-| | | | 592.0-

| preparation of composite plastic, | | | | |

| | schůdková | | | |

------+---+------------------------------+--------+-----+-----+------------

81132 | | Crown bevelled-| | | | 561.0-

| | metal-ceramics | | | |



Fixed bridges abutment design of bridges



81201 | | Crown steel, sheath | 1 | | | 815.0-

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

81202 | | Crown steel, sheath | 1 | | | 867.0-

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

81203 | | Crown sheath ceramic, | | | | 550.0-

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

81211 | | Crown bevelled-plastic, | 1 | | | 519.0-

| preparation to the lost | | | | |

------+---+------------------------------+--------+-----+-----+------------

81212 | | Crown bevelled-plastic, | 1 | | | 550.0-

| | schůdková perm | | | |

------+---+------------------------------+--------+-----+-----+------------

81221 | | Crown bevelled-| | | | 519.0-

| preparation of composite plastic, | | | | |

| | in | | | |

------+---+------------------------------+--------+-----+-----+------------

81222 | | Crown bevelled-| | | | 550.0-

| preparation of composite plastic, | | | | |

| | schůdková | | | |

------+---+------------------------------+--------+-----+-----+------------

81231 | | Crown bevelled-| | | | 519.0-

| | metal-ceramics | | | |

------+---+------------------------------+--------+-----+-----+------------

81251 | | The root CAP, one | | | | 597.0-

| | Canal | | | |

------+---+------------------------------+--------+-----+-----+------------

81252 | | The root CAP, two ducts | | | | 662.0-

------+---+------------------------------+--------+-----+-----+------------

81253 | | The root CAP, three and more | | | | 753.0-

| | Canal | | | |



Connection pilířových construction



81301 | The bridge-| | 1 | | | 470.0-



Connection pilířových construction



81302 | The bridge, a faceted-| | 1 | | | 321.0-

| |: plastic | | | |

------+---+------------------------------+--------+-----+-----+------------

81303 | The bridge, a faceted-| | | | | 321.0-

| composite plastic | | | | |

------+---+------------------------------+--------+-----+-----+------------

81311 | The ceramic bridge | | | | | 321.0-

------+---+------------------------------+--------+-----+-----+------------

81312 | The bridge, a faceted-| | | | | 321.0-

| | metal-ceramics | | | |



Adhesive refunds



81531 | | Adhesive aluminium splint-| | | | 1230.0-

| | to 6 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

81532 | | Adhesive aluminium splint-| | | | 1716.0-

| and more teeth | 7 | | | |



Temporary fixed refunds, repairs of fixed refunds



81601 | | A makeshift protective Crown | | | | 282.0-

| | | | | |

------+---+------------------------------+--------+-----+-----+------------

81611 | | A makeshift protective bridge | | | | 679.0-

| |-up to 6 plastic teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

81612 | | A makeshift protective bridge | | | | 929.0-

| |-plastic 7 + teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

81621 | | Fix fixed refunds | | | | 208.0-

| |-new bearing bezel | | | |

------+---+------------------------------+--------+-----+-----+------------

81631 | | Fix fixed refunds | | | | 508.0-

| |-bearing joining | | | |



Partial dentures dental defect



82001 | Partial removable replacement | | | | | (I)

| with simple retention | | | | |

| |-to elements 6 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

82002 | Partial removable replacement | | | | | (I)

| with simple retention | | | | |

| |-7 elements and more teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

82011 | Partial removable replacement | | 3 | | | 2010.0-

| with cast anchor elements |-| | | |

| | to 6 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

82014 | Partial removable replacement | | 3 | | | 2146.0-

| with cast anchor elements |-| | | |

| and more teeth | 7 | | | |

------+---+------------------------------+--------+-----+-----+------------

82021 | Partial removable replacement | | 3 | | | 2490.0-

| |-stabilises the bottom with cast | | | |

| |-7 connection bracket and more | | | |

| | teeth | | | |

------+---+------------------------------+--------+-----+-----+------------


82022 | Partial removable replacement | | 3 | | | 2502.0-

| upper bunk with cast | | | | |

| |-7 plate and more teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

82104 | | The top skeleton replacement-| 3 | | | 1260.0-

| | 2 anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

82105 | | The top skeleton replacement-| 3 | | | 1395.0-

| | 3 or more anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

82114 | | The lower compensation-skeleton | 3 | | | 1246.0-

| | 2 anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

82115 | | The lower compensation-skeleton | 3 | | | 1345.0-

| | 3 or more anchor elements | | | |

------+---+------------------------------+--------+-----+-----+------------

82141 | | Aluminium splint pickup-| | | | 1374.0-

| | to 6 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

82142 | | Aluminium splint pickup-| | | | 2008.0-

| and more teeth | 7 | | | |

------+---+------------------------------+--------+-----+-----+------------

82151 | | Aluminium splint fixed-up to 6 teeth | | | | 1712.0-

------+---+------------------------------+--------+-----+-----+------------

82152 | | Aluminium fixed splint-| | | | 2321.0-

| and more teeth | 7 | | | |



The total dentures



82201 | | The total remuneration of the top | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

82203 | | The total remuneration of the top with cast | 3 | | | 1531.0-

| | top bunk | | | |

------+---+------------------------------+--------+-----+-----+------------

82204 | | The total remuneration of the top hybrid | | | | 1326.0-

------+---+------------------------------+--------+-----+-----+------------

82211 | | The total replacement of the bottom | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

82212 | | The total replacement of the bottom with cast | 3 | | | 1555.0-

| | Base | | | |

------+---+------------------------------+--------+-----+-----+------------

82213 | | The total compensation of the lower hybrid | | | | 1351.0-



Repair of casting, rebaze



82301 | | Fix-tooth vypadlého | | | | 164.0-

| from refunds | | | | |

------+---+------------------------------+--------+-----+-----+------------

82311 | | Fix on the model-cracked | | | | 225.0-

| broken replacement | | | | |

------+---+------------------------------+--------+-----+-----+------------



82320 | | Fix or edit the retention | | | | 363.0-

| compensation elements, | | | | |

------+---+------------------------------+--------+-----+-----+------------

82331 | | Edit-extension of the base | | | | 587.0-

| |-up to 4 teeth | | | |

------+---+------------------------------+--------+-----+-----+------------

82332 | | Edit-extension of the base | | | | 600.0-

| |-5 or more teeth | | | |



------+---+------------------------------+--------+-----+-----+------------

82341 | | Fix wireframe-| | | | 876.0-

| joining, scoring | | | | |



------+---+------------------------------+--------+-----+-----+------------

82351 | | Edit-rebaze partial | | | | 353.0-

| dentures unhashed | | | | |

------+---+------------------------------+--------+-----+-----+------------

82352 | | Edit-rebaze partial | | | | 940.0-

| | dentures bearing | | | |

------+---+------------------------------+--------+-----+-----+------------

82353 | | Edit-rebaze total | | | | 405.0-

| without the fingerprint | | | | |

------+---+------------------------------+--------+-----+-----+------------

82354 | | Edit-rebaze total | | | | 1122.0-

| refund with fingerprint | function | | | |

| | framing | | | |

Reconstruction of the refund



83001 | | Obturátor floor with partial | | | | (I)

| resin replacement | | | | |

------+---+------------------------------+--------+-----+-----+------------

83002 | | Obturátor floor with partial | 3 | | | (I)

| skeleton replacement | | | | |

------+---+------------------------------+--------+-----+-----+------------

83003 | | Obturátor floor with a total || | | | (I)

| replacement teeth | | | | |

------+---+------------------------------+--------+-----+-----+------------

83011 | Partial refund | poresekční | | | | (I)

| | top JAWS | | | |

------+---+------------------------------+--------+-----+-----+------------

83012 | Partial refund | poresekční | | | | (I)

| the upper jaw with the Chamber, | | | | |

------+---+------------------------------+--------+-----+-----+------------

83021 | Partial refund | poresekční | | | | (I)

| | lower jaw | | | |

------+---+------------------------------+--------+-----+-----+------------

83031 | | Total poresekční recovery | | | | (I)

| | top JAWS | | | |

------+---+------------------------------+--------+-----+-----+------------

83032 | | Total poresekční recovery | | | | (I)

| | lower jaw | | | |



Rehabilitation and therapeutic AIDS



84001 | | Fusing resin | | | | (I)

| the occlusal splint | | | | |

------+---+------------------------------+--------+-----+-----+------------

84011 | | Fixed resin nákusná | | | | (I)

| |-splint | | | |

------+---+------------------------------+--------+-----+-----+------------

84012 | | Fixed skeletovaná nákusná | 3 | | | (I)

| |-splint | | | |

------+---+------------------------------+--------+-----+-----+------------

84021 | | Sensing resinous nákusná | | | | (I)

| |-splint | | | |

------+---+------------------------------+--------+-----+-----+------------

84022 | | Nákusná cam skeletovaná | 3 | | | (I)

| |-splint | | | |

------+---+------------------------------+--------+-----+-----+------------

84031 | | Cover of postoperative plate | | | | (I)

| | Kiliánova Board | | | |

------+---+------------------------------+--------+-----+-----+------------

84032 | | Carrier transplant | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

84034 | | Oklusní surgical splint-| | | | (I)

| | bimaxilární plate | | | |

------+---+------------------------------+--------+-----+-----+------------

84035 | | N t brace | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

84036 | | Strut plate to support | | | | (I)

| orbital trash | | | | |

------+---+------------------------------+--------+-----+-----+------------

84041 | | Rozvolňovač the oral closure | | | | (I)

------+---+------------------------------+--------+-----+-----+------------

84042 | | Spring gag | | | | (I)



Orthodontic products



86001 | | Orthodontic diagnostic | | | P | (I)

| documentation models | | | | |

------+---+------------------------------+--------+-----+-----+------------

86010 | | Simple functional sensing | | and | P | (I)

| | device (monoblocks, propulsor) | | | |

------+---+------------------------------+--------+-----+-----+------------

86011 | | Simple functional sensing | | (b) | P | 1289.0-

| | device (monoblocks, propulsor) | | | |

------+---+------------------------------+--------+-----+-----+------------

86013 | | Moderately complex functional | | and | P | (I)

| | removable appliance | | | |

| | (klammt, balters) | | | |

------+---+------------------------------+--------+-----+-----+------------

86014 | | Moderately complex functional | | (b) | P | 1770.0-

| | removable appliance | | | |

| | (klammt, balters) | | | |

------+---+------------------------------+--------+-----+-----+------------

86016 | | Complex functional removable appliance | | and | P | (I)

| | (fránkel, bimler, lehman, | | | |

| | hansa-platte) | | | |

------+---+------------------------------+--------+-----+-----+------------

86017 | | Complex functional removable appliance | | (b) | P | 2450.0-

| | (fránkel, bimler, lehman, | | | |

| | hansa-platte) | | | |

------+---+------------------------------+--------+-----+-----+------------

86020 | | Positioner | | and | P | (I)

------+---+------------------------------+--------+-----+-----+------------

86021 | | Positioner | | (b) | P | 3258.0-

------+---+------------------------------+--------+-----+-----+------------

86030 | | Simple plate cam | | and | P | (I)

| |-up to 4 devices elements (wire., | | | |

| | 1 screw) | | | |

------+---+------------------------------+--------+-----+-----+------------


86031 | | Simple plate cam | | (b) | P | 1043.0-

| |-up to 4 devices elements (wire., | | | |

| | 1 screw) | | | |

------+---+------------------------------+--------+-----+-----+------------

86033 | | A complex plate removable appliance | | and | P | (I)

------+---+------------------------------+--------+-----+-----+------------

86034 | | A complex plate removable appliance | | (b) | P | 1323.0-

------+---+------------------------------+--------+-----+-----+------------

86036 | | Obtain canopy sunshades | | and | P | (I)

------+---+------------------------------+--------+-----+-----+------------

86037 | | Obtain canopy sunshades | | (b) | P | 965.0-

------+---+------------------------------+--------+-----+-----+------------

86040 | | Fixed device to extend | | and | P | (I)

| | midpalatal suture | | | |

------+---+------------------------------+--------+-----+-----+------------

86041 | | Fixed device to extend | | (b) | P | 1933.0-

| | midpalatal suture | | | |

------+---+------------------------------+--------+-----+-----+------------

86050 | | Laboratory-made nábradek | | and | P | (I)

------+---+------------------------------+--------+-----+-----+------------

86051 | | Laboratory-made nábradek | | (b) | P | 709.0-

------+---+------------------------------+--------+-----+-----+------------

86070 | | Laboratory prepared | | and | P | (I)

| intraoral | arc | | | |

------+---+------------------------------+--------+-----+-----+------------

86071 | | Laboratory prepared | | (b) | P | 542.0-

| intraoral | arc | | | |

------+---+------------------------------+--------+-----+-----+------------



86080 | | Repair or adjustment of the scanning | | | | (I)

| a simple apparatus (lom |. | | | |

| | 1 wire. Element) | | | |

------+---+------------------------------+--------+-----+-----+------------

86081 | | Repair or adjustment of the scanning | | | P | (I)

| apparatus bearing the ' | ' | | | |

------+---+------------------------------+--------+-----+-----+------------



Annex 5



Indication list of Spa care for hospital rehabilitation



SECTION AND



A. list of indicator groups for adults



Even Diseases Oncology



(II) circulatory system diseases



(III) diseases of the digestive system



(IV) Disease of metabolic disorders and endocrine glands



In Diseases of the respiratory system



VI nerve diseases



VII Diseases of the musculoskeletal system



(VIII) Diseases of the urinary system



(IX) mental disorders



X Skin Diseases



XI Disease Gynecologic



B. indication list for spa hospital rehabilitation care for adults

------------------------------------------------------------------------------------------------------------------------------------

The Number Of Indications BASIC RECURRING

the indication for therapy treatment vacation

------------------------------------------------------------------------------------------------------------------------------------

-method of providing spa treatment-method of providing a spa hospital

rehabilitative care: rehabilitation care:

The (complex) or P (contribution) to the (complex) or P (contribution)

-other criteria related-other criteria related

to each individual indications indications

-the length of the treatment-the length of the treatment

-the deadline for the onset of treatment stay-the deadline for the onset of treatment stay

-the possibility of an extension-extension

------------------------------------------------------------------------------------------------------------------------------------

EVEN DISEASES ONCOLOGY

------------------------------------------------------------------------------------------------------------------------------------

I/1-malignant tumors. To 21 days to 21 days

Within 12 months after their comprehensive Hodgkin's disease

treatments (with the exception of up to 36 months from the beginning of the base.

long-term hormone therapy).



The possibility of an extension. P 21 days in the indicated cases, P 14 days



Hodgkin's disease after 36 months from the beginning of

Basic stay.



P 21 days in the indicated cases, P 14 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

(II) CIRCULATORY SYSTEM DISEASES

------------------------------------------------------------------------------------------------------------------------------------

II/1-Symptomatic ischemic P P 21 days 21 days, in indicated cases, P 14 days

heart disease.

------------------------------------------------------------------------------------------------------------------------------------

II/2-State after myocardial infarction. To 28 days

Within 12 months after the occurrence of myocardial infarction.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

(II)/3-Hypertensive disease to 28 days P 21 days in the indicated cases, P 14 days

II.-III. grade evaluation of Hypertension (III). the degree of hypertensive disease complicated refractory.

hypertensive disease. coronary artery disease,

congestive heart failure,

stroke, transient

Ischemic atakou or chronic

renal insufficiency on the basis

Vascular nefrosklerosy.



The possibility of an extension.

P 21 days

The other.



------------------------------------------------------------------------------------------------------------------------------------

II/4-a disease of the arteries of the legs on to the 21 days to 21 days

the basis of aterosklerotickém (II) (b). Disease of the arteries of the legs on the basis of a disease of the arteries of the legs on the basis

or inflammatory. aterosklerotickém II (b). aterosklerotickém



P 21 days (II) (b). within 18 months from the beginning of the basic

The other. stay, if invasive treatment is not possible.



P 21 days in the indicated cases, P 14 days

The other.

If invasive treatment is not possible.

------------------------------------------------------------------------------------------------------------------------------------

II/5-functional disorders of the peripheral to the 21 days P 21 days in indicated cases, P 14 days

vessels and States after thrombosis.



-Chronic lymphatic oedema. Functional disorders of the peripheral vessels

as an occupational disease, according to another

the legislation, which provides for the

the list of occupational diseases,

at the earliest 3 months after

the acute stage.



P 21 days

The other.

Functional disorders of the peripheral vessels and

conditions after thrombosis at the earliest

3 months after the acute stage.



------------------------------------------------------------------------------------------------------------------------------------

II/6-conditions after the 28 days after cardiac P 21 days in the indicated cases, P 14 days

performances of the type:

replacement valve bioprotézou Direct transfer of health care within 12 months from the beginning of the base.

or metallic prosthesis, bed care provider facility

Reconstructive procedures or

valves, Atrial Septal defects within 3 months after the operation.

or chambers,

Surgical Revascularization Option extension.

myocardium – coronary artery

bypass surgery (CABG),

operation of congenital heart P 21 days

defects in adults, other

left ventricular aneurysm operation,

heart tumors, surgery operation

the pericardium,

thoracic aortic aneurysm operation.

------------------------------------------------------------------------------------------------------------------------------------

(II)/7-stages after percutaneous P 21 days

transluminal coronary within 3 months after percutaneous transluminal

angioplasty (PTCA). coronary angioplasty (PTCA).



------------------------------------------------------------------------------------------------------------------------------------

II/8-States after reconstruction and to 21 days

revaskularizačních conditions after operations, reconstruction and

on the outside of the heart and the vascular system revaskularizačních on Vascular Surgery

thoracic aortic aneurysm. the system outside of the heart to the 4 months after

-Conditions after percutaneous surgery.

transluminal angioplasty.

P 21 days

In the range of 4 to 12 months after percutaneous

transluminal angioplasty.


------------------------------------------------------------------------------------------------------------------------------------

II/9-after a heart transplant. To 28 days to 28 days

Direct transfer of health care within 12 months from the beginning of the base.

bed care provider facility

or within 12 months after the operation. The possibility of an extension.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

(III) DISEASES OF THE DIGESTIVE SYSTEM

------------------------------------------------------------------------------------------------------------------------------------

III/1-chronic and recurrent P P 21 days 21 days, in indicated cases, P 14 days

diseases of the stomach and intestines

with maldigestivními symptoms

even when the standard

pharmacotherapy.



-Conditions after heavy intestinal

infections, parazitózách, and

fungal diseases.

------------------------------------------------------------------------------------------------------------------------------------

III/2-States after stomach surgery, to 21 days 21 days, P in indicated cases, P 14 days

the duodenum, esophagus and intestines within 6 months after the operation. In the range of 12 to 18 months after the operation, or

with the postresekční symptomatologií their complex treatment lasting

endoscopically proven. The possibility of an extension. of 138.39 days;.



P 21 days

In the range of 6 to 12 months after surgery.

------------------------------------------------------------------------------------------------------------------------------------

III/3-Crohn's disease. To 21 days to 21 days

-Ulceroza Colitis. A severe form of the disease. Recurring exacerbations of the disease: 1 during the

calendar year to stabilize the State.

The possibility of an extension.

P 21 days in the indicated cases, P 14 days

P 21 days of rest.

The other.

------------------------------------------------------------------------------------------------------------------------------------

III/4-chronic gallbladder disease P P 21 days 21 days, in indicated cases, P 14 days

and gall tract with lithiazou, to maintain remission.

If the operation is contra-indicated.

-Sclerosing cholangoitis.

-Functional disorders of the gall tract.

------------------------------------------------------------------------------------------------------------------------------------

III/5-States after complicated operations to 21 days P 21 days in indicated cases, P 14 days

gallbladder and bile tract, after

surgery for stenosis and lithiazu within 6 months after the complicated operations Continued dysfunction of the biliary tract.

biliary tract post-surgery gallbladder and gallstone-tract.

pankreatitidocholangoitis,

Icterus, instrumentation for stenosis After biliary surgery and lithiázu

paths, endoscopic retrograde biliary tract.

Cholangiopancreatography (ERCP).

-Conditions after dissoluci stones and the possibility of extension.

extracorporeal lithotripsy.

P 21 days

Within 6 months after the dissoluci stones

and extracorporeal lithotripsy.

------------------------------------------------------------------------------------------------------------------------------------

III/6-conditions after acute hepatitis for 21 days to 21 days

any toxic etiology and within 6 months of the determination of disease of liver damage when the persistent

liver damage (medicines even when conservative therapy. signs of things to process as a disease

the influence of the work). of the profession under other legislation,

-Chronic hepatitis with the possibility of extension. which sets out the list of occupational diseases.

persistence of positives markers.

-Associated autoimmune hepatitis. P 21 days in the indicated cases, P 14 days

-Primary biliary cirrhosis.

Other when the persistent biochemical

or histological signs of liver disease.

------------------------------------------------------------------------------------------------------------------------------------

III/7-States after resection procedures to 21 days P 21 days in indicated cases, P 14 days

and transplantation of the liver after resection or speed up to 6

and transplantation operations months after the operation.

pancreatic cancer. Conditions after transplantation into 12

months after the operation.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

III/8-conditions after acute pancreatitis to 21 days P 21 days in indicated cases, P 14 days

or after an exacerbation of chronic within 6 months from the initiation of treatment of acute

pancreatitis. pancreatitis or after Lengthy maldigesce and exacerbation of malabsorption in the

-Proven chronic chronic pancreatitis, the proven failure of nutritional status, if

pancreatitis. is the cause of the dysfunction of the pancreas.

When complications within 12 months from the

the initiation of treatment of acute pancreatitis or

After the exacerbation of chronic pancreatitis.



The possibility of an extension.



P 21 days

The other.



------------------------------------------------------------------------------------------------------------------------------------

(IV) DISEASES OF METABOLIC DISORDERS AND ENDOCRINE GLANDS

------------------------------------------------------------------------------------------------------------------------------------

IV/1-Diabetes mellitus. P to 21 days 21 days in the indicated cases, P 14 days



States with complications (microangiopathy statuses with complications (microangiopathy

and makroangiopatie, neuropathy). and makroangiopatie, neuropathy).



P 21 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

IV/2-conditions after total thyreoidektomii. P to 21 days 21 days in the indicated cases, P 14 days

-Hypothyroidism in difficult-to-

ongoing drug substitution. Up to 6 months after surgery. Difficult to ongoing substitution or

in the development of secondary symptoms

P 21 days (in particular, arthropathy and benign myopathy).

Within 6 months of the determination of the disease

hypotyreozy.

------------------------------------------------------------------------------------------------------------------------------------

IV/3-States after operations of hyperfunkčního to 21 days

a benign adenoma of the pituitary gland

and the adrenal gland in the presence of up to 6 months after surgery.

secondary symptoms

(in particular, arthropathy and myopathy). The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

IN NON-TUBERCULOSIS DISEASES OF THE RESPIRATORY SYSTEM

------------------------------------------------------------------------------------------------------------------------------------

V/1-States after surgery of the upper respiratory to 28 days

and lower respiratory tract infections

tract; does not concern the conditions after the States of lower respiratory tract after operation

the operations of the tonsil, adenoidních within 6 months after the operation.

vegetation and nasal septum.

-Conditions after lung transplantation. The possibility of an extension.



To 28 days



Conditions after lung transplant to 12 months

After the transplant.

The possibility of an extension.



To 21 days



Conditions after operation of upper respiratory tract

within 6 months after the operation.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

V/2-damage to the larynx and vocal cords to 21 days P 21 days in indicated cases, P 14 days

as a result of voice overload.

-Conditions after fonochirurgické treatment. When through the use of all possibilities when through the use of all possibilities

conservative or surgical treatment, conservative or surgical treatment

It does not modify the features of the voice. It does not modify the features of the voice.

------------------------------------------------------------------------------------------------------------------------------------

V/3-conditions after the complicated inflammation to 21 days

surfaces In the four months after their hospitalisation.

------------------------------------------------------------------------------------------------------------------------------------

In/4-Bronchiektazie to 21 days to 21 days

-Recurrent inflammation of the lower


chronic inflammation of the respiratory tract and the possibility of extension. 1 during a calendar year.

as a disease of the respiratory system

According to another legal profession

the regulation, which lays down a list of

occupational diseases.

The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

In/5-bronchial asthma. To 28 days to 28 days

-Chronic obstructive pulmonary

the disease. Proven ventilation disorder-the decline in Proven ventilation failure-fall

the value of a volume of air vydechnutého the value of a volume of air vydechnutého

in the first second at maximum effort in the first few seconds at maximum effort

(FEV) 1 sec repeatedly below 60% of the proper (FEV) 1 sec repeatedly below the 60% of the relevant

the value or necessity of long-term (multiple values or the need for long-term (more

than 6 months in a year) system than 6 months in the year) system

kortikoterapie for the disease. kortikoterapie for the disease.



The possibility of an extension. 1 during a calendar year.



P 21 days extension.

The other.

P 21 days in the indicated cases, P 14 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

V/6-Interstitial Pulmonary Fibrosis to 28 days to 21 days

any etiology in systematic occupational disease pursuant to other legal occupational disease pursuant to other legal

healing. the regulation, which lays down the list of diseases Act, which sets out the list of diseases

of the profession. of the profession.



The possibility of an extension. 1 during a calendar year.



The possibility of extending to 28 days.

When proven ventilation failure-fall

the value of the vital capacity (VC) repeatedly to 21 days

below 80% of predicted.

When proven ventilation failure-fall

The possibility of an extension. the value of the vital capacity (VC) repeatedly

below 80% of predicted.

P 21 days

The other. 1 during a calendar year.



The possibility of an extension.



P 21 days in the indicated cases, P 14 days

The other.



------------------------------------------------------------------------------------------------------------------------------------

V/7-the consequences of toxic gases to 28 days to 21 days

fumes, vapor and corrosive irritant

money on upper respiratory and occupational disease by other means, within 12 months from the beginning of the base.

lower respiratory tract. the regulation, which lays down the list of diseases

of the profession.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

VI NERVE DISEASES

------------------------------------------------------------------------------------------------------------------------------------

Vi/1-facial palsy. To 28 days to 28 days

-Postpoliomyelitický syndrome.

-Weak palsy, outside of post-traumatic, facial palsy in the acute phase, Postpoliomyelitický syndrome.

including the poinfekční if it is not continuous ambulatory

polyradikuloneuritis or inpatient rehabilitation care once during the calendar year.

following up on their acute effective.

phase. The possibility of an extension.

Postpoliomyelitický syndrome.

Other diseases for the duration of the feeble P 21 days in the indicated cases, P 14 days

peripheral paralysis with accompanied by:

elektromyografií (EMG) and after other periods for the duration of a poor peripheral

gradual adjustment functions. polio with accompanied by elektromyografií

(EMG) and for gradual adjustment functions.

The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

Vi/2-Polyneuropathy with paretickými to 28 days to 28 days

speeches.

Weak palsy with disabilities 0. up to 3. Weak palsy with disabilities 0. up to 3.

the degree of muscle test and demonstrable degree test and proven

disabilities by electromyography (EMG). disabilities by electromyography (EMG).



The possibility of an extension. 1 x in the course of 24 months.



P 21 days extension.

The other.

P 21 days in the indicated cases, P 14 days



The other.

------------------------------------------------------------------------------------------------------------------------------------

(VI)/3-Root syndromes with P to 21 days 21 days in the indicated cases, P 14 days

iritačně-zánikovým syndrome.



In direct follow-up to hospitalization

the neurological or rehabilitation

Department inpatient care (within 3 months after

their hospitalization), or in cases

nejevících signs of improvement after 6 weeks of

continuous outpatient rehabilitation

care, which has been excluded of the indication

to neurochirurgickému or

spondylochirurgickému surgery.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

Vi/4-inflammatory disease of the central to 28 days to 28 days

nerves:

condition after meningoencephalitis and, for persistent palsy with The 36 months from the beginning of the basic residence,

encephalitis, documented elektromyografickým if you still experience heavy to medium's palsy

myelitis and encephalomyelitis that, testing (EMG) tests and after, and is a prerequisite for the improvement of health

After a period of gradual encefalomyelopolyradi-editing functions. State.

kuloneuritis, no later than 6 months after their

hospitalization if they are present. The possibility of an extension.

spastickoparetické signs.

The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

VI/5-Hemiparézy, and paraparézy to 28 days to 28 days

Vascular origin with signs

restorative function. In direct follow-up to hospitalization, To 36 months from the beginning of the basic

not later than 6 months after the end of the stay, if you still experience heavy

hospitalization. to medium's palsy and is the assumption

In the aftermath of the acute stage of the disease. for the improvement of health.



The possibility of an extension. The possibility of an extension.



P 21 days in the indicated cases, P 14 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

Vi/6-conditions after injuries and 28 days to 28 days

the operations of the brain, the spinal cord paresis with gradual To Persistent 36 months from the beginning of the basic residence,

and peripheral nerves with the editing functions, not later than 6 months if there is persistent heavy to medium paresis

disorders of motility after surgery or injury. and is a prerequisite to improve health.

signs of restorative function.



The possibility of an extension. The possibility of an extension.



P 21 days in the indicated cases, P 14 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

Vi/7-multiple sclerosis and the other for 28 days to 28 days

demyelinating disease

in remission. The possibility of an extension. 1 in the course of 24 months.



P 21 days in the indicated cases, P 14 days

------------------------------------------------------------------------------------------------------------------------------------

Vi/8-a neuromuscular disease to 28 days to 28 days

primary, secondary and

degenerative. The possibility of an extension. 1 during a calendar year.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

Vi/9-Syringomyelie with paretickými to 21 days to 21 days

speeches.

1 in the course of 24 months.



P 21 days in the indicated cases, P 14 days

------------------------------------------------------------------------------------------------------------------------------------

VI/10-cerebral palsy in to 28 days to 28 days

a separate mobility options

and without significant psychological changes, to the age of 21.


assuming the maintenance work

skills or full independence for 28 days

and self-sufficiency.

Over 21 years of age.

1 in the course of 24 months.



P 21 days in the indicated cases, P 14 days

------------------------------------------------------------------------------------------------------------------------------------

VI/11-Parkinson's disease. To 21 days to 21 days

(Not applicable to Parkinsonského

syndrome and secondary if the premise of improving the

movement of the syndrome of health and maintain self-sufficiency.

in the treatment of psychofarmaky.)

1 in the course of 24 months.

------------------------------------------------------------------------------------------------------------------------------------

VII DISEASES OF THE MUSCULOSKELETAL SYSTEM

------------------------------------------------------------------------------------------------------------------------------------

VII/1-Rheumatoid arthritis I to IV. To 28 days to 28 days

stages of evaluation of rheumatoid

arthritis, including juvenile Treatment from II. stages of disease with functional Treatment from II. stages of disease with functional

arthritis, consistently treated disabilities class (b). disabilities class (b).

in the context of out-patient care.

The possibility of an extension. 1 during a calendar year.



P 21 days extension.



The disease without a previous exacerbation of P 21 days in the indicated cases, P 14 days

and treatment in case of lower stages

disease than II. the stage with a functional Disease without exacerbation

disabilities class (b). and treatment in case of lower stages

disease than II. with a functional stage

disabilities class (b).

------------------------------------------------------------------------------------------------------------------------------------

VII/2-Ankylosing spondylitis to 28 days to 28 days

(Bechterew's disease), consistently

treated in the outpatient care. From The II. stages of disease with functional From II. stages of disease with functional

disabilities, disabilities class b class b.,



in the continuing care of a rheumatologist or continuous care or rheumatologist

a rehabilitation physician. a rehabilitation physician.



The possibility of an extension. The possibility of an extension.



P P 21 days 21 days in the indicated cases, P 14 days

The other. The other.

------------------------------------------------------------------------------------------------------------------------------------

VII/3-other seronegative for 28 days to 28 days

spondartritis has consistently treated

in the context of out-patient care, Reiter's Involvement of the spine (II). and higher stages of spinal Disability II. and a higher stage

syndrome, enteropatická arthritis, according to the classification for ankylosing according to the classification for ankylosing

reactive-parainfectious), spondylitis. Spondylitis.

-Secondary artitis, consistently

treated in the outpatient care. Chronic arthritis, peripheral joints Chronic Arthritis, peripheral joints

from a functional disability class II. b. from a functional disability class II. b.

stage classification for the classification stage for rheumatoid arthritis, rheumatoid arthritis,

artritis. artritis.



The possibility of an extension. First 12 months from the beginning of the basic

stay and once during a calendar year.

P 21 days

The other. The possibility of an extension.



P 21 days in the indicated cases, P 14 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

VII/4-extra articular rheumatism, to 28 days to 28 days

consistently treated in the framework of the

out-patient care. In remission. In remission.

-Diffuse disease binders

consistently treated within the extension. 1 in the course of 24 months.

ambulatory care (System

Lupus erythematodus, exacerbation of an underlying disease

Scleroderma, after their last comprehensive treatment

polymyositis, dermatomyositis, acute phase and before the expiry of the 24 months.

Sjogren's syndrome and other

pop-up syndromes). The possibility of an extension.



P 21 days in the indicated cases, P 14 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

VII/5-Osteoporosis with complications, to 21 days to 21 days

If continuous ambulatory

rehabilitation care longer than Bone changes that are the result of Bone changes that are the result of

3 months is not effective or work in compressed air work in compressed air as

following the hospitalization occupational disease pursuant to other legal occupational disease pursuant to other legal

for the complication of osteoporosis. the regulation, which lays down the list of diseases Act, which sets out the list of diseases

-Bone changes that are out of the profession. of the profession.

as a result of work in compressed

the air as occupational disease, pathological fractures of the spine pathological fractures of the spine in the wake

under other legislation, in the immediate wake of the removal of the corset.

which sets out the list of diseases of their immobilization in bed

of the profession. or removal of the corset. Within 24 months from the start of the base.



P 21 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

VII/6-painful syndromes of tendon, to 21 days to 21 days

tendinous sheaths, bursae, ligaments, an occupational disease pursuant to other legal occupational disease pursuant to other legal

muscle, skeletal muscle or regulation, which lays down the list of diseases Act, which sets out the list of diseases

joints (including occupational disease. by profession, within 12 months from the beginning of the

due to the effect of the vibration of the base.

and long-term, excessive, P 21 days

unilateral overload as 21 days in the indicated cases, P 14 days

occupational diseases in another Other.

the law, which lays down the other.

the list of occupational diseases).

------------------------------------------------------------------------------------------------------------------------------------

VII/7-Koxartroza, gonartroza to 21 days to 21 days

in continuous ambulatory care

Orthopedic and rehabilitation From III. degree reviews by disease III. ratings under

doctor. Kellgrena. Kellgrena.



II. the degree of functional impairment (b), since the degree of functional disability II (b),

If this is about a painful form of with if this is about a painful form of with

frequent exacerbations and frequent exacerbations and quick fast

progression or repeated inflammatory disease progression or repeated inflammatory

irritation. irritation and it is expected to improve

momentum and maintain self-sufficiency.

The possibility of an extension.

1 in the course of 24 months.

P 21 days

The other, States to operation contraindicated

If it is not continuous ambulatory

rehabilitation care efficient. 1 during a calendar year.



P 21 days in the indicated cases, P 14 days

I. to II. the degree of illness, if it is not

ongoing outpatient care effective,

assuming a reduction in long term

Pharmacotherapy or out on the operating

treatment.

The States prohibited the operation,

If there is no ongoing outpatient care

effective.

------------------------------------------------------------------------------------------------------------------------------------

VII/8-Arthritis in the other for 21 days to 21 days

localizations.

-Arthropathy. Painful form with frequent exacerbations. If this is about a painful form of frequent

exacerbations and rapid progression or

in the case of repeated inflammatory irritation;

always assuming the improvement in momentum and

maintain self-sufficiency.



1 in the course of 24 months.



P 21 days in the indicated cases, P 14 days



Others, if not continuous ambulatory

care effective, provided the reduction

long-term pharmacotherapy.

------------------------------------------------------------------------------------------------------------------------------------

VII/9-Chronic vertebral P to 21 days 21 days in the indicated cases, P 14 days

algický syndrome of functional

origin in continuous outpatient Chronic vertebral algický

rehabilitation care. syndrome of functional origin in direct

following the hospitalization (up to 3

months after their hospitalization)

or cases showing signs of improvement


After 6 weeks of continuous ambulatory

rehabilitation care.



The possibility of an extension.



P 21 days



The other.

------------------------------------------------------------------------------------------------------------------------------------

VII/10-States after orthopedic to 28 days

operations with the use of joint

the refund. Immediately, as soon as possible

load the therapeutic rehabilitation, not later than

within 3 months after injury or surgery;

in the case of postoperative komplikacído

6 months after surgery.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

VII/11-musculoskeletal conditions after injuries to 28 days to 28 days

and after orthopedic

operations including conditions after Immediately, as soon as possible the load within 24 months after surgery

the operations of the rehabilitation, treatment of intervertebral nejpozdějivšak intervertebral discs, spinal stenosis

discs and stenosis of the channel within 6 months after an injury or surgery; channel or accident when persistent

the backbone, if it is not systematic in the case of post-operative complications serious momentum and limitations

outpatient or inpatient, within 12 months after the operation. It is the assumption of self-sufficiency and improve the

rehabilitation care efficient. the State of health.

The possibility of an extension.

P 21 days in the indicated cases, P 14 days

Other syndrome surgical treatment failure

(FBS).

------------------------------------------------------------------------------------------------------------------------------------

VII/12-lower to amputacích after 21 days

limbs, degree of activity 1 to

4, when the policy holder is equipped with a 12 months after surgery.

the prosthetic.

------------------------------------------------------------------------------------------------------------------------------------

(VIII) DISEASES OF THE URINARY SYSTEM

------------------------------------------------------------------------------------------------------------------------------------

VIII/1-Recurrent and chronic P to 21 days 21 days in the indicated cases, P 14 days

non-tuberculous infections of the kidney and

urinary tract infection-resistant Chronic pyelonefritis in solitary

treatment with antibiotics (ATB) and another kidney.

pharmacological treatment, in a systematic

the care of a urologist for at least 12 months. Cystic kidney disease. The level of

-Cystic kidney disease. serum creatinine permanently exceeds the

150 μmol/1.



The possibility of an extension.



P 21 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

VIII/2-Nephrolithiasis without congestion to 21 days P 21 days in indicated cases, P 14 days

in the urinary tract.

-Ectopic calcification. Nephrolithiasis in solitary kidney In prokázáném clinical effect of previous

bilateral nephrolithiasis, or if a spa hospital rehabilitation care.

the States are not indicated to the operating

treat or lithotripsy.



Cystinová nephrolithiasis.



Bilateral ectopic calcification.



The possibility of an extension.



P 21 days

The other.



------------------------------------------------------------------------------------------------------------------------------------

VIII/3-States after operations of the kidneys and to 21 days

urinary tract including the operations

endovezikálních and conditions after within 6 months after the surgery, kidney and

complicated Prostatectomy and urinary tract, including operations

nefrolitotrypsii, rehabilitation after endovezikálních and after

lithotripsy extrakorporálními Prostatectomy and nefrolitotrypsii.

shock waves (LERV).

P 21 days



Other



up to 6 months.

------------------------------------------------------------------------------------------------------------------------------------

VIII/4-Chronic prostatitis or P P 21 days 21 days, in indicated cases, P 14 days

chronic prostatovesikulitis

resistant to pharmacological

treatment and treatment with antibiotics (ATB)

in the continuing care of a urologist

a minimum of 12 months.

------------------------------------------------------------------------------------------------------------------------------------

VIII/5-after a kidney transplant to 21 days P 21 days in indicated cases, P 14 days

when stabilized graft function

(kidney transplant). Within 6 months after the transplant, when the States after kidney transplant

-The donor graft (kidneys). complications within 12 months (not applicable to the donor graft).

After the transplant.



The possibility of extending in the case of

transplants.

------------------------------------------------------------------------------------------------------------------------------------

(IX) MENTAL DISORDERS

------------------------------------------------------------------------------------------------------------------------------------

IX/1-Psychosis in remission. To 28 days to 28 days



In direct follow-up to hospitalization within 24 months from the start of a basic stay

in inpatient psychiatric ward in a proven effect of previous residence.

or when continuous ambulatory care

as an alternative to the subsequent bed extension.

psychiatric care after every exacerbation.

P 21 days in the indicated cases, P 14 days

The possibility of an extension.

The other.

P 21 days



The other.

------------------------------------------------------------------------------------------------------------------------------------

IX/2-severe neurotic disorders to 21 days to 21 days

and other nepsychotické disorders.

In direct follow-up to hospitalization for up to 12 months from the beginning of the basic residence

inpatient psychiatric ward or a proven effect of previous residence.

When continuous ambulatory care as

alternative bed extension subsequent.

psychiatric care after every exacerbation.

P 21 days in the indicated cases, P 14 days

The possibility of an extension.

The other.

P 21 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

X SKIN DISEASES

------------------------------------------------------------------------------------------------------------------------------------

X/1-atopic eczema. To 21 days to 21 days



To 25 years of age, the elderly in direct as an alternative to inpatient care in the field of

following a hospitalization for treatment of hyperhidrosis.

inpatient Department of dermatovenereology

or as an alternative to this care. 1 in the course of 24 months.



The possibility of an extension. The possibility of an extension.



P P 21 days 21 days in the indicated cases, P 14 days

The other. The other.

------------------------------------------------------------------------------------------------------------------------------------

X/2-generalized and artropatická to 28 days to 28 days

Psoriasis vulgaris.

In direct follow-up to hospitalization as an alternative to inpatient care in the field of

the inpatient Department of dermatovenereology of hyperhidrosis.

or as an alternative to this care.

1 during a calendar year.

The possibility of an extension. The possibility of an extension.



P P 21 days 21 days in the indicated cases, P 14 days

The other. The other.

------------------------------------------------------------------------------------------------------------------------------------

X/3-Toxic contact dermatitis, 28 days to 21 days

-Eczema as occupational disease

in the continuing care of occupational diseases in another occupational disease pursuant to other legal

dermatovenerologa. the legislation, which sets out a list of rules, which sets out the list of diseases

occupational diseases. of the profession.



The possibility of an extension. 1 during a calendar year.



P 21 days extension.

The other.

P 21 days in the indicated cases, P 14 days

The other.


------------------------------------------------------------------------------------------------------------------------------------

X/4-chronic dermatoses hung for 28 days P 21 days in the indicated cases, P 14 days

the outpatient treatment.

The treatment shall be granted exceptionally, in direct

following the hospitalization

inpatient Department of dermatovenereology

or as an alternative to this care.



The possibility of an extension.



P 21 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

X/5-States after burns and after 28 days to 21 days

Reconstructive procedures, where

significant CONTRACTURE. Within 3 months of their care within 24 months from the start of the base.

relevant specialists.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XI DISEASE GYNECOLOGIC

------------------------------------------------------------------------------------------------------------------------------------

XI/1-sterility and infertility to 21 days to 21 days

primary (3 and more spontaneous

abortion) women in 40 years. Women under 40 years of age.

-Secondary sterility on

the basis of inflammatory and functional. The sterility of women over 35 years after the sterility of women over 35 years after the

-Abortus habitualis. negative testing partner women. negative testing partner women.



Infertility (3 and more spontaneous Infertility (3 and more spontaneous

abortion) following a negative genetic abortion) following a negative genetic

examination of both partners. examination of both partners.



The possibility of an extension. Within 24 months from the start of the base.



P 21 days in the indicated cases, P 14 days

Women under 40 years of age.

------------------------------------------------------------------------------------------------------------------------------------

XI/2-repeating inflammatory to 21 days P 21 days in indicated cases, P 14 days

internal diseases of the genitals and

their consequences (adnexitis within 3 months after resolution of acute women 40 years of age.

chronica, metritis chronica, exacerbation of pelvic inflammatory disease

adhesiones pelvis minoris, in women under 40 years of age.

occlusio tubarum, kolpitis

chronica). The possibility of an extension.



P 21 days

The other.

------------------------------------------------------------------------------------------------------------------------------------

XI/3-States after complicated to 28 days

gynecological operations.

-Conditions after complicated operations

in the small pelvis.



Within 3 months after the operation.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------



SECTION B



Indication list of Spa rehabilitation clinic for care of children and

Puppy



A. list of indicator groups for children and adolescents



XXI Disease cancer



XXII of the circulatory organs



XXIII of the Diseases of the digestive system



XXIV of metabolic disorders and endocrine glands and obesity



XXV respiratory diseases



XXVI nerve diseases



XXVII Diseases of the musculoskeletal system



ARTICLE XXVIII of the Diseases of the urinary system



XXIX mental disorders



XXX Skin Diseases



XXXI gynecological Diseases



B. indication list of Spa rehabilitation clinic for care of children and

Puppy



Number indication

------------------------------------------------------------------------------------------------------------------------------------

The Number Of Indications BASIC RECURRING

the indication for therapy treatment vacation

------------------------------------------------------------------------------------------------------------------------------------

-method of providing spa treatment-method of providing a spa hospital

rehabilitative care: rehabilitation care:



The (complex) to the (complex)

-other criteria related-other criteria related

to each individual indications indications

-the length of the treatment-the length of the treatment

-the deadline for the onset of treatment stay-the deadline for the onset of treatment stay

-the possibility of an extension-extension

------------------------------------------------------------------------------------------------------------------------------------

XXI DISEASE CANCER

------------------------------------------------------------------------------------------------------------------------------------

XXI/1-malignant tumors. To 28 days



Within 24 months after their comprehensive

anticancer treatment.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXII OF THE CIRCULATORY ORGANS

------------------------------------------------------------------------------------------------------------------------------------

XXII/1-congenital and acquired defects for 28 days to 28 days

the heart and major blood vessels after surgery.

-Conditions after a heart transplant. The possibility of an extension. Haemodynamic residual defects.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXII/2-systemic rheumatic and other to 28 days to 28 days

collagen disease with disabilities

the circulatory apparatus and joint form. The possibility of an extension. 1 in the course of 24 months,



When you relapse following the termination of the

acute phase before.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXII/3-juvenile hypertension. To 28 days to 28 days



The possibility of an extension. 1 during a calendar year.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXII/4-severe risk to resulted in 28 days

factors (Dyslipidemia or

the combination of other risk the possibility of an extension.

factors: arterial hypertension,

obesity, genetic load).

------------------------------------------------------------------------------------------------------------------------------------

XXIII OF THE DISEASES OF THE DIGESTIVE SYSTEM

------------------------------------------------------------------------------------------------------------------------------------

XXIII/1-chronic diseases of the stomach. To 28 days to 28 days

-Functional disorders of the stomach.

-Chronic gastritis and the possibility of extension. 1 during a calendar year.

duodenitis erosiva.

-Peptic ulcer disease of the stomach and up to 48 months from the beginning of the basic

the duodenum. stay in a proven effect

-States after operations of the esophagus, the previous stay.

the stomach and duodenum.

The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXIII/2-chronic bowel disease. To 28 days to 28 days

-Functional disorders of the small and

the large intestine. The possibility of an extension. Chronic enterocolitis and Crohn's disease.

-Chronic enterocolitis, including

Crohn's disease and other primary once during the calendar year.

Malabsorption Syndromes.

-Dermatogenní malabsorption syndromes. The possibility of an extension.

-Coeliakie.

Intestini-Polyposis. Other:

-Megacolon congenital and acquired.

-States after operations on thin even once during the calendar year.

the colon. To 48 months from the beginning of the base.

The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXIII/3-diseases of the liver. To 28 days to 28 days

-States after infectious hepatitis.

-Chronic hepatitis. The possibility of an extension. 1 during a calendar year.

-Cirrhosis in State compensation.

-Toxic damage to the liver. Conditions after transplantation in 12 months to 36 months from the beginning of the base.

-States after Infectious Mononucleosis after the operation.

with a liver disorder. The possibility of an extension.

-Conditions after injuries, operations and

transplantation of the liver.

-Other hepatopatie.

------------------------------------------------------------------------------------------------------------------------------------


XXIII/4-chronic gallbladder disease to 28 days to 28 days

and bile ducts.

-Congenital bile formation and the possibility of extension. 1 during a calendar year.

Biliary excretion.

-Chronic cholecystitis. In the 36 months since the beginning of the basic

-Biliary dyspepsia. stay in a proven effect prior

-States after operations of the gallbladder and stay.

the bile ducts.

The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

(XXIII)/5-chronic diseases of the pancreas. To 28 days to 28 days

-Conditions after acute pancreatitis.

-Chronic pancreatitis. The possibility of an extension. Chronic diseases of the pancreas

-Pancreatic achylie Congenital cystic fibrosis.

I obtained.

-Cystic fibrosis. 1 during a calendar year.

-Conditions after injuries, operations and

pancreas transplants. The possibility of an extension.



To 28 days

The other.

1 during a calendar year.

In the 36 months since the beginning of the base.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXIV, METABOLIC DISEASES AND DISORDERS AND ENDOCRINE GLANDS AND OBESITY

------------------------------------------------------------------------------------------------------------------------------------

XXIV/1-Diabetes mellitus. To 28 days to 28 days



The possibility of an extension. 1 during a calendar year.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXIV/2-obesity associated with other to 28 days to 28 days

risk factors.

The possibility of an extension. 1 during a calendar year.



In the 36 months since the beginning of the basic

stay in a proven effect prior

the stay.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXIV/3-Tyreopatie. To 28 days to 28 days

-States after operations of the thyroid gland.

-States after operations of benign Option extension. Tyreopatie.

tumors of the adrenal gland and pituitary gland.

1 during a calendar year.



In the 36 months since the beginning of the base.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXV NON-TUBERCULOSIS DISEASES OF THE RESPIRATORY SYSTEM

------------------------------------------------------------------------------------------------------------------------------------

XXV/1-Recurrent complicated to 28 days to 28 days

otitis after operating solutions.

The possibility of an extension. The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXV/2-chronic bronchitis/to 28 days to 28 days

recurrent bronchitis.

The possibility of an extension. 1 during a calendar year.



To 48 months from the beginning of the base.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXV/3-Status after repeated inflammation to 28 days

the lungs over the last 2 years.

The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXV/4-Bronchiektasie. To 28 days to 28 days



The possibility of an extension. The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXV/5-Asthma bronchiale. To 28 days to 28 days



The possibility of an extension. The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXV/6-States after operations, and to 28 days to 28 days

traumas upper and lower

respiratory tract and lungs with the exception of the possibility of an extension. The possibility of an extension.

conditions after tonsilektomii and

operation adenoidních vegetation.

-States after operations of malformations

chest with reduced lung function.

------------------------------------------------------------------------------------------------------------------------------------

XXV/7-cystic fibrosis. To 28 days to 28 days



-Interstitial Pulmonary fibrosis. The possibility of an extension. The possibility of an extension.



-Sarcoidosis the lung.

------------------------------------------------------------------------------------------------------------------------------------

XXVI NERVE DISEASES

------------------------------------------------------------------------------------------------------------------------------------

XXVI/1-Syndrome peripheral to 28 days to 28 days

any motor neuron

the etiology. The possibility of an extension. The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXVI/2-muscular dystrophy and to 28 days to 28 days

other muscle disease.

The possibility of an extension. The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXVI/3-cerebral palsy. To 28 days to 28 days



-Cerebellar syndromes. The possibility of an extension. The possibility of an extension.



-Driving fault within the small cerebral involvement.

------------------------------------------------------------------------------------------------------------------------------------

XXVI/4-other drivers fault to 28 days to 28 days

a central origin:

-driving fault after inflammation of the possibility of an extension. The possibility of an extension.

brain and spinal cord, autoimmune,

degenerative and heredofamiliární

disease control

rehabilitation care.

-driving disorders after stroke

the incidents of brain.

-driving disorders after injuries of the brain.

-driving disorders after surgery

tumors of the central nervous system.

------------------------------------------------------------------------------------------------------------------------------------

XXVI/5-Root syndromes to 28 days to 28 days

the Czech origin.

The possibility of an extension. During a relapse of the disease.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXVII DISEASES OF THE MUSCULOSKELETAL SYSTEM

------------------------------------------------------------------------------------------------------------------------------------

XXVII/1-juvenile chronic arthritis. To 28 days to 28 days



-Other chronic rheumatic Option extension. The possibility of an extension.

diseases of joints and spine.

------------------------------------------------------------------------------------------------------------------------------------

XXVII/2-inherited or acquired for 28 days to 28 days

orthopaedic defects.

The possibility of an extension. The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXVII/3-conditions after injuries and 28 days to 28 days

Orthopedic operations

in the event of motor functions. The possibility of an extension. To 36 months after surgery or injury.

------------------------------------------------------------------------------------------------------------------------------------

XXVII/4-Scoliosis that requires corset to 28 days to 28 days

from the Ib by Cobb, in the continuous

rehabilitation care. The possibility of an extension. The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXVII/5-Osteochondrosis in the stage to 28 days

reparačním.

Morbus Perthes disease in the stage of extension.

reparačním.

-Primary and secondary

Osteoporosis children and

adolescent age.

------------------------------------------------------------------------------------------------------------------------------------

XXVII/6-Morbus Scheuermann. To 28 days



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXVII/7-Vii algický to 28 days to 28 days

syndrome.

The possibility of an extension. When you relapse.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

ARTICLE XXVIII OF THE DISEASES OF THE URINARY SYSTEM

------------------------------------------------------------------------------------------------------------------------------------


XXVIII/1-Recurrent or lingering for 28 days to 28 days

inflammation of the kidneys and urinary tract

paths on the basis of anatomical possibility of extension. In case of confirmed activity process of the disease.

or functional.

------------------------------------------------------------------------------------------------------------------------------------

XXVIII/2-Urolithiasis in situ, to 28 days to 28 days

After the spontaneous departure

konkrementu, eliminating the possibility of an extension. When you relapse.

surgical or endoscopic

along the way, or litotrypsií extension.

extrakorporálními shock

the waves (LERV).

------------------------------------------------------------------------------------------------------------------------------------

XXVIII/3-States after operations to 28 days

the urinary system

outside the urolitiázu. Within 3 months after the operation; When a postoperative

complications within 6 months after the operation.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXVIII/4-chronic diffuse to 28 days to 28 days

Glomerulonephritis.

-Lipoic nephrosis. The possibility of an extension. In the 36 months since the beginning of the base.

-Hereditary nephropathy

at the stage of remission. The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXVIII/5-after a kidney transplant. To 28 days to 28 days



The possibility of an extension. To 36 months post-transplant.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXVIII/6-functional disorders of urination to 28 days to 28 days

(even without the inflammatory causes)

in cases, if there is no possibility of extension. Within 12 months from the beginning of the base.

ongoing outpatient care

effective. The possibility of an extension.

-Children having reached the age of 9

the age of the

the existing regime and

medical measures.

------------------------------------------------------------------------------------------------------------------------------------

XXIX MENTAL DISORDERS

------------------------------------------------------------------------------------------------------------------------------------

XXIX/1-Psychosis in remission. To 28 days to 28 days



In direct follow-up to hospitalization within 24 months from the start of the base.

in inpatient psychiatric ward

or when continuous outpatient care the possibility of extension.

as an alternative to the subsequent bed

psychiatric care after every exacerbation.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXIX/2-neurotic disorders and another to 28 days to 28 days

nepsychotické disorders.

In direct follow-up to hospitalization within 24 months from the start of the base.

in inpatient psychiatric ward

or when continuous outpatient care the possibility of extension.

as an alternative to the subsequent bed

psychiatric care after every exacerbation.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXX SKIN DISEASES

------------------------------------------------------------------------------------------------------------------------------------

XXX/1-Psoriasis vulgaris-chronic for 28 days to 28 days

and recurrent forms.

The possibility of an extension. When the activity of the disease process.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXX/2-chronic and relapsing to 28 days to 28 days

including atopic eczema.

The possibility of an extension. When the activity of the disease process.

-Chronic prurigo.

The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXX/3-Indurativní and konglobující to 28 days to 28 days

forms of acne.

The possibility of an extension. When the activity of the disease process.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXX/4-Scleroderma. To 28 days to 28 days



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXX/5-Ichthyosis. To 28 days to 28 days



The possibility of an extension. The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXX/6-chronic dermatoses. To 28 days to 28 days



The possibility of an extension. When the activity of the disease process.



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXX/7-States after burns and to 28 days to 28 days

After reconstructive surgery

where there is shrinkage of scar tissue. The possibility of an extension. To 36 months after the burn or



The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXXI GYNECOLOGICAL DISEASES

------------------------------------------------------------------------------------------------------------------------------------

XXXI/1-Recurrent inflammatory to 28 days to 28 days

diseases of the external and internal

of the genitals. The possibility of an extension. In the 36 months since the beginning of the base.

-A post-inflammatory change in a small saucepan.

The possibility of an extension.

------------------------------------------------------------------------------------------------------------------------------------

XXXI/2-primary and secondary: to 28 days to 28 days

amenorrhea,

oligomenorrhea and dysmenorrhea, the possibility of extension. In the 36 months since the beginning of the base.

If there is no out-patient care

effective. The possibility of an extension.

-Menstrual Irregularities

cycle when a contraindication

hormonal treatment.

------------------------------------------------------------------------------------------------------------------------------------

XXXI/3 States with postoperative to 28 days to 28 days

complications after operations

(within 3 months after the operation): the possibility of an extension. Within 12 months from the beginning of the base.

-in a small saucepan.

-after other abdominal operations, the possibility of extension.

with the relationship to the landscape of the small pelvis.

-After appendectomii.

------------------------------------------------------------------------------------------------------------------------------------

XXXI/4-hormonal dysfunction after 28 days to 28 days

their pharmacological

ovarian cancer protection when the possibility of an extension. Within 12 months from the beginning of the base.

treatment for genital and

extragenitální tumour extension.

the disease.

------------------------------------------------------------------------------------------------------------------------------------



Selected provisions of the novel



Article II of Act No. 458/2000 Coll.



Transitional provision



Point values and the amount of the reimbursement paid by health care, including the regulatory

the restrictions provided for under the existing legislation, shall apply to the

1. half of the year 2001; If there is no after entry into force of this Act, to the agreement

price according to § 17 para. 5 of Act No. 48/1997 Coll., on public

health insurance and amending and supplementing certain related

laws, as amended by this Act, shall remain in force the prices fixed

for the 1. half of 2001.



Article II of Act No. 176/2002 Sb.



Transitional provision



Request insurance payers about immunity, increases to the premiums

or finance charge, filed an arbitration authority before the entry into force of this

law and arbitration authority pending the entry into force of this Act

the undecided are assessed under this Act.



Article. VII of Act No. 422/2003 Coll.



Transitional provision



For the self-employed person does not consider the person exercising the

the activities of the agent on the basis of mandate contracts concluded under the business

code, if this contract has been concluded before 1 January 2002. January 2004.



Article. XIII of law No. 359/2004 Sb.



TRANSITIONAL PROVISION



1. The provisions concerning the incompatibility of the function of the members of the European Parliament

According to § 53 para. 2 (a). (c)), and (d)) of Act No. 62/2003 Coll., on elections to the

The European Parliament and amending certain acts, will for the first time


members of the European Parliament elected in the first elections to the European

Parliament in 2004.



2. The provisions of sections of the second to eleventh will for the first time on the MEP

The European Parliament elected in the first elections to the European

Parliament in 2004.



Article. VIII of Act No. 435/2004 Coll.



In the list of medicinal products, and foods for special medical purposes

under § 15 para. 5 the first sentence Act No. 48/1997 Coll., on public

health insurance and amending and supplementing certain related

laws, as amended by article. VII, point 1 to this Act, the date of application

the effectiveness of this law written to medicines and food for

Special medical purposes contained to this day in the General

health insurance companies in the Czech Republic. List of medicinal products and

foods for special medical purposes under the first sentence, the Ministry of

Health shall publish the effective date of this Act on its

page on the Internet.



Article II of Act No. 123/2005 Sb.



Transitional provision



Application for inclusion in the list of medicinal products and food for special

medical purposes covered by health insurance, filed to the Ministry of

health services before the date of entry into force of this Act and the Ministry of

health to the entry into force of this Act are undecided

be assessed under this Act.



Article. LXV Act No. 261/2007 Coll.



Transitional provisions



1. the maximum prices established according to current price regulations for

medicines and foods for special medical purposes, that the

the basis of the price regulation issued under this Act shall be subject to the prices

the regulation of the maximum price is valid until the date on which the decision

The Institute on the fixing of maximum prices under this Act. Maximum price

provided for under the previous price laws for medicinal products and

foods for special medical purposes, on the basis of the price

the regulation issued under this Act are not subject to price regulation

the maximum price is valid until the issue of price regulation pursuant to this

the law.



2. the marketing authorisation holder, the manufacturer or importer of a medicinal product, or

foods for special medical purposes shall be obliged to submit an application for

determination of the maximum prices within 90 days of the effective date of this Act,

If the medicines and foods for special medical purposes, by

price regulation issued under this Act shall be subject to the regulation of

the maximum price and the maximum price has not been determined in accordance with the existing

price laws. Remuneration provided for this product or

food for special medical purposes shall cease on the day following the expiry of the 90

days of the effective date of this Act, if not filed within this time limit

the request for the fixing of the maximum price and the amount and conditions of payment.



3. the amount and conditions for reimbursement of medicines and foods for special

the medical purposes set out before the date of entry into force of this Act

According to the existing legislation, the effective date of this Act,

consider the amount and conditions for reimbursement under this Act until the application

the decision of the Institute on the determination of the amount and conditions of payment.



4. the procedure for the fixing of maximum prices for the executor on the date of a final

the effectiveness of this law shall be completed in accordance with existing regulations.



5. the Institute to 180 days from the entry into force of this Act shall initiate the procedure for the

reduction of the maximum prices on medicines and foods for special

medical purposes 31. December 2007 exceeded the limits referred

in § 39a para. 2.



Article. XXII of the Act No. 362/2009 Sb.



Transitional provisions



1. the basic payment reference group established under section 39 c of paragraph 1. 7

Act No. 48/1997 Coll., in the version in force from the date of entry into force of this

the law, to perform the first revision is considered the basic remuneration of the medicinal

medicine or food for special medical purposes, as provided for in

the last administrative action concerning the determination or changing the amount and conditions of payment

before the date of entry into force of this Act, in principle, any

therapeutically interchangeable water a medicinal product or a foodstuff for

Special medical purposes and has not been determined if the basic remuneration, shall be deemed to

for the basic remuneration remuneration determined in accordance with the previous legal

regulations. The basic remuneration under the first sentence in the first

revision, but not longer than for a period of 365 days from the date of entry into force of

This law, reduced by 7%.



2. On the date of entry into force of this Act shall set out the maximum prices and

the amount of the payment of all medicines and foods for special medical

the purpose of reducing the transposition of the first revision of their payments, but not longer than

for a period of 365 days from the date of entry into force of this law, by 7%. It

does not apply to the reimbursement of medicines and foods for special medical

the purpose of which has been established and the terms of payment under section 39b to 39 h

This law or for which a change was made to the above terms and conditions of payment

pursuant to section 39i of paragraph 1. 2 or § 39 l of Act No. 48/1997 Coll., as amended effective

before the date of entry into force of this Act. The request for an increase in the maximum

prices may be made in the period referred to in the first sentence.



3. On the date of entry into force of this Act shall be reported by the highest price

medicines and foods for special medical purposes covered by

public health insurance, which are not subject to price regulation price

the manufacturer, reduce to the implementation of the first revision of their payments, but not longer

than for a period of 365 days from the date of entry into force of this law, by 7%,

where holders of registration with authorised medicinal products and

domestic producers or importers of unregistered medicinal products or

foods for special medical purposes, these medicinal products or

foods for special medical purposes during this period, the placing on the market

not more than these reduced prices.



4. On the date of entry into force of this Act, the State Institute for the control of

medicinal products shall be published by the prices and level of remuneration adjusted in accordance with points 2 and 3 in the list of

medicines and foods for special medical purposes covered by the

health insurance.



5. In exceptional cases, the marketing authorisation holder

medicinal product may apply for exemption from the reduction of the prices referred to in point 2 or

3. the application must contain sufficient justification and in the proceedings on the application for

an exception to the price reduction of the State Institute for drug control procedure referred to in

the provisions of Act No. 48/1997 Coll., in the version in force from the date of acquisition

the effectiveness of this law, governing the fixing of maximum prices

that an exception granted only if the price of the medicinal product decreased by

section 2 or 3 is the lowest of the prices for such medicinal product detected

in the Member States of the European Union, pursuant to section 39 c of Act No. 48/1997 Coll., on

the version in force from the date of entry into force of this law, medicine

It is necessary to ensure the availability of effective and safe health care

paid for by public health insurance and cannot reasonably be

require that the medicinal product is made available on the Czech market at reduced

the price. Exemptions granted the State Institute for drug control will publish

without delay.



Article. (II) Act No. 298/2011 Sb.



Transitional provisions



1. The legal relations arising from the written agreement contained in

the public interest pursuant to 48/1997 Coll., in the version in force before the date of application

the effectiveness of this law, the health insurance company and holder of the

registration, the manufacturer or importer does not apply to section 39 c of paragraph 1. 2 (a). (c))

Act No. 48/1997 Coll., in the version in force from the date of entry into force of this

the law.



2. the amount of compensation provided for by the decision of the State of the medicinal product

Institute for drug control (hereinafter referred to as "the Institute") in accordance with Act No. 48/1997

Coll., in the version in force from the date of entry into force of this Act,

considers the level of remuneration of the medicinal product as laid down by law No.

48/1997 Coll., in the version in force until the date of entry into force of this Act,

reduced by the maximum amount of trade margins and on the applied tax

the added value. The amount of the basic remuneration reference group established

the Institute's decision pursuant to Act No. 48/1997 Coll., in the version in force from

the effective date of this Act, is deemed to be the amount of the basic remuneration

established by decision of the Institute by Act No. 48/1997 Coll., as amended by

effective from 1 January 2006. January 2008 to the date of entry into force of this Act,

reduced by the maximum amount of trade margins and on the applied tax

the added value. If the basic remuneration established according to the second sentence,

then the Institute lays down the procedure under section 39 c of paragraph 1. 2 to 5 of law No.

48/1997 Coll., in the version in force from the date of entry into force of this Act.



3. the Department within 60 days from the date of entry into force of this Act shall initiate procedures

to reject reimbursement for medicinal products and foods for particular

medical purposes that are written on the basis of Act No. 261/2007 Coll.

stabilization of public budgets, in the list referred to in paragraph 1(b). paragraph 39n 1 of the law

No. 48/1997 Coll., in the version in force until the date of entry into force of this Act,

and are marked with the symbol B, H, K, T, and U, in order to verify the conditions of the

laid down by section 15 para. 6 of Act No. 48/1997 Coll., in the version in force from the date of


entry into force of this Act. If the Department finds that the reasons for maintaining

the remuneration paid to the management stops and shall forthwith initiate the procedure for the change of the amount and

the terms of payment. In the case of refusal of payment remains the maximum price

medicinal product or foods for special medical purposes in

the validity of.



4. the Institute within 60 days from the date of entry into force of this Act shall initiate procedures

to reject reimbursement for medicinal products and foods for particular

medical purposes, incorporating medicinal substances within the scope of

the annex to Decree No 385/2007 Coll., on the establishment of the list of medicinal substances

for additional support or treatment, in the version in force until the date of

entry into force of this Act, for the purpose of verification of the conditions laid down in §

15 paragraph 1. 6 (a). and Act No. 48)/1997 Coll., in the version in force from the date of

entry into force of this Act. If the control has been demonstrated that the

This is not about medicines to support or additional treatment, Institute of

control stops.



5. the proceedings initiated pursuant to Act No. 48/1997 Coll., in the version in force until the date of

entry into force of this Act, the procedure shall be completed according to the existing

legislation; It does not apply to section 39 g of paragraph 1. 3 and 8, section 39 h of paragraph 1. 2 and 3,

§ 39n and 39o Act No. 48/1997 Coll., in the version in force from the date of acquisition

the effectiveness of this Act.



6. the Institute to 120 days from the date of entry into force of this Act, it shall initiate the

the procedure for the reduction of the maximum prices on medicines and food for

Special medical purposes on the date of entry into force of this Act

exceeded the limitations referred to in § 39a para. 2 of Act No. 48/1997 Coll., on

the version in force from the date of entry into force of this Act.



7. the proceedings initiated pursuant to section 39i and 39 l of Act No. 48/1997 Coll., as amended by

effective until the date of entry into force of this law, the Institute by resolution stops,

If



and assumptions are true) to begin the shortened revision under section 39p

Act No. 48/1997 Coll., in the version in force from the date of entry into force of this

of the Act, and



(b)) if within a period of 30 days from the date of entry into force of this Act

a decision in the case. The day following the legal force

the resolution in the first sentence, the Institute will initiate proceedings under § 39p of the law No.

48/1997 Coll., in the version in force from the date of entry into force of this Act.



8. If the proceedings referred to in point 8, stopped, set out above, remittance of medicinal

medicines and foods for special medical purposes shall be construed as

the highest possible remuneration for the final consumer in accordance with section 39 h of paragraph 1. 1

Act No. 48/1997 Coll., in the version in force from the date of entry into force of this

the law.



9. The appeal against the decision in deep or shortened revision,

the decision on the fixing of maximum prices or decisions fixing the amount of

and conditions of remuneration, as well as their modification or cancellation, and against

the decision in the review issued before the date of entry into force of

This Act have suspensory effect. This decision shall be enforceable

According to the existing legislation.



10. the procedure for price competition under section 39e of Act No. 48/1997 Coll., as amended by

effective until the date of entry into force of this Act, the date of acquisition of the executor

the effectiveness of this law, the Institute by order of stops. Liabilities from price

competition completed under section 39e of Act No. 48/1997 Coll., in the version in force in

the effective date of this Act, apply under Act No. 48/1997 Coll.,

in the version in force until the date of entry into force of this Act, if the

based on the result of this price competition set the basic remuneration

reference group.



11. the Institute to 15. January 2012 will launch proceedings on the cancellation of the payment of the medicinal

products and foods for special medical purposes, of which the price for

the final consumer is less than or equal to $ 50.



Article. (II) Act No. 369/2011 Sb.



Transitional provisions



1. Change to the health insurance company to 1. day of the calendar quarter can be

the effective date of this Act, only if, before the

the effective date of this Act, the request for a change

health insurance company to 1. day of the calendar quarter following the

date of submission of the application.



2. When providing health care under § 15 para. 3 of Act No. 48/1997

Coll., which began before the date of entry into force of this Act,

procedure referred to in article 15, paragraph 2. 3 of Act No. 48/1997 Coll., as amended effective

from the date of entry into force of this Act, if the conditions are met in the

It laid down.



3. the date of entry into force of this Act has not yet valid and effective payment of the

those medicinal products that may be issued without a

Regulation shall be abolished. Control to reject the payment to these medicinal products

not, and if it is kept, the effective date of this Act shall be

such proceedings be terminated.



4. the procedure for cancellation of the payment of the medicines and foods for special

medical purposes, of which the price for the final consumer is less than or

equal to 50 CZK, does not, and if it is kept, the effective date of this

the Act such proceedings be terminated.



Article. ARTICLE XXVIII of the Act No. 458/2011 Sb.



Transitional provisions



1. the amount and terms of payment of those medicinal products which can be

to be issued without a prescription, shall expire on 30 April 2005. June 2012 for

those medicinal products, for which the Institute into a 1. June 2012 does not receive

the request from all health insurance companies for reimbursement when you

the provision of outpatient health services in the public interest. The procedure for

determination, alteration, cancellation or refusal of payment of these medicinal

products, does not, and if conducted, on the date of termination of payment of such

proceedings terminated.



2. the procedure for cancellation of the payment of the medicines and foods for special

medical purposes, of which the price for the final consumer is less than or

equal to 50 CZK, does not, and if conducted, on the date of termination of payment of such

proceedings terminated.



Article. VI of Act No. 44/Sb.



Transitional provision



If it was before the date of entry into force of this Act, has embarked on one of the

processes or activities referred to in section 35 of Act No. 48/1997 Coll., as amended by

effective before the date of entry into force of this Act, it shall pay, as well as

all of the other provisions referred to in this activity and how to apply

This started a transplant even if they were initiated or completed

After the effective date of this Act, the health insurance fund referred to in section

35A of the Act No. 48/1997 Coll., in the version in force before the date of entry into force of

of this Act.



Article. (II) Act No. 256/2014 Sb.



Transitional provisions



1. the health insurance fund is required to pay to the insured person during the period prior to the

the effective date of this Act, the amount exceeding the limit for

regulatory fees and charges for prescribed medicines partially paid

medicines and foods for special medical purposes pursuant to section 16b, para.

2 of Act No. 48/1997 Coll., in the version in force before the date of entry into force of

of this Act.



2. the administrative procedure for recovering the amounts under section 16b of the Act No. 48/1997 Coll.,

in the version in force before the date of entry into force of this Act, initiated

the design of the insured person before the date of entry into force of this law shall be completed

According to § 53 para. 1 of Act No. 48/1997 Coll., in the version in force before the date of

entry into force of this Act.



3. in the proceedings for the payment of amounts in excess of the limit for regulatory fees

and supplements for prescribed medicines partially paid or

foods for special medical purposes under section 16b of the Act No. 48/1997

Coll., in the version in force before the date of entry into force of this law, for the

the period before the date of entry into force of this Act brought in disputed

cases on the proposal of the insured person after the date of entry into force of this Act,

proceed according to § 53 para. 1 of Act No. 48/1997 Coll., as amended effective

before the date of entry into force of this Act.



Article. (II) Act No. 1/2015 Sb.



Transitional provisions



1. Spa sanatorium rehabilitation care, in which the provision was

exposed to the proposal before the date of entry into force of this Act, shall be granted

pursuant to Decree No 267/2009 Coll., on the establishment of the indicator list for the

Spa sanatorium rehabilitation care for adults, children and adolescents, as amended by

effective 31 December 1998. December 2014.



2. Therapeutic stay made pursuant to Decree No 267/2012 Coll. as

the base is considered a basic therapeutic stay pursuant to Act No. 48/1997

Coll., in the version in force from the date of entry into force of this Act.



3. Therapeutic stay made pursuant to Decree No 267/2012 Coll. as

recurring is considered to be recurring therapeutic stay under Act No.

48/1997 Coll., in the version in force from the date of entry into force of this Act.



4. If the insured person has carried out the most curative stay in period 1. October

2009 to 30. September 2012, it will be considered a curative stay in basic

curative stay pursuant to Act No. 48/1997 Coll., in the version in force from the date of

entry into force of this Act.



5. The Spa sanatorium rehabilitation care, in which the provision was

exposed to the draft in the period from 1. January 2015 until the date of entry into force of this

the law, and that has been provided to the insured person for the first time, the indication

considered the basic therapeutic stay pursuant to Act No. 48/1997 Coll., on

the version in force from the date of entry into force of this Act.




6. Spa sanatorium rehabilitation care, in which the provision was

exposed to the draft in the period from 1. January 2015 until the date of entry into force of this

law and which corresponds to the indication on the basis of previously

curative stay took place, the insured person shall be deemed a recurring therapeutic

stay under Act No. 48/1997 Coll., in the version in force from the date of acquisition

the effectiveness of this Act.



Article. (II) Act No. 200/2015 Sb.



Transitional provisions



1. The contract pursuant to § 17 para. 1 and § 17 para. 7 (b). d) of Act No. 48/1997

Coll., in the version in force from the date of entry into force of this Act, including the

changes and additions, which shows the amount of the payment of health insurance companies

the providers of health services under the health services paid

public health insurance or the scope of these services, which are

effective on the date of entry into force of this law, shall be published by the health

the insurance company no later than 6 months from the date of entry into force of this

the law.



2. the contract referred to in § 17 paragraph 2. 1 and § 17 para. 7 (b). d) of Act No. 48/1997

Coll., in the version in force from the date of entry into force of this Act, including the

changes and additions, which shows the amount of the payment of health insurance companies

the providers of health services under the health services paid

public health insurance or the scope of these services, which have been

concluded before the date of entry into force of this Act and to

effective after the date of entry into force of this law, shall be published by the health

the insurance company no later than 6 months from the date of entry into force of this

the law; This agreement shall become effective on the date specified in them.



3. Health insurance companies are required to disclose whether or not the contract pursuant to § 17

paragraph. 1 and § 17 para. 7 (b). d) of Act No. 48/1997 Coll., as amended effective

from the date of entry into force of this Act, including any amendments and additions, from the

showing the amount of payment of health insurance providers

health services for the health care services covered by the public

health insurance or the scope of these services, which have been concluded in

2014 and 2015 and expired before the date of entry into force of this

of the Act, no later than 12 months from the date of entry into force of this Act.



4. the Institute of health information and statistics of the United Kingdom passes the

The Ministry of health for the first time, current data and methodologies in accordance with section 41a

paragraph. 1 of Act No. 48/1997 Coll., as amended by this Act, for the calendar

the year following the year in which this law came into effect.



5. Until such time as the Ministry of health for the first time will receive current information

and methodology pursuant to § 41 para. 1 of Act No. 48/1997 Coll., as amended by this

the law, the Ministry of Health publishes a list of groups

in acute care hospitalizations related to diagnosis, their

the relative cost, marshaling rules of admissions to these

groups and methodologies for reporting provided covered services in acute

inpatient care, which is available on its Web site.



6. the general health insurance company in the Czech Republic and departmental, sectoral,

corporate and other health insurance companies follow the section 41a of paragraph 1. 3

Act No. 48/1997 Coll., as amended by this Act, from the date of establishment of the

The national registry of covered services.



7. Contract and payment of covered services, including their changes

and additions concerning the extent of covered services, concluded prior to

the effective date of this Act, not later than 5 years from the date of

entry into force of this law shall be in accordance with section 17 para. 1 of the law

No. 48/1997 Coll., in the version in force from the date of entry into force of this

the law.



1) Council Directive 89/105/EEC of 21 December 1988 December 1988 relating to the transparency

the measures regulating the pricing of medicinal products and

their inclusion in the scope of national systems

health insurance.



Directive of the European Parliament and of the Council of 2011/24/EU of 9 June. March 2011

on the application of patients ' rights in cross-border healthcare.



The implementing Commission directive 2012/52/EU of 20. December 2012

down measures to facilitate the recognition of prescriptions

issued in another Member State.



1A) of section 6 of Act No. 586/1992 Coll., on income taxes, as amended

regulations.



1B) Directive No. 89/105/EEC relating to the transparency of measures regulating the formation of

prices for medicines for human use and their inclusion in the area

the scope of national health insurance systems.



1 c) section 3 of the Act No. 219/2000 Coll., on the Czech Republic and its assets

in legal relations.



1 d) Law No 249/1997 Coll., on agriculture, as amended.



2) Act No 455/1991 Coll., on trades (trade licensing

Act), as amended.



3) Eg. Act No. 85/1996 Coll., on the legal profession, law No. 359/1992

Coll., on notaries and their activities (notarial regulations), law No. 524/1992

Coll. on Auditors and Chamber of Auditors of the Czech Republic, Act No.

523/1992 Coll., on income tax advice and the Chamber of tax advisors of the Czech

Republic Act No. 36/1967 Coll. on experts and interpreters, law No.

237/1991 Coll., on patent agents, law No. 360/1992 Coll., on the

the profession of authorised architects and on the exercise of the profession of

Chartered Engineers and technicians active in construction, as amended by

amended.



4) Eg. Act No. 35/1965 Coll., on literary, scientific and

works (the Copyright Act), as amended.



4A) § 7 para. 8 and § 36 odst. 2 (a). e) of Act No. 586/1992 Coll., on

as amended.



5) section 76 et seq.. and § 93 et seq.. Act No. 513/1991 Coll., the commercial

code.



6) § 7 para. 2 (a). (b)) of Act No. 586/1992 Coll., on income taxes.



§ 6a) 566-575 of the commercial code.



7) Act No. 117/1995 Coll., on State social assistance, as amended by Act No.

137/1996 Coll.



8) § 32 and subs. Act No. 187/2006 Coll., on sickness insurance.



9) § 7 para. 1 and § 17 para. 7 of Act No. 1/1991 Coll., on employment, in the

as amended.



10) Law No 111/2006 Coll. on assistance in material need.



11) section 8 of Act No. 108/2006 Coll., on social services.



12 section 1 of the Decree of the Ministry) labour and Social Affairs No. 283/1995 Coll.



12A) § 80 (b). (b)), and (c)) Act No. 100/1988 Coll., on social

security, as amended by Act No. 133/1997.



14) § 4 of law No. 187/2006 Sb.



15) § 2 (2). 1 (b). (b)) Government Regulation No. 303/1995 Coll., on minimum

rates of pay.



16) § 31 para. 1 of law No 117/1995 Sb.



16A) Act No. 222/2003 Coll., on temporary protection of foreigners.



16B) Act No. 325/1999 Coll., on asylum and on the amendment of Act No. 283/1991 Coll., on the

Police of the Czech Republic, as amended, (asylum Act),

in the wording of later regulations.



16 c) § 47i Act No. 359/1999 Coll. on social and legal protection of children, in

as amended.



16 d) § 40a of the Act No. 117/1995.



17) Act No. 586/1992 Coll., on premiums for general health

insurance, as amended.



17B) § 2 (2). 1 (b). d) of Act No. 570/1991 Coll., of the commercial

offices, as amended by Act No 215/2006 Sb.



18) section 27 of Act No. 586/1992 Coll., as amended by Act No. 15/1993.



18A) § 45a para. 6 of Act No. 455/1991 Coll., on trades

(Trade Act), as amended by Act No 215/2006 Sb.



19) § 7 para. 1 of the law No. 280/1992 Coll., on departmental, disciplinary,

corporate and other health insurance companies, as amended by Act No.

149/1996 Coll.



19a) article 3 of the European Parliament and Council Regulation (EC) No 141/2000 of the

16 December 2002. December 1999 on orphan medicinal products.



20) Decree of the Minister of Foreign Affairs No. 143/1988 Coll., on the Convention on

Racing health services (No. 161).



Act No. 20/1966 Coll., on the health care of the people, as amended

regulations.



21) § 39 para. 2 of Act No. 20/1966 Coll., as amended by Act No. 548/1991

SB.



22A) § 16 para. 2 and 3 of Act No. 222/1999 Coll., on the scope of military

obligations and on military administrative offices (military law).



22B) section 166 of the Act No. 221/1999 Coll., on the soldiers of the occupation.



22 c) § 21 para. 2 of the Act No. 435/2004 Coll.



23A) Law No 289/2002 Coll., on donation and transplantation subscriptions

tissues and organs and on amendments to certain acts (the transplant law).



23B) Decree No. 23/2001 Coll., laying down the types of foods intended

for particular nutritional uses and how to use them.



23B) thatweshouldalsomentionatleastbriefly. 20 Act No. 20/1966 Coll., as amended by Act No. 422/2004

SB.



23 c) of section 10 of Act No. 526/1990 Coll., on prices, as amended by the Act No. 261/2007

SB.



24) Act No. 526/1990 Coll., on prices, as amended by Act No. 135/1994 Coll.



25) CZECH REPUBLIC Ministry of health Decree No. 256/1992 Coll., which

the list of medical procedures with point values, as

amended.



27) CZECH REPUBLIC Ministry of health Decree No. 434/1992 Coll., on the

emergency medical service, as amended.



27A) Decree No. 134/1998 Coll. issuing the list of health

performances with spot values, as amended.



27 c) § 1 and 2 of Act No. 245/2000 Coll., on public holidays, on the other


holidays, on significant days and days of rest, as amended by

amended.



27 d) in section 38 of Act No. 20/1966 Coll., on the health care of the people, as amended by

amended.



27 e) Act No. 109/2002 Coll. on the execution of institutional care or protective

education in school facilities and on preventive educational care in

school facilities and amending other laws, as amended

regulations.



27F) Act No. 258/2000 Coll., on the protection of public health and amending

some related laws, as amended.



27 g) Law No 111/2006 Coll. on assistance in material need, as amended by

amended.



27 h) of section 48 of Act No. 108/2006 Sb.



27i) section 42 of Act No. 359/1999 Coll. on social and legal protection of children, in

as amended.



27J) section 24 of Act No. 20/1966 Coll., as amended.



27 k) section 191a to 191g of the Act No. 99/1963 Coll., the code of civil procedure, in

as amended.



27l) Law No 289/2002 Coll., on donation and transplantation subscriptions

tissues and organs and on amendments to certain acts (the transplant)

as amended.



27 m) section 48 to 50 and 52 of Act No. 108/2006 Sb.



27n) § 71 para. 4 and § 73 para. 3 of Act No. 108/2006 Coll., as amended by

Act No. 261/2007 Coll.



28) Law No. 280/1992 Coll., as amended.



28A) Law No 96/2004 Coll., on conditions for the acquisition and recognition

competence for the exercise of paramedical professions and to the exercise

activities related to the provision of health care and amending

certain related laws (the law on the paramedical

occupations), as amended by Act No. 127/2005 Coll.



29) section 53 of Act No. 20/1966 Coll., as amended by Act No. 548/1991.



Decree of the Ministry of health no. 77/1981 Coll. on

health care workers and other professional workers in

the health sector.



30) section 73b of Act No. 100/1988 Coll. on social security, as amended by

Act No. 308/1993 Coll.



31) for example. Decree of the Ministry of health no. 91/1984 Coll., on

measures against communicable diseases, as amended by Decree No 204/1988 Coll.



32) § 23 para. 3 and 4 of Act No. 20/1966 Coll., as amended by Act No.

548/1991.



33) section 73b and 93a of the Act No. 100/1988 Coll. as amended by Act No. 308/1993 Coll.

Decree of the Ministry of labour and Social Affairs No. 310/1993 Coll. on the payment order

for the provision of social care in health facilities.



34) title III, part 1, Act No. 258/2000 Coll., on the protection of public health

and amending certain related laws.



36) Act No. 20/1966 Coll., as amended. Decree

The Ministry of health of the CZECH REPUBLIC No. 61/1990 Coll. on the management of medicines and

healthcare needs, as amended by Decree No 427/1992 Sb.



§ 8 paragraph 37). 7 of the Decree of the Ministry of health of the CZECH REPUBLIC No. 61/1990 Coll.

as amended by Decree No 427/1992 Sb.



38) § 12, 13 and 14 of the directives of the Ministry of health no. 49/1967, P. 1.

MZ on the assessment of medical fitness to work, as amended by directives no.

17/1970 p. MZ CZECHOSLOVAKIA, Reg. 2/1968 Coll. and the amount 20/1970 Sb.



39) section 11, 12, 13 and 14 of the directives of the Ministry of health no. 49/1967

MZ., as amended by directives No 17/1970 p. MZ CZECHOSLOVAKIA, Reg. 2/1968

Coll. and the amount 20/1970 Sb.



40) § 12 para. 8 directives of Ministry of health No 49/1967, P. 1.

MZ, as amended by directives No 17/1970 p. MZ CZECHOSLOVAKIA, Reg. 2/1968 Coll. and

the amount of the Sb 20/1970.



42A) Decree No. 288/2004 Coll., laying down the details of the

authorisation of medicinal products, changes, renewals, classification

medicinal products for the issue, transfer, registration, issuing permits for

parallel imports, presenting and designing specific treatment

programs with the use of unregistered medicinal products for

How to report and evaluate the adverse effects of the

of the product, including the requirements of the psur

security, and the type and scope of the notice of the use of an unauthorised

of the medicinal product (Registration Ordinance on medicinal products).



42B) Act No. 79/1997 Coll., as amended.



42 c) Act No. 137/2006 Coll., on public procurement, as amended

regulations.



42D) § 17 of the Act No. 513/1991 Coll., the commercial code, as amended

regulations.



42E) Act No. 500/2004 Coll., the administrative code, as amended by law no 413/2005

SB.



42f), for example, section 8 of Act No. 553/1991 Coll. on general health

the insurance company of the Czech Republic, as amended.



43) Act No. 553/1991 Coll., on the Czech General health insurance company

Republic, as amended.



44) Law No. 280/1992 Coll., as amended.



44a) Law No 378/2007 Coll., on pharmaceuticals and on changes of some

related laws (law on medicinal products), as amended.



45) Appendix III (1). 3 Decree of the Czech Office of work safety and

The Czech Mining Authority no 110/1975 Coll., on registration and registration

work-related accidents and reports of traffic accidents (accidents) and disorders

technical equipment, as amended by Decree No. 274/1990 Coll.



46) Appendix. (I) Decree of the Czech Office of work safety and the Czech

Mining Authority no 110/1975 Coll., as amended by Decree No. 274/1990 Coll.



46A) Law No 245/2006 Coll., on public nonprofit constitutional

medical devices and amending certain laws.



46A) Act No. 169/1999 Coll., on the imprisonment and amending

some related laws, as amended.



47) Act No. 71/1967 Coll., on administrative proceedings (administrative code).



47) Act No. 500/2004 Coll., the administrative code, as amended.



47A) Act No. 99/1963 Coll., the civil procedure code, as amended

regulations.



47B) Act No. 182/2006 Coll., on bankruptcy and the ways of its solution

(insolvency law), as amended.



49) § 2a para. 1 of law No 266/1991 Coll., on the scope of the authorities of the United

States in the field of prices, as amended.



for example, 49) European Parliament and Council Regulation (EC) No 883/2004 on the

coordination of social security systems, as amended by regulation of the European

Parliament and of the Council (EC) no 988/2009 and Commission Regulation (EU) No 1244/2010,

European Parliament and Council Regulation (EC) no 987/2009

down detailed rules for the application of Regulation (EC) No 883/2004 on the coordination

of social security systems, as amended by Commission Regulation (EU) No.

1244/2010, the European Parliament and of the Council Regulation (EU) no 1231/2010,

extending the provisions of Regulation (EC) No 883/2004 and Regulation (EC)

No 987/2009 to nationals of third countries, to which this

not already covered by regulation only because of their nationality and

European Parliament and Council Regulation (EU) No 492/2007 of 5 June. April

2011 on free movement of workers within the Union.



51) European Parliament and Council Regulation (EC) No 883/2004 of 29 April 2004.

April 2004 on the coordination of social security systems, as

the text of the.



European Parliament and Council Regulation (EC) no 987/2009 of 16 January 1996. September

2009 laying down detailed rules for the application of Regulation (EC) No 883/2004

on the coordination of social security systems, as amended.



The European Parliament and of the Council Regulation (EU) no 1231/2010 of 24.

November 2010, extending the provisions of Regulation (EC) No 883/2004

and Regulation (EC) no 987/2009 to nationals of third countries on the

which are not already covered by this regulation only by reason of their State

jurisdiction.



52) article 20 of the European Parliament and Council Regulation (EC) No 883/2004 of the

29 April 2004. April 2004 on the coordination of social security systems, in

as amended.



53) Law No. 372/2007 Coll., on health services and conditions of their

provision (law on health services), as amended

regulations.



54) Act No. 109/2002 Coll. on the execution of institutional care or protective

education in school facilities and on preventive educational care in

school facilities and amending other laws, as amended

regulations.



55) section 48 of Act No. 108/2006 Sb.



56) section 42 of Act No. 359/1999 Coll. on social and legal protection of children, in

as amended.



57) Law No 513/91 Coll., the civil code.



58) section 48 to 50 and § 52 of Act No. 108/2006 Sb.



59) § 71 para. 4 and § 73 para. 3 of Act No. 108/2006 Sb.



60) § 23 para. 3 of the law on health services.



61) section 27 of the Act on health services.